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ABSTRACT 
 
Part 1: Monitoring Response to Single-Dose (1000cGy) Radiotherapy in a 
RIF-1 Tumor Model 
The current standard of measure for monitoring chemotherapeutic and radiotherapeutic 
treatment response is tumor volume.  Unfortunately, changes in tumor volume are 
generally slow and tumor volume does not necessarily indicate the degree of tumor 
viability.  The development of marker(s) with the ability to detect an early therapeutic 
response would greatly aid in patient management, opening the possibility for both rapid 
dose optimization and replacement of ineffective therapies with alternative treatment.  
Previous studies have shown that diffusion measurements using magnetic resonance 
imaging (MRI) techniques are sensitive to therapy-induced changes in cellular structure, 
allowing demarcation between regions of necrosis and viable tumor tissue.  This 
sensitivity, based on the correlation between water apparent diffusion coefficient (ADC) 
values and tumor cellular density, may allow diffusion measurements to be employed in 
non-invasive monitoring of treatment response.  Therapy-induced increases in tumor 
ADC preceding tumor regression have been reported in a variety of experimental tumor 
models and several human brain tumors.  Despite the demonstrated diffusion sensitivity 
to therapeutic response in these particular studies, shortcomings still remain that hinder 
the efficacy of clinical application in oncology.  Earlier studies have concentrated on the 
mean ADC present within the tumor, either within the entire tumor volume or a region-
of-interest (ROI) defined by the user, and their evolution pre-treatment and post-
treatment.  Because of inter- and intra-tumor heterogeneity, volume-averaged ADC 
measurements suffer from poor correlation with treatment efficacy.  In addition, most 
studies make little or no attempt to characterize the entire tumor volume (necrotic, viable, 
edema).  The identification of regions of differing tissue viability should aid in the 
staging of treatment, therefore making accurate and reproducible tissue segmentation an 
important goal.   
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The results of earlier, single-parameter studies indicate that a multi-parametric approach 
in which several MR parameters are monitored (ADC, T2, M0) may provide greater 
power than that of the single parameter approach.  A multi-parametric or multi-spectral 
(MS) analysis uses pattern-recognition techniques, such as clustering, for image 
segmentation.  Clustering algorithms use characteristics of the multiple MR-parameter 
dataset to group tissue of similar type, e.g., fat, muscle, viable tumor, necrosis.  
Specifically, k-means (KM) is an unsupervised segmentation algorithm that groups 
together similar tissue based on the difference in MR parameter space between the image 
voxel of interest and the mean parameter values of the voxels in that cluster.  In the first 
step of the classification algorithm, it is applied to separate the data into two clusters (k = 
2), tissue and background noise voxels.  All voxels classified as background noise are set 
to zero and removed from further processing.  In the second step, KM is applied to the 
remaining tissue voxels to segment the data into multiple tissue types.  In the case of 
tumors, it is not clear in advance how many different types of tissue exist.  The number of 
clusters, k, should be varied to ensure that all relationships between tissues are found.  In 
the final step, the resulting KM maps may be compared to histological slices taken from 
the same tissue as the imaging slices in order to identify the tissue type of each cluster.   
 
In line with the studies and analyses described above, quantitative MRI was performed to 
investigate the spatial correlation between ADC, spin-spin (T2) relaxation times, and 
proton density (M0) in murine radiation-induced fibrosarcoma (RIF-1) tumors following 
single-dose (1000cGy) radiotherapy using the KM algorithm (Chapters 3 and 4) and 
different combinations of features and/or clusters.  For all cluster/feature combinations, 
an in-depth comparison between KM-derived volume estimates and conventional 
histology via the hematoxylin-eosin (H&E) staining procedure (for identification of 
viable tumor versus necrosis), as well as via hypoxic-inducible factor-1α (HIF-1α) 
immunohistochemistry (for identification of regions of hypoxia versus well-oxygenated 
tissue) was performed (Chapter 3).  The optimal cluster/feature combination was 
determined by minimizing the sum-of-squared-differences (SSD) between the actual 
datapoints and the ideal one-to-one correlation that should exist between KM-derived 
volume estimates and histology-derived volume estimates.  The optimal cluster/feature 
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combination was determined to be a 2-feature (ADC, T2) and 4-cluster (2 regions each of 
viable tissue and necrosis) segmentation. This KM method was then applied in analysis 
of the radiotherapeutic response: first, to gain insight into the various processes whose 
combination yield the total ADC response over time; second, to identify the contribution 
of tissue heterogeneity to the treatment response and changes in tumor growth kinetics 
and cell kill (Chapter 4).  Comparisons between control and various time-points out to 14 
days post-radiotherapy permitted more accurate tissue characterization and prediction of 
therapeutic outcome over analysis using ADC alone.   
 
The results based on histological validation demonstrated: (1) MS analysis provides an 
improved tissue segmentation method over results obtained from conventional methods 
employing ADC alone; (2) MS analysis permits subdivision based on the degree of 
necrosis, as well as delineation between well-oxygenated and hypoxic viable tissue; and 
(3) Individual KM volumes corresponded well with both H&E volumes and regions with 
increased HIF-1α expression.  The results based on the radiotherapeutic response 
demonstrated: (1) MS analysis provides a method for monitoring the range of tissue 
viability as a function of time post-treatment; (2) MS analysis permits assessment of the 
various contributions to the total ADC response post-treatment; (3) The relative fractions 
of well-oxygenated (i.e., radiosensitive) versus hypoxic (i.e., radioresistant) tissue pre-
treatment may be predictive of treatment response; and (4) The early ADC increase did 
not seem to be a result of radiation-induced vasogenic edema, but instead was most likely 
due to a slight reduction in cellular density following therapy.  These studies provide a 
non-invasive method of tissue characterization that may be used in monitoring treatment 
response and optimizing drug dose-timing schemes, with the potential for predicting 
treatment efficacy.  
 
Part 2: Role of Spreading Depression in Ischemic Stroke 
Stroke is a prevalent disease that ranks as the 3rd leading cause of death and disability in 
the United States, according to NIH statistics, costing millions of dollars in medical costs 
and lost wages.  At present, the mechanism by which focal ischemia evolves into 
infarction remains poorly understood.  By determining the patho-physiological 
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mechanisms involved in the evolution of focal brain ischemia, therapeutic strategies may 
be designed for instances of acute ischemic stroke.  In the late 1980s, researchers 
discovered MRI techniques that allow the detection of stroke very early after onset.  Such 
techniques as diffusion-weighted imaging and perfusion-weighted imaging (DWI and 
PWI) have been applied both clinically and experimentally.  Previous studies employing 
these techniques suggest that cortical spreading depression plays a detrimental role in the 
evolution of focal brain ischemia.  Spreading depression (SD) is characterized by a 
spontaneous and reversible depression of cortical electrical activity that spreads from the 
site of onset as a wave with a speed of 2-5 mm/min.  It is accompanied by an ionic 
redistribution, with efflux of potassium ions (K+) and influx of sodium, chloride, and 
calcium (Na+, Cl-, Ca2+) ions, as well as water.  This results in cellular swelling and a 
decreased extracellular space (ES), yielding a decline in ADC.  A positive correlation 
between the number of both spontaneous and induced SDs and infarct volume has well 
been documented, supporting the idea that SD inhibition might be neuroprotective if 
initiated early after ischemic onset.   
 
Even though these studies show promise in their ability to track SD using diffusion 
mapping, changes in ADCs reflect cytotoxic edema and do not necessarily correspond to 
SD or SD-like depolarizations or calcium (Ca2+) influx, leading to cell death.  Recent 
studies have reported the use of manganese ions (Mn2+) as a depolarization-dependent 
contrast agent in monitoring brain activation through the application of glutamate, as well 
as in the study focal ischemia.  Since extracellular accumulation of potassium (K+) ions 
or glutamate in ischemic tissue is believed to play a central role in the initiation and 
propagation of SDs, and knowing that Mn2+, having an ionic radius similar to that of 
Ca2+, is handled in a manner similar to Ca2+, these studies suggest the possible use of 
manganese ions (Mn2+) in tracking SD or SD-like depolarizations in the evolution of 
focal brain ischemia. 
 
In order to determine the utility of Mn2+ as a marker for SD, two sets of T1-weighted MRI 
experiments were performed before applying Mn2+ in an experimental stroke model 
(Chapter 6).   First, for verification purposes, a glutamate administration group was 
 x
evaluated to validate our use of the manganese-enhanced MRI (MEMRI) method 
previously developed by Aoki et al, a modification of the original by Lin and Koretsky.   
When satisfied that the contrast enhancement was specific to glutamate only, a second set 
of experiments was performed.  Here, experimental SD was elicited by chemical 
stimulation (direct application of concentrated potassium chloride [KCl] on the exposed 
cortical surface) and compared with control conditions (perfusion of sodium chloride 
[NaCl] on exposed brain cortex).  This study demonstrated: (1) Mn2+, specific to Ca2+ 
channel activity, is a more accurate marker for SD than DWI or T2* methods; (2) Cortical 
restriction of MEMRI enhancement supports the contention that apical dendrites are 
necessary for SD propagation; (3) Subcortical enhancement is a result of cortical-
subcortical neuronal connectivity; and (4) Because of the relatively slow clearance of 
Mn2+, MEMRI permits higher spatial resolution and signal-to-noise ratios (SNRs) via 
increased signal averaging. Based on these results, preliminary experiments involving the 
study of SD in focal ischemia using Mn2+ were performed (Chapter 7).  Initial results 
indicate: (1) MEMRI of ischemia, when compared with standard DWI/PWI methods, 
may provide a method for estimating the likelihood of progression to infarct at acute time 
points post onset of stroke.   These studies provide a foundation for further investigation 
into the role of SD in stroke, and the application of Mn2+ towards the design of 
therapeutic strategies targeting SD inhibition. 
 
Conclusions and Medical Significance 
The research within this dissertation employed magnetic resonance imaging techniques 
for monitoring the temporal evolution of pathological disease states such as focal 
ischemia and cancer, with and without therapeutic intervention.  Optimization of these 
techniques in experimental models will open the possibility for future application in a 
clinical setting.  Clinical availability of these non-invasive methods, with the ability to 
detect an early therapeutic response or to provide staging and prediction of tissue fate, 
would greatly aid in patient management of both cancer and stroke. 
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PRINCIPLES OF NUCLEAR MAGNETIC RESONANCE 1
1.1 Introduction  
This chapter will discuss the principles of nuclear magnetic resonance (NMR), beginning 
with a historical introduction describing the discovery and development of magnetic 
resonance imaging (MRI).  Section 1.2 will describe basic physical concepts, such as 
electromagnetic (EM) theory and the origin of the NMR signal, combining classical and 
quantum mechanical NMR descriptions.  An overview of relaxation processes, 
specifically T1 (spin-lattice), T2 (spin-spin), and T2* in Section 1.3 will build on this 
foundation.  The ability of specific NMR parameters, such as repetition time (TR) and 
echo time (TE), to generate tissue-specific contrast will also be discussed.  Next, the basis 
of MRI in terms of slice-selective gradients, frequency-encoding, phase-encoding, and 
Fourier reconstruction will be covered in Section 1.4.  The final section of this chapter 
will detail current imaging pulse sequences starting with the spin-echo, the oldest 
imaging method used, and ending with newer methods like echo-planar imaging and 
diffusion imaging.  By the end of this chapter the reader should have a good grasp of 
NMR theory and its evolution.  Several sources of information were used in preparation 
of this chapter, in particular books by Gadian (1), Callaghan (2), Hashemi et al. (3), 
Bernstein et al. (4), and Schmitt et al. (5).  
1.1.1 Magnetic Resonance Imaging: A Historical Introduction 
Nuclear magnetic resonance (NMR) is a powerful technique for the investigation of 
chemical and physical properties at the molecular level.  Independently discovered by 
Bloch et al. (6) and Purcell et al. (7) in 1946, NMR began as an analytical tool used 
primarily by chemists for the determination of molecular structure and configuration.  It 
wasn’t until the 1970s, with Lauterbur’s generation of the first two-dimensional NMR 
image (8), that NMR evolved into an imaging modality.  The development of basic 
imaging techniques by Kumar et al. (9) and Mansfield (10), along with the necessary 
imaging hardware, transformed magnetic resonance imaging (MRI) into a non-invasive 
method capable of providing anatomical contrast superior to computed tomography (CT) 
without the problem of ionizing radiation.  Since the 1980s, MRI has served as an 
indispensable diagnostic tool, with unlimited applications to the fields of biology, 
chemistry, physics, and engineering. 
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1.2 Basic Physical Principles 
In order to understand the NMR phenomenon a review of the basic physical principles, 
beginning with electromagnetic (EM) theory, is needed.  Some of these principles are 
best explained with Newtonian physics and others using quantum mechanics.  For all 
intents and purposes, the message conveyed is the same in either case. 
1.2.1 Electromagnetic Theory 
Wave Concept of EM Radiation 
EM radiation travels through space in the form of waves.  It consists of an electric field 
component, E, a magnetic field component, B, and a velocity of propagation, C, 
equivalent to the speed of light (Fig. 1-1). The electric and magnetic field components are 
orthogonal and have the same frequency.    They may be characterized by the classical 
wave equation: 
 
λ
c=v  (1.1) 
where c is the speed of light (3.0 × 108 m/s), λ is the wavelength (m) and ν is the 
frequency (s-1).   
Particle Concept of EM Radiation 
Certain EM radiation reacts with matter as if it were particles rather than waves.  These 
particles, discrete packets of energy called quanta, are characterized by a specific 
frequency of radiation.  Using this frequency and Planck’s constant, the actual energy 
may be calculated: 
 vhE =  (1.2) 
where h is Planck’s constant (4.13 × 10-18 keV⋅s), ν is the frequency (s-1), and E is the 
energy (keV).   
MRI and the EM Spectrum 
Different branches of NMR study molecular phenomena associated with the absorption 
of particular frequency components, typically 5 to 200 MHz, in the radiofrequency (RF) 
portion of the EM spectrum.  This is why the EM pulses used to generate the MRI signal 
are called RF pulses.  The various regions of the EM spectrum, radiowaves, microwaves, 
visible light, and x-rays are diagrammed in Fig. 1-2. 
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 E 
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Figure 1-1:  Individual components of the electromagnetic (EM) wave.  E is the electric 
component and B is the magnetic component.  These two components are perpendicular, 
have the same frequency, and travel at the speed of light, C. 
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Figure 1-2:  The electromagnetic (EM) spectrum.  The imaging windows for radiowaves, x-
rays, and visible light are outlined in blue.  The various types of EM radiation are noted on 
the right, starting with high-energy gamma rays and x-rays at the top, and ending with the 
low-energy radiowaves at the bottom. 
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1.2.2 Nuclear Angular Momentum 
Angular momentum is necessary for nuclear detection by NMR.  The total angular 
momentum of a particle arises from two types of rotational motion, orbital rotational 
motion and spin rotational motion.  While orbital rotational motion depends on the 
particle’s mass, velocity, and radius of orbit, spin rotational motion is an intrinsic 
property of the particle itself.  For a nucleus, the orbital motion of the nucleons (both 
protons and neutrons) is caused by the spinning motion of the entire nucleus rather than 
the orbital motion of its individual constituents.  The orbital angular momentum may be 
represented by: 
 hn  ωmrp 2 ==  (1.3) 
where m is the mass (kg), r is the radius of orbit (m), ω is the angular velocity (rad·s-1), 
and p is the orbital angular momentum (kg·m2·s-1 = J·s).  This portion of the equation is 
the classical representation.  The quantum mechanical representation, given by nħ, is the 
principle quantum number n multiplied by ħ, Planck’s constant h (6.6 × 10-34 J·s) divided 
by 2π.  Based on Equation 1-3, the orbital angular momentum has discrete values (is 
quantized) in integral multiples of ħ.  Similarly, spin angular momentum is also quantized 
in units of ħ and may be defined as: 
 [ ]1/21)I(Ip += h  (1.4) 
where ħ is Planck’s constant h (6.6 × 10-34 J·s) divided by 2π, I is the spin quantum 
number (unitless), and p is the spin angular momentum (J·s).  The value of I is dependant 
on the nuclear structure.  Protons, neutrons, and electrons, each having a spin of ½, pair 
with themselves, spin-up (+½) and spin-down (-½), canceling one another out.  The 
protons and neutrons that remain unpaired determine the total spin angular momentum of 
the nucleus. For nuclei to be NMR observable, they must have an odd number of protons 
and/or neutrons to have a non-zero value of the spin quantum number, I (1H, 19F, and 31P 
are examples of spin ½ nuclei).  I is zero for nuclei with even numbers of both protons 
and neutrons (12C and 16O have zero spin and are not NMR observable).    
1.2.3 Magnetic Dipole Moment 
A nucleus having net spin angular momentum (i.e., I ≠ 0), generates an EM field whose 
magnetic component causes it to act like a bar magnet.  The nuclear magnetic dipole 
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moment, µ, describes the magnitude and direction of this local magnetic field.  For a 
single spinning, positively-charged proton, the magnetic dipole moment (J/T) created 
may be described in terms of the spin angular momentum p (J·s) and the gyromagnetic 
ratio γ, a proportionality constant unique to a given nucleus:  
 γpµ =  (1.5) 
Certain nuclei possess a magnetic dipole moment (MDM), such as 1H, 19F, 31P, 23Na, 13C, 
and 17O.  1H, 19F, and 31P are of particular interest in light of their natural abundance and 
large gyromagnetic ratios (Table 1-1).  Both properties yield a larger MDM and, 
therefore, a larger possible NMR signal. 
 
Table 1-1.  Table of Nuclear Properties  
Nucleus # Protons # Neutrons 
Spin Quantum 
Number (I) 
% Natural 
Abundance 
Gyromagnetic 
Ratio* (MHz/T) 
1H 1 0 1/2 99.985 42.58 
13C 6 7 1/2 1.10 10.71 
17O 8 9 5/2 0.038 5.77 
19F 9 10 1/2 100 40.08 
23Na 11 12 3/2 100 11.27 
31P 15 16 1/2  100 17.25 
*Note that the gyromagnetic ratios reported here are expressed in terms of γ/2π. 
1.2.4 Directional Quantization of µ and p  
Directional Dependence of p 
In addition to magnitude, the nuclear spin angular momentum p has a directional 
component, pz.  Classically, pz could take on any value between p and –p.  However, 
remembering that the spin angular momentum p is limited to the discrete values given by 
equation 1-4, it is also the case that the vector is limited to directions corresponding to: 
 Iz mp h=  (1.6) 
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where pz is the component of the spin angular momentum along the z-axis (J·s), ħ is 
Planck’s constant h (6.6 × 10-34 J·s) divided by 2π, and mI is the directional spin quantum 
number.  In this equation, mI may take on values from –I, -I+1, ..., I-1, I.  For a spin-½ 
nucleus such as 1H, I = ½, therefore, mI may be +½ or –½, allowing only two possible 
orientations of pz.  
Directional Dependence of µ 
Recalling the quantization of p (given by Eq. 1-4), and the relationship between p and µ 
defined in Eq. 1-5, the magnetic dipole moment µ may be redefined as: 
 1/21)][I(Iγµ += h  (1.7) 
The orientation of µ is thus also limited to discrete values determined by µz, the z-
component of the MDM: 
 Izz mγγpµ h==  (1.8) 
Similarly, for a spin ½ nucleus such as 1H, I = ½, therefore, mI may be +½ or -½, 
allowing only two possible orientations of µz.  Fig. 1-3 illustrates the two possible 
orientations of µ and p for a spin-½ nucleus, termed spin-up and spin-down, in addition 
to the orientation angle, θ, between these vectors and the z-axis. 
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2
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Figure 1-3:  Quantization of the nuclear spin angular momentum p and 
the nuclear magnetic dipole moment µ for the 1H-nucleus.  The 
magnitudes for each vector, p and µ, as well as the magnitudes for their 
projection onto the z-axis, pz and µz, are shown.   
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1.2.5 Nuclear Energy States  
B0 Field Energy Level Dependence 
The nuclear spin angular momentum p and the nuclear magnetic dipole moment µ are 
restricted to (2I+1) possible orientations or states.  In the absence of an external magnetic 
field, the energies of the (2I+1) states, independent of the orientation of µ, are degenerate 
(i.e., have the same value).  If instead the nuclei are introduced into an external magnetic 
field, B0, this degeneracy is removed.  The interaction between µ and this B0 field 
(known as the Zeeman effect) has an associative potential energy E given by: 
 0zBµE =  (1.9) 
where µz is the component of the MDM along the z-axis (J/T), B0 is the external 
magnetic field (also oriented along the z-axis, expressed in units of T), and E is the 
potential energy (J).  For a spin-½ nucleus, the energy levels associated with the two 
orientations of µz (defined in Eq. 1.8 and diagrammed in Fig. 1-3) are given by: 
 
2
Bγ
E 0
h±=  (1.10) 
where the negative term is the lower energy state (aligned with, or parallel to, the B0 
field) and the positive term is the upper energy state (aligned against, or anti-parallel to, 
the B0 field).  These are also termed ‘spin-up’ and ‘spin-down’, respectively (Fig. 1-4). 
Energy Level Transitions 
For transitions (also referred to as spin flips) between energy levels, EM radiation in the 
RF spectrum must be absorbed or emitted, depending on whether there is a transition 
from the lower-to-upper or upper-to-lower energy state.  The quantum of radiation 
required for a single transition has a characteristic frequency (Eq. 1.2) and a magnitude 
equivalent to the energy difference between the two states, γħB0.  From conservation of 
energy, this frequency may be redefined as: 
 00 B2
ν π
γ=  (1.11) 
where ν0 is the frequency of absorbed or emitted radiation (rad·s-1), γ is the gyromagnetic 
ratio (MHz/T), and B0 is the magnetic field strength (T).  Since the gyromagnetic ratio is 
intrinsic of nuclei, each nucleus will have a unique resonance frequency in a given B0 
field. 
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Figure 1-4:  Zeeman effect: quantization of nuclear energy states.  For a collection of 
protons in the presence of an external magnetic field B0, the degeneracy between energy 
levels is removed.  The ‘spin-up’ orientation of µz (parallel to B0) is of lower energy and 
this state contains more protons than the higher energy, ‘spin-down’ configuration.  
 
Spin-State Populations: The Boltzmann Distribution 
In NMR, the proton signal is measured from a large collection of spins distributed 
between the two energy levels (defined in Eq. 1.10).  The detected signal is a result of the 
population difference between these two states, α (E1) and β (E2), and may be described 
in terms of the Boltzmann distribution: 
 /KTEI IeN
−=  (1.12) 
where EI is the energy of state I (J), K is the Boltzmann constant (1.38 × 10-23 J K-1), T is 
the temperature (K) and NI is the population of nuclei in state I.  If this equation is used to 
calculate the populations of spins for α and β, then the ratio of the two will yield the 
population difference between the two energy states: 
 
2KT
∆EN ∆n T=  (1.13) 
0Bγ∆Ewhere h=  and NT is the total number of nuclei.  This population difference yields 
a total magnetic moment of the system, or net magnetization, Mz, equivalent to the sum 
of all of the z-components of the individual nuclear magnetic dipole moments: 
 ∑
=
=
I
-Im
mz,mz µNM  (1.14) 
where Nm is equal to the population of nuclei in state m and µz,m is the z-component of 
the individual nuclear magnetic moment in state m (J/T).  The number of states is 
equivalent to (2I+1), where I is the spin quantum number of the nucleus.   
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The NMR signal, which is proportional to ∆n and equivalent to M0 (the total 
magnetization at the Boltzmann equilibrium), increases with increasing field strength 
(B0), and is greater for nuclei possessing larger gyromagnetic ratios (i.e., 1H, 19F, etc).   
1.2.6 Motion of Magnetic Dipole Moments 
Classical Approach  
In the presence of an external magnetic field, B0, a magnetic dipole moment µ will 
experience a torque L that tends to tip the magnetic moment towards B0: 
 0Bµdt
dpL ×==  (1.15) 
From this equation, the torque L is equal to the time rate of change of the angular 
momentum p.  Recalling the relation between µ and p in Eq. 1.5, the motion of µ may be 
described further by: 
 0Bγµdt
dpγ
dt
dµ ×==  (1.16) 
Here, the time rate of change of the MDM is equal to the time rate of change of the 
angular momentum (Eq. 1.15) multiplied by the gyromagnetic ratio.   In the presence of 
this static magnetic field, the torque L induces the precession of µ about B0 at a particular 
frequency, ω0 (Fig. 1-5a).  The rate or frequency of precession is proportional to the 
strength of the magnetic field and is expressed by the Larmor equation: 
 00 γB=ω  (1.17) 
where γ is the gyromagnetic ratio (MHz/T), B0 is the magnetic field strength (T) and ω0 is 
the Larmor frequency (MHz).  This frequency is directly related to the frequency 
described in Eq. 1.11 (by a factor of 1/2π); therefore, EM radiation in the RF spectrum 
satisfies the resonance condition and may be applied to perturb the system from 
equilibrium.  In the presence of an applied RF field, B1, with frequency ω, the motion of 
µ is from interaction with the static magnetic field B0, as well as the applied RF field, B1.  
This motion is described by: 
 ( )10 BBγµdt
dpγ
dt
dµ +×==  (1.18) 
PRINCIPLES OF NUCLEAR MAGNETIC RESONANCE 10
Here, µ precesses about the effective magnetic field, Beff, which is the resultant of B0, 
B1¸and a “fictitious” field ω/γ (11).  This is viewed most easily in the rotating frame (Fig. 
1.5b).  If ωr of the rotating frame is equal to the Larmor frequency  ω0, then the effective 
magnetic field ‘seen’ by µ is equal to the applied field B1.  Further consideration of RF 
perturbations to a collection of nuclei will be discussed in more detail using the quantum-
mechanical approach.  
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Figure 1-5:  Precession of an individual nuclear magnetic moment µ about B0 in 
the laboratory frame (a) and the precession of an individual nuclear magnetic 
moment µ about the effective magnetic field in the rotating frame (b).  In the 
presence of an external magnetic field, B0, µ precesses at the Larmor frequency, 
ω0, given by ω0 = γB0.  With an additional applied RF field, B1, the precession 
depends on the interaction of µ with both B0 and B1, termed the effective static 
magnetic field, Beff. 
Quantum-Mechanical Approach 
Although the classical model describing the motion of an individual nuclear magnetic 
moment is useful in understanding the NMR phenomenon, it has limitations in terms of 
effectively explaining the interactions between nuclei.  To overcome the limitations of 
the classical model, Felix Bloch developed a set of differential equations describing the 
dynamics of nuclear magnetization.  For a collection of spins, the vector sum of the 
individual MDMs yields the net magnetization, M, the total magnetic moment of the 
system.  In the absence of an external magnetic field, B0, the individual MDMs will have 
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random spin vector orientations whose sum yields a net magnetization equal to zero.  In 
the presence of an external magnetic field, B0, each MDM precesses about B0 at the 
Larmor frequency, ω0.  Based on the Boltzmann distribution, more nuclei are parallel 
versus anti-parallel to B0 (i.e., in the lower-energy state versus the higher-energy state), 
resulting in a net longitudinal or z-magnetization, M0.  The vector sum of the transverse 
or xy-components of M results in the phase cancellation of the nuclei and no coherent 
transverse magnetization, Mxy, at the Boltzmann equilibrium.  Therefore, the remaining 
longitudinal magnetization M0 (also known as Mz) has constant magnitude, and is parallel 
to B0.  These microscopic and macroscopic concepts of the net magnetization are 
diagrammed in Fig. 1-6.   
B0 B0z z 
x 
y 
M0 
a b 
x 
y 
 
Figure 1-6:  Microscopic (a) and macroscopic (b) pictures for a collection of protons in 
the presence of an external magnetic field, B0.  The individual magnetic dipole moment 
(MDM) of each proton precesses about B0 at the Larmor frequency, ω0.  The protons 
will appear to precess on the surface of two ‘cones’, one with a positive z-component 
and one with a negative z-component.  Because there are more protons in the upper 
‘cone’, there will be a nonzero vector sum M0, or net longitudinal magnetization, of 
constant magnitude, parallel to B0.  Note that the sum of the transverse components of 
individual MDMs results in phase cancellation and thus no residual transverse 
magnetization Mxy.   
 
At the Boltzmann equilibrium the motion of the net magnetization M, the vector sum of 
the individual magnetic moments, may be described by the time rate of change of M: 
 ( )0BMγdt
dM ×=  (1.19) 
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Upon application of an RF field, B1, the net magnetization M is rotated away from the z-
axis by some angle θ.  When viewed from the laboratory frame, the net magnetization M 
precesses about B0 at the Larmor frequency ω0 and angle θ with respect to the z-axis.  In 
the rotating frame (ωr = ω0), M ‘experiences’ no torque and therefore, appears stationary.  
This is illustrated in Fig. 1-7.   
 
 
 z 
x 
y 
a b 
z’ 
y’
x’
M 
M
Mz 
Mxy
M
θ θ 
B0 
 
Figure 1-7:  Visualization of the net magnetization M in the laboratory frame (a) and 
the rotating frame (b).  In the laboratory frame, M precesses about B0 at the Larmor 
frequency.  In the rotating frame, since the rotational frequency ωr is equal to the 
Larmor frequency ω0, M ‘experiences’ no torque and appears stationary.  Following 
application of the B1 field, the net magnetization M is at some angle θ with respect to 
B0 and the z-axis.  The z-component of the magnetization M is called the longitudinal 
magnetization and is termed Mz.  The xy-component of the magnetization M is called 
the transverse magnetization and is termed Mxy.  
 
In the presence of an RF field, B1, Eq. 1.19 must be modified for the inclusion of the 
external magnetic field, B0, and the applied RF field, B1: 
 ( )BMγ
dt
dM ×=  (1.20) 
Here, B consists of both B0 and B1.  By expanding the cross product in Eq. 1.20, time 
derivatives may be written for each component of M: 
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( )
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dt
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Since B consists of the static field, B0, and the RF field, B1, the individual components of 
B (Bx, By, and Bz) are equal to: 
 
0z
1y
1x
BB
sinωBB
cosωBB
=
=
=
t
t
 (1.22) 
Upon perturbation from thermal equilibrium by an RF field, B1, the net magnetization M 
will return to equilibrium via T1 and T2 relaxation processes (to be discussed further in 
Section 1.3).  The inclusion of these relaxation processes yields the full Bloch equations 
in the laboratory frame: 
 
( ) ( )
1
0z
yx
z
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y
z1x0
y
2
x
z1y0
x
T
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tMctMsinγ
dt
dM
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tMcγBMγB
dt
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−−+−=
−+−=
−+=
osωω
osω
ω
 (1.23) 
In NMR, it is convenient to describe the net magnetization, M, using the rotating frame.  
Here, the z-axis, parallel to B0, is the axis of rotation while the x and y axes rotate at the 
Larmor frequency, ω0.  By this convention, M0 is invariant in terms of magnitude, as it is 
parallel to B0 and the rotational axis.  For all subsequent discussions of M0, the rotating 
frame of reference with the rotational axis parallel to B0 will be used when describing the 
motion of nuclei. 
1.2.7 Free Induction Decay 
In Fourier transform NMR experiments, RF pulses of set duration, τ, are used to generate 
a magnetic field, B1, orthogonal to the static B0 field.  This B1 field rotates the net 
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magnetization M away from the z-axis (Fig. 1-8).  The degree of rotation, θ, also termed 
the flip angle, is dependent on both the strength of the applied RF field, B1, as well as the 
duration over which it is applied: 
 τγBθ 1=  (1.24) 
Depending on the experiment, θ will either be 90° (flipping M into the transverse plane) 
or 180° (flipping M onto the negative z-axis).  The importance of RF pulses in NMR lies 
in the ability to create a transverse component of the net magnetization.  This is because 
the net magnetization in the XY plane (Mxy) is the only component of magnetization that 
induces a NMR signal.   
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Figure 1-8:  Application of a B1 field flips the net magnetization, M, from 
equilibrium along the z-axis by an angle θ that is dependent on the strength of 
the B1 field and the duration over which it is applied.  In addition, it is 
important to note that the direction that M moves away from the z-axis by the 
angle θ is dependent on the direction along which the B1 field is applied.  
 
Upon application of an RF pulse producing a given flip angle, θ, perturbation of the net 
magnetization yields a transverse component (Mxy) that is detected by an RF receive coil 
encompassing the sample-of-interest.  This transverse component arises from the phase 
coherence to the spins comprising the xy-magnetization.  Over time, the spin system will 
return to the Boltzmann equilibrium, the xy-plane phase coherence will be lost, and the 
transverse magnetization will decay to zero.  Remembering that the net magnetization is 
precessing about the z-axis at the Larmor frequency, the measured evolution of the 
transverse signal is an exponentially-decaying sinusoid called a free induction decay, or 
FID (Fig. 1-9).  The loss of phase coherence and exponential decay of the transverse 
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magnetization is from the relaxation processes (T2/T2*) upon return to equilibrium.  T2* 
contributions include the intrinsic T2 relaxation from nuclear interactions, as well as 
contributions from magnetic susceptibilities, B0-field inhomogeneities, and molecular 
diffusion.  Section 1.3 will further detail T2 and T2* relaxation.   
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Figure 1-9:  Sample free induction decay (FID) signal following application of a RF 
pulse with a set flip angle θ.  As θ moves from 0° to 90°, the component of 
magnetization in the transverse plane increases, yielding larger FID amplitude. 
 
1.3 Relaxation Processes 
The two main relaxation mechanisms in NMR are spin-lattice (T1) relaxation and spin-
spin (T2) relaxation.  Following perturbation by a magnetic field, B1, the net 
magnetization of the spin system will return to the Boltzmann equilibrium via 
exponential decay processes.  The exponential process whereby the longitudinal 
magnetization, Mz, returns to its equilibrium state (along the z-axis) is measured by the 
time constant T1.  Similarly, the exponential process whereby the transverse 
magnetization, Mxy, decays to zero from its starting value (based on the flip angle θ) is 
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measured by the time constant T2.  These time constants, T1 and T2, vary based on tissue 
type, disease state, etc., allowing their manipulation to generate tissue contrast in 
magnetic resonance imaging (MRI) applications.  The following sections will describe T1 
and T2 relaxation processes, as well as the generation of tissue contrast in MR images. 
1.3.1 Spin-Lattice (T1) Relaxation 
T1 is called the longitudinal relaxation time because it refers to the time taken for 
realignment of the net magnetization with the longitudinal z-axis.  It is also known as the 
spin-lattice relaxation time, referring to the time taken for the spins to transfer the 
absorbed energy from the applied RF pulse to their surroundings (the “lattice”) in order to 
return to the Boltzmann equilibrium.  From the Bloch equations for the laboratory frame 
(Eq. 1.23), the longitudinal component arising from relaxation processes is: 
 
1
0zz
T
MM
dt
dM −−=  (1.25) 
Solving this equation, the exponential growth of the longitudinal magnetization may be 
described by: 
  ( ) ( )1t/T0z αe1MtM −−=  (1.26) 
where t is the time following the RF pulse, M0 is the value of the magnetization at 
Boltzmann equilibrium prior to the RF pulse, T1 is the time required for the longitudinal 
component to return to 63% of its original value, and Mz(t) is the change in the 
longitudinal magnetization over time.  In Eq. 1.27, α is dependent on the type of pulse 
applied—for a 90° pulse, α = 1, for a 180° pulse α = 2.   
Progressive Saturation 
Progressive saturation is one of several methods used for measuring the T1 relaxation 
time of the sample-of-interest. It involves the application of two 90° pulses separated by a 
waiting period t = TR, termed the repetition time.   Following application of the first 90° 
pulse to flip the magnetization from the longitudinal z-axis to the transverse xy plane, the 
spin system has phase coherence and there is no remaining longitudinal magnetization 
(Mz = 0).  Over the time t = TR, the longitudinal component (Mz) recovers to the 
longitudinal z-axis.  The amount of recovery is dependent on the ratio of TR to the T1 of 
the sample-of-interest, and is measured by applying a second 90° pulse to flip the 
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recovered longitudinal magnetization into the transverse plane for receipt by the RF 
receive coil.  Through acquisition of several FIDs at varying TRs, the signal amplitude of 
the FID versus repetition time (TR) may be plotted for calculation of T1.  The progressive 
saturation method is diagrammed in Fig. 1.10.   
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Figure 1-10:  Progressive saturation method for the measurement of T1 
relaxation.  Top:  PS pulse sequence for T1 measurement.  Middle:  The changes 
in the net magnetization, M, are diagrammed by the arrows.  Bottom:  Sample 
plot of signal intensity versus time (with increasing TR). 
 
Inversion Recovery 
Inversion recovery, like progressive saturation, is a method used for measuring the T1 of 
the sample-of-interest. This particular method involves the application of a 180° pulse 
and a 90° pulse, separated by a waiting period t = TI, termed the inversion time.   The 
application of the 180° pulse serves to flip the magnetization from the longitudinal +z-
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axis to the longitudinal –z-axis.  Over the time t = TI, the longitudinal magnetization will 
recover by a given amount, dependent on the ratio of TI to the T1 of the sample-of-
interest.  This recovery is measured by applying a 90° pulse to flip the recovering 
longitudinal magnetization into the transverse plane for detection by the RF receive coil.  
Through acquisition of several FIDs at varying TIs, the signal amplitude of the FID 
versus inversion time (TI) may be plotted for calculation of T1.  The inversion recovery 
method is diagrammed in Fig. 1.11. 
 
180°(+x) 90°(+x) 
TR 
RF 
Mz 
M0 
Mz(t) 
Time (t) T1
0.63 (2M0) 
-M0 
Null, t = 0.69T1 
 
Figure 1-11: Inversion recovery method for the measurement of T1 relaxation.  Top:  
IR pulse sequence for T1 measurement.  Middle:  The changes in net magnetization, M, 
are diagrammed by the arrows.  Bottom:  Sample plot of signal intensity versus time 
(increasing TI). 
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1.3.2 Spin-Spin (T2) Relaxation 
The transverse relaxation time, T2, refers to the time taken for the exponential decay of 
the transverse component of the net magnetization.  It is also known as the spin-spin 
relaxation time, referring to the time taken for dephasing of the spins via spin-spin 
interactions, in order to return to the Boltzmann equilibrium.  In addition to dephasing 
from spin-spin interactions, other contributions exist from B0 field inhomogeneities, 
differences in magnetic susceptibility, and molecular diffusion effects.  All these sources 
contribute to the total transverse relaxation time, T2*: 
 MDMSIH TTTTT 2222
*
2
11111 +++=  (1.27) 
where T2IH is the dephasing time due to B0 field inhomogeneities, T2MS is the dephasing 
time due to magnetic susceptibility differences, and T2MD is the dephasing time from 
molecular diffusion effects.   From the Bloch equations for the laboratory frame (Eq. 
1.23), the change in the transverse component arising from relaxation processes is: 
 
2
xyxy
T
M
dt
dM −=  (1.27) 
Following application of a single 90° pulse, the decay of the transverse magnetization 
follows an exponential process with the time constant of T2* rather than just T2:  
  ( ) *2t/T0xy eMtM −=  (1.28) 
where t is the time following the RF pulse, M0 is the Boltzmann equilibrium value of the 
z-magnetization just prior to the 90° RF pulse, T2* is the time required for the transverse 
component to decay to 37% of its original value, and Mxy(t) is the change in the 
transverse magnetization over time.     
Hahn Spin Echo 
The Hahn spin echo is a method that eliminates contributions from B0 field 
inhomogeneities and magnetic susceptibilities, allowing the measurement of T2 for a 
sample-of-interest.  This particular method involves the application of a 90° pulse and a 
180° pulse, separated by a waiting period t = TE/2, with TE termed the echo time.   The 
application of the 90° pulse serves to flip the z-magnetization to the transverse xy plane.  
Immediately after the pulse is turned off, the spins are in phase with one another (i.e., Mxy 
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is a maximum). Over the time t = TE/2, spin dephasing will occur through T2* relaxation 
processes. Application of the 180° pulse reverses the phases of individual spins relative 
to the Larmor frequency.  Another delay of t = TE/2 allows for rephrasing of the spin 
system, after which the remaining transverse magnetization (known as a spin-echo) is 
measured by the RF receive coil.  During the two TE/2 time periods, the sources of 
dephasing from B0 field inhomogeneities and magnetic susceptibilities are constant, 
therefore, they are phase cancelled at TE/2 following the 180° pulse.  Through 
acquisition of several spin echoes at varying TEs, the signal amplitude of each echo 
versus echo time (TE) may be plotted for calculation of T2.  The Hahn spin echo method 
is diagrammed in Fig. 1.12. 
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Figure 1-12: Hahn spin echo method for the measurement of T2 relaxation.  Top:  
HSE pulse sequence for T2 measurement.  Middle: The changes in the net 
magnetization, M, are diagrammed by the arrows.  Bottom:  Sample plot of 
signal intensity versus time (increasing TE). 
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1.3.3 Relaxation Mechanisms and Generation of Tissue Contrast 
Molecular Motions and Dipole-Dipole Coupling 
In NMR, dipole-dipole coupling modulated by rotational and translational molecular 
motions is the major contributor to T1 and T2 relaxation, and therefore, the ability to 
generate tissue contrast for a sample-of-interest.  In terms of rotational motion, the time 
required for a molecule to rotate 1/2π (1 radian) is termed the correlation time, or τc.  It 
also indicates the time between molecular collisions, which may be interpreted as the 
time a molecule remains in one state of motion.  The correlation time τc has an associated 
range of frequencies (0 to 1/τc Hz), a subset of which are of particular interest when at or 
near the Larmor frequency.   
Static Component of Dipole-Dipole Coupling 
When two protons are placed near one another (e.g., in a water molecule) they couple, 
each experiencing a small contribution δB from the other proton in addition to the 
external magnetic field B0.  For bulk water at room temperature, the molecules’ rapid 
isotropic movements (τc ~ 10-12 sec) result in averaging of the positive and negative phase 
contributions and zero contribution to T2 decay.  In contrast, water molecules bound to 
macromolecules such as globular proteins have significantly longer correlation times (τc 
~ 10-5-10-8 sec).  The slow rotational rate of the bound system results in a small 
contribution to the total magnetic field due to interactions with its neighbors (no motional 
averaging), leading to T2 relaxation from dephasing and a non-zero static component of 
dipole-dipole coupling. 
Dynamic Component of Dipole-Dipole Coupling 
Translational motion and rotational tumbling motion, the sources of the dynamic 
component of dipole-dipole coupling, contribute to both T1 and T2 decay.  For an 
individual water molecule, the total magnetic field experienced by each nucleus is the 
sum of the external magnetic field B0 and the local contribution δB from its neighbor.  
These fluctuations in the magnetic field behave similar to the B1 field generated by an RF 
pulse.  When exposed to a fluctuating magnetic field, the nuclei may absorb energy from 
the field and change spin states.  Following this exchange there is random dephasing of 
the transverse magnetization (T2 relaxation) as well as energy transfer to the lattice with 
recovery of the longitudinal magnetization (T1 relaxation). 
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Spectral Density Distribution 
The molecular motions within a system (i.e., a collection of molecules) may be 
represented by a uniform distribution of molecules rotating at frequencies ranging from 
zero to ω =1/τc.  This frequency distribution is represented by the spectral density 
function, J(ω): 
 ( ) 2
c
2
c
τω1
τ
ωJ +=  (1.29) 
where τc is the correlation time and ω is the rotational frequency of the molecule.  Fig. 1-
13 diagrams the relationship between J(ω) and ω for three different molecular 
environments—large molecules (i.e., proteins), medium-sized molecules (i.e., lipids), and 
small molecules (i.e., water).  For a sample in a given magnetic field, the measured 
relaxation rates (T1 and T2) depend on the fluctuations in the local magnetic field at or 
near the Larmor frequency.  In other words, only molecules with motional frequencies 
near the resonance frequency ω0 contribute significantly to the T1 and T2 values measured 
with NMR.  Since ω0 is B0 field dependent, the fraction of molecules with motional 
frequencies equal to ω0 generally decreases with increasing B0, causing a reduction in 
relaxation rate. 
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Figure 1-13: Relationship between the spectral density function J(ω) and the rotational or 
motional frequency (ω).  Top: For increasing molecular size, there is a corresponding 
increase in correlation time τc and a smaller range of permitted rotational frequencies.  
Bottom:  For increasing B0 field, there is a corresponding increase in ω0 and generally a 
reduction in the fraction of molecules with motional frequencies having significant 
contribution to the relaxation rates. 
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MRI Tissue Contrast: Exploiting Differences in T1 and T2 
The resultant differences in T1 and T2 values from molecular motions and dynamic 
dipole-dipole coupling permit generation of tissue contrast.  These differences allow 
delineation between tissues such as fat, soft tissue, water, and proteinaceous fluid.  They 
also allow delineation between healthy soft tissue and pathological lesions, as well as 
between white matter, gray matter, and cerebrospinal fluid (CSF) in the brain.  
Exploitation of T1- and T2-weighting for differentiating between brain tissues and for 
lesion identification (i.e., tumors) will be shown in the following sections. 
T1-weighting: Short TR/Short TE 
In the brain, the myelin sheath of white matter has similar properties to fat, whereas gray 
matter is closer to soft tissue.  This yields a shorter T1 in white matter versus that of gray 
matter.  CSF, on the other hand, has a long T1.  On a T1-weighted image (acquired using a 
short TR and a short TE) the white matter would be bright (i.e., high signal intensity), the 
gray matter would be intermediate in intensity, and the CSF would be dark (Fig. 1-14). 
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Figure 1-14: T1-weighted contrast.  Left: T1-recovery and T2-decay curves of white matter, gray 
matter, and CSF.  For short TR and short TE values, the contrast between these tissues is maximized 
based on their differences in T1.  The T2 effect is minimized by using a short TE value.  Right: T1-
weighted image of the human brain.  T1W image reproduced from 
<http://www.mr.ethz.ch/3t/patient_2.html>.   
     
For healthy soft tissue versus pathological lesions (i.e., tumors), the difference in signal 
intensities on a T1-weighted image is minimal.  The best contrast for distinguishing 
tumors from surrounding tissue is T2-weighted imaging.  Since tumors tend to have 
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higher water content (due to edema from inflammatory processes), they have increased 
T1 and T2 relaxation times in comparison to normal healthy tissue. 
T2-weighting: Long TR/Long TE 
In the brain, white matter has a slightly shorter T2 than gray matter.  CSF, on the other 
hand, has the least dephasing and therefore the longest T2 of the three tissues.  On a T2-
weighted image (acquired using a long TR and a long TE) the white matter would be 
dark, the gray matter would be intermediate in intensity, and the CSF would be bright 
(Fig. 1-15, top).  In tumors, the T2 tends to be longer than healthy soft tissue.  This is 
because of the reduced dephasing from decreased cell density and increased water 
content.  This allows for differentiation between the tumor and the surrounding tissue 
(Fig. 1-15, bottom).  Diffusion-weighted imaging also provides contrast between lesions 
and soft tissue.  This particular type of contrast will be discussed in detail in Chapter 2. 
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Figure 1-15: T2-weighted contrast.  Top Left: T1-recovery and T2-decay curves of white matter, gray 
matter, and CSF.  Bottom Left:  T1-recovery and T2-decay curves of soft tissue and tumor.   For long TR 
and long TE values, the contrast between these tissues is maximized based on their differences in T2.  The 
T1 effect is minimized by using a long TR value.  Top Right: T2-weighted image of the human brain.  
Bottom Right: T2-weighted image of a human brain tumor.  Images reproduced from 
<http://www.mr.ethz.ch/3t/patient_2.html> and <http://www.mr.ethz.ch/3t/patient_3.html>. 
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Proton Density: Long TR/Short TE 
In the brain, if a very short TE is chosen in combination with a long TR value, the signal 
intensities for the individual tissues (white matter, gray matter, and CSF) will reflect their 
respective proton densities (i.e., M0) (Fig. 1-16). This type of weighting is many times 
used to compare the relative water content of two tissues or regions of interest. 
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Figure 1-16: Proton Density-weighted contrast.  Left: T1-recovery and T2-decay curves of white matter, 
gray matter, and CSF.  For a long TR and short TE, the contrast between these tissues is maximized 
from their differences in proton density (i.e., M0).  The T2 effect is minimized by using a short TE 
value.  Right: Proton Density-weighted image of the brain.  Images reproduced from 
<http://www.mr.ethz.ch/3t/patient_2.html> and <http://www.mr.ethz.ch/3t/patient_3.html>. 
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1.4 Magnetic Resonance Imaging 
In order to translate from magnetic resonance spectroscopy (MRS) techniques to MRI, 
several important steps are required, most importantly, spatial encoding.  In this section, 
signal composition (frequency, phase, amplitude) will be discussed prior to that of 
specific image acquisition and processing techniques.  The methodology behind slice 
selection and slice offset, the concepts of frequency encoding and phase encoding, as 
well as the rephasing gradients necessary will also be covered.   
1.4.1 Underlying Signal Composition: Phase, Frequency, and Amplitude 
NMR signals are measured with respect to the rotating frame of reference; therefore, their 
oscillation frequencies are represented by ω0 ± ω.  During the acquisition phase of the 
NMR experiment, a RF receive coil measures the total signal (FID) with respect to time 
(Fig. 1-17).  This FID has phase, frequency, and amplitude.  Since the FT permits 
transformations between time and frequency space, a 1D-FT taken of the FID will yield a 
plot of signal amplitude with respect to frequency.  If the FID’s composition contains a 
single frequency of oscillation, there will be one Lorentzian-shaped peak located 
symmetrically about that frequency and whose full-width-at-half-maximum height 
(FWHH) is related to the time constant for exponential decay.  If instead the FID’s 
composition has two frequencies of oscillation, there will be two Lorentzian-shaped 
peaks, both symmetrically disposed about their individual resonance frequencies.  NMR 
signals many times are composed of signals with varying frequency and amplitude, a 
direct result of tissue heterogeneity (fat, muscle, etc).  For MRS, these principles of 1D-
FT NMR allow investigation of chemical composition, structure, etc.  In terms of MRI, 
the application of a sinc-shaped RF pulse is only half of the picture.  The second half 
involves application of a non-uniform field (linear field gradient) for spatial encoding. 
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Figure 1-17: Sample FIDs and their 1D Fourier transformations (FT).  Top: Conversion of a single 
exponentially-dampened sinusoid between time and frequency space.  The full-width-at-half-maximum 
height (FWHH) is inversely proportional to the exponential decay constant, in this case T2*, times 1/π.  
Bottom:  Conversion of two exponentially-dampened sinusoids between time and frequency space.  The 
black dashed line is the total FID, equivalent to the sum of the individual components (red, blue).  These 
represent the two frequency components (red = low, blue = high). 
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1.4.2 Slice Selection and Slice Offset 
For excitation of a particular range of frequencies (i.e., bandwidth), a sinc-shaped 
(sin(x)/x) RF pulse of a particular duration is applied.  The sinc pulse, usually on the 
order of three to four milliseconds in duration, corresponds to a rectangular shaped 
excitation (power spectrum) in the frequency domain (Fig. 1-18, top). Slice selection is 
performed through the application of a linear magnetic field gradient during the RF 
excitation, yielding dependence of the Larmor frequency on the spatial location of the 
nuclei:  
 ( ) ( )zGBγzω z0 +=  (1.30) 
where γ is the gyromagnetic ratio, B0 is the external magnetic field, Gz is the linear 
gradient applied along the z-direction, z is the position along the gradient direction, and 
ω(z) is the angular frequency corresponding to a particular location along the z-axis.  
This gradient, often referred to as a slice-select gradient, may be applied along the x, y, or 
z axes depending on the desired slice orientation.  If the slice-select gradient is applied 
during RF pulse transmission, the range of frequencies (i.e., bandwidth = ∆ω) excited 
corresponds to a range of magnetic field strengths proportional to the slice thickness, ∆z 
(Fig. 1-18, bottom): 
 
zγG
∆ω∆z =  (1.31) 
where γ is the gyromagnetic ratio, Gz is the linear gradient applied along the z-direction, 
∆ω is the bandwidth, and ∆z is the slice-thickness.   
Slice Thickness Adjustment 
In order to change the slice thickness, either the bandwidth or the strength of the slice-
select gradient must be changed.  In MRI, the bandwidth (and hence the RF pulse 
duration) is usually kept constant while the slice-select gradient strength is increased or 
decreased depending on the desired slice thickness.  In order to decrease the slice 
thickness, a stronger (i.e., steeper) gradient is used. 
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Figure 1-18: Slice-selection methods.  Top:  To excite a particular range of frequencies, a sinc (sin(x)/x) 
pulse is applied.  This sinc pulse in the time domain corresponds to a rectangular excitation profile in the 
frequency domain.  Top Left: Time-domain, 3-lobe, sinc pulse of duration 3T.  Top Right:  Frequency-
domain rectangular excitation profile.  Bottom:  To change the slice thickness, the bandwidth (∆ω) or the 
strength of the linear gradient (G) needs to be altered.  In MRI, the bandwidth is generally kept constant 
and the magnetic field gradient is changed to obtain the desired slice thickness.  Bottom Left:  A narrower 
bandwidth is used to decrease the slice thickness (∆zA<∆zB).  Bottom Right:  At a specific bandwidth (∆ω), 
a steeper magnetic field gradient (line A) is used to decrease the slice thickness (∆zA).  By lowering the 
strength of the magnetic field gradient (line B), a thicker slice may be obtained (∆zB). 
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Slice Offset 
To change the slice position, the RF pulse frequency (i.e., carrier frequency) must be 
increased by a set amount relative to ω0.  This frequency offset is dependent on the 
strength of the slice-select gradient and may be represented by the following equation: 
 ( ) zγGzω z=  (1.32) 
equivalent to the latter half of Eq. 1.30.  For example, for a slice offset of 1 cm in the 
presence of a 1 G/cm gradient, the frequency of the RF pulse must be increased by a 
value of 4258 Hz. 
Image Acquisition: Addition of Slice-Select Gradients 
With the addition of the slice-select gradients, the MRI pulse sequence diagram for a 
standard spin-echo experiment will include the slice-selective 90° and 180° RF pulses, 
the slice-select gradients, and the signal-acquisition period (Fig. 1-19).  The frequency-
encoding gradients and phase encoding gradients, as well as the rephasing gradients, still 
remain to be discussed.   
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Figure 1-19: Spin-echo pulse sequence diagram with the 90° and 180° slice-
selective RF pulses, the slice-select gradients, and the signal-acquisition period.   
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1.4.3 Frequency-Encoding and Phase-Encoding 
In order to further encode the spatial information within each slice, in particular, the 
amount of signal corresponding to each voxel (volume element) of interest, frequency-
encoding and phase-encoding techniques are employed.  Signal composition (phase, 
frequency, and amplitude), described briefly in section 1.4.1, is extremely important to 
spatial localization methods.  The measured signal from a single-slice MRI experiment, 
without frequency-encoding or phase-encoding gradients, is the signal from the entire 
slice.   
Frequency-Encoding 
In order to obtain the spatial information along the x-direction of the slice plane, for 
example, a gradient Gx is applied during acquisition of the echo.  This is termed the 
frequency-encoding or read-out gradient.  Based on the spatial extent of the nuclei, the 
application of this gradient changes the Beff experienced for each voxel, and, therefore, 
the precessional frequency, ωeff .  Again, there will be a range of frequencies (signal 
bandwidth) corresponding to the spatial location of the nuclei, and dependent on the 
gradient amplitude. This relationship, a variation of Eq. 1.31, is equivalent to: 
  
AT
N
BWwith ,
γG
BWFOV freq
x
x ==  (1.33) 
where γ is the gyromagnetic ratio (Hz/G), BW is the signal bandwidth (Hz), Gx is the 
gradient amplitude (G/cm), and FOVx is the field of view along the readout or x-direction 
in this case (cm).  BW, which is usually user specified, is dependent on the number of 
points sampled (Nfreq) and the acquisition time (AT).  From Eq. 1.33, increased spatial 
resolution in the readout direction may be obtained via the following methods: decreased 
FOVx with a corresponding increase in Gx, increased Nfreq, or decreased BW.  For a 
constant BW, increasing the Nfreq will increase the AT and yield a reduction in the SNR 
for each sampling point (i.e., the greater the number of points sampled, the lower the 
available signal on a point-by-point basis).  Similarly, decreasing BW increases the SNR 
by reducing the available noise on a point-by-point basis.  In general, the resolution is 
greater for adjustment of the gradient amplitude (Gx) than that of the BW.  With this in 
mind, BW (and hence AT) is usually kept constant in MRI experiments and Gx is varied 
based on the desired FOVx. 
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Image Acquisition: Addition of Frequency-Encoding Gradients 
With the addition of the frequency-encoding (readout) gradients, the MRI pulse sequence 
diagram for a standard spin-echo experiment will include the slice-selective 90° and 180° 
RF pulses, the slice-select gradients, the readout gradients, and the signal acquisition 
period (Fig. 1-20).  The phase-encoding gradients as well as the rephasing gradients still 
remain to be discussed. 
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Figure 1-20: Spin-echo pulse sequence diagram with the 90° and 180° slice-
selective RF pulses, the slice-select gradients, the frequency-encoding (readout) 
gradients, and receiver channels.   
 
Phase-Encoding 
In order to get the spatial information along the y-direction of the slice plane, a gradient 
Gy is applied.  This is termed the phase-encoding gradient.  Gy is usually applied between 
the slice-selective RF pulses—in the case of the spin-echo experiment the phase-
encoding gradient would be applied between the 90° and 180° pulses.  Although Gy may 
also be applied after the slice-selective RF pulses, it must be applied prior to the echo or 
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readout.  Based on the spatial extent of the nuclei, application of this gradient induces a 
phase-shift for each voxel.  Again, there exists a range of precessional frequencies 
corresponding to the spatial location of the nuclei, dependent on the gradient amplitude:   
  yγGω(y) y=  (1.34) 
where γ is the gyromagnetic ratio (Hz/G), Gy is the gradient amplitude (G/cm), y is the 
position along the phase-encoding or y-direction (cm), and ω(y) is the frequency of 
precession experienced at the y-position (Hz).  Exposure to Gy for a period of time t 
generates a phase shift, ∆φ, of specific magnitude:  
 ytγG∆ y=φ  (1.35) 
where γ is the gyromagnetic ratio (Hz/G), Gy is the gradient amplitude (G/cm), and y is 
the position along the phase-encoding or y-direction (cm).  Since the phase information 
imparted to the nuclei is retained through the experiment, it is standard practice to repeat 
the pulse sequence a number of times (Nphase) using an equivalent number of phase-
encoding gradient increments (Gy-inc).  In MRI, a bipolar phase-encoding gradient is used, 
meaning the phase imparted will be ±180°, with a -180° phase shift and a +180° phase 
shift experienced by the near and far edges of FOVy, respectively.  With this in mind, Gy-
inc may be defined as: 
 
tγFOV
1G
y
inc-y =  (1.36) 
where γ is the gyromagnetic ratio, FOVy is the field of view in the phase-encoding or y-
direction, and t is the time of Gy-inc application.  From Eq. 1.35 and the number of phase-
encoding steps (Nphase), the maximum amplitude (positive or negative) of Gy-inc may be 
determined. 
Image Acquisition: Addition of Phase-Encoding Gradients 
With the addition of the phase-encoding gradients, the MRI pulse sequence diagram for a 
standard spin-echo experiment will include the slice-selective 90° and 180° RF pulses, 
the slice-select gradients, the readout gradients, the phase-encoding gradients, and the 
signal acquisition period (Fig. 1-21).  The rephasing gradients still remain to be 
discussed.   
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Figure 1-21: Spin-echo pulse sequence diagram with the 90° and 180° slice-
selective RF pulses, the slice-select gradients, the phase-encoding gradients, the 
frequency-encoding (readout) gradients, and the signal acquisition period.   
 
1.4.4 Rephasing Gradients 
Although it would seem that the MRI pulse sequence diagram is now complete for a 
standard spin-echo experiment, without rephasing gradients for both slice-selection and 
readout the acquired signal and final image intensity would be diminished.  Because there 
is dephasing of the nuclei during application of the slice-select gradient, a rephasing 
gradient is applied after the fact for phase-shift correction (i.e., all the nuclei should have 
the same phase).  Dephasing is also present during the application of the readout gradient.  
In order to have the nuclei in phase at the midpoint of readout (i.e., the echo is centered 
during signal acquisition), a rephasing gradient is applied prior to application of the 
readout gradient.  The addition of the rephasing gradients to the pulse sequence diagram 
for the standard spin-echo experiment is diagrammed in Fig. 1-22. 
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Figure 1-22: Complete spin-echo pulse sequence diagram.  Individual 
components include: the 90° and 180° slice-selective RF pulses, the slice-select 
gradients, the phase-encoding gradients, the frequency-encoding (readout) 
gradients, the rephasing gradients (shaded gray), and receiver channel (with the 
resultant signal acquisition period).     
 
 
1.4.5 Signal Processing: Conversion Between K-Space and Image Space 
Besides a thorough coverage of MRI image acquisition techniques, a methodological 
discussion of the conversion between data space and image space is warranted.  A brief 
description of the utility of 1D-FT for NMR spectroscopic methods was given in section 
1.4.1, and will be expanded upon here.  Specifically, the properties of k-space and the use 
of the 2D-FT for conversion from k-space to image space will be discussed. 
What is K-Space? 
K-space is a 2D presentation of the raw data, with frequency-encoding (Hz) along the 
first axis and phase-encoding along the second.  Both axes have inclusion of time.  As the 
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frequency-encoding axis (ν) is traversed, each step or increment is a single sampling 
point.  The total length of the axis is equivalent to the number of sampling points Nfreq 
acquired over the acquisition time AT.  As the phase-encoding axis (φ) axis is traversed, 
each step or increment is a single phase-encoding increment (φinc) related to the 
increment of the gradient amplitude, Gy-inc, and the total number of increments (Nphase).  
Overall, the matrix size associated with the k-space representation of the data is 
equivalent to Nfreq × Nphase. 
K-Space Composition  
Since a rephasing gradient is applied in order to center the echo in the acquisition 
window, it follows that individual rows of k-space along the frequency direction have the 
weakest amplitude at the beginning and end of each row (i.e., high frequencies).  In 
contrast, the center of each row of k-space (zero frequency) has maximal amplitude 
because it contains the signal contribution of the spin echoes (i.e., where the nuclei are in 
phase).  Additionally, since the phase-encoding gradient dephases the signal, it follows 
that individual rows acquired with higher amplitude phase gradients have greater signal 
dephasing and smaller amplitude than those acquired with a lower amplitude phase 
gradients.  Overall, the center of k-space (where the phase and frequency shifts are near 
zero) contains maximal signal intensity.  In this case, the central portion of k-space may 
appear more important than the remainder as it contains the majority of the spatial 
information.  However, if the peripheral regions of k-space (i.e., the edges) are 
disregarded, the fine detail (i.e., high frequency information) of the image is lost and the 
sharp interfaces between various regions are degraded.  The idea of k-space and the 
importance of the central and peripheral regions to image quality are diagrammed in Fig. 
1-23. 
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Figure 1-23: K-space composition and importance of both low- and high-frequency regions.    Top Left: 
k-space is the 2D raw data with dimensions a function of frequency and phase.  The center of each row of 
k-space (i.e., zero frequency) has the maximum amplitude because it contains the signal contribution of 
the spin echoes (i.e., where the nuclei are in phase).  Moving away from the center of each row, the 
nuclei become progressively more out of phase, decreasing the signal amplitude.  Frequencies at νa and 
νb have the weakest signal.  Since the phase-encoding gradient dephases the signal, rows acquired with 
higher phase-encoding gradient (i.e., at φa or φb) have increased dephasing from the additional phase 
imparted to the nuclei.  Top Right: Sample k-space data.  Bottom Left:  Corresponding image.  Bottom 
Middle:  Image constructed from only data at the center of k-space.  Bottom Right:  Image constructed 
from only data at the edges of k-space. 
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Fourier Reconstruction 
The 2D k-space representation of the data may be converted into image space using a 2D-
FT.  Application of a 2D-FT permits conversion of the frequency and phase information 
into an image with signal amplitude dependent on spatial location, similar to application 
of the 1D-FT for conversion of NMR spectroscopic data from the time domain to the 
frequency domain (described in Section 1.4.1).  Most MRI systems perform a 2D-FT 
using the fast Fourier transform (FFT), a faster method than that of the digital Fourier 
transform (DFT).  As the signal (FID) is sampled at a constant interval, each data point 
making up the total FID will have discrete amplitude and time values.   Therefore, for a 
DFT the number of calculations required to solve the series of delta functions from k-
space for image formation is Nfreq × Nphase.  For the FFT, the required number of 
calculations is instead Nphase × log2Nfreq.  In order for log2Nfreq to be a whole number, the 
Nfreq needs to be a power of 2 (i.e., 64, 128, 256, etc.) when the FFT is used.  It is usually 
standard to then use an equivalent Nphase for a square matrix and FOV, or an Nphase that is 
at least a power of 2 if not equivalent to Nfreq.  Matrices that are 64 × 64, 128 × 128, 256 
× 256 are standard in animal MRI studies as the FOVs are at least an order of magnitude 
smaller than in the clinical setting. 
 
1.5 Imaging Methods 
With the growing number of MRI pulses sequences in practice today an understanding of 
the fundamentals, such as spin-echo (SE) imaging and gradient-echo (GE) imaging, as 
well as fast imaging techniques such as echo-planar imaging (EPI), is necessary.  In 
addition to these methods, employed for generation of T1, T2, and T2* contrast, diffusion-
weighted imaging (DWI) and perfusion-weighted imaging (PWI) methods will be 
discussed.  This information will provide suitable background for the MRI methods 
applied in later chapters (specifically Chapters 3-4 and Chapters 6-7). 
1.5.1 Spin-Echo (SE) Imaging 
Hahn Spin-Echo (HSE) 
The mechanisms of spin-echo formation through application of 90° and 180° RF pulses 
were described previously in Section 1.3.2, with a step-by-step discussion of the spin-
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echo pulse sequence for image acquisition in Section 1.4.  This type of spin-echo, from 
first discovered by Hahn in 1950 (12), involves application of two slice-selective RF 
pulses (sin x/x), a 90° and a 180°, separated by a time t = TE/2 (Fig. 1-22).  During the 
transmit phase, the slice-selective gradients are applied in order to excite a specified 
frequency bandwidth (BW).  Application of the 90° RF pulse flips the longitudinal 
magnetization into the transverse plane.  Immediately following the 90° RF pulse, a 
rephasing gradient is applied to remove the dephasing effect of the slice-select gradient.  
Concomitant with this rephasing gradient, the first increment of the phase-encoding 
gradient is applied, giving a specific amount of phase to the nuclei dependent on their 
spatial location along the phase or y-direction.  Following the t = TE/2 period, the 180° 
RF pulse is applied to flip the magnetization about one of the transverse axes (x or y).  
Prior to acquisition of the echo, a pre-dephasing gradient is applied along the frequency-
encoding direction.  This is done to dephase the transverse magnetization and counteract 
the dephasing effects of the subsequent frequency-encoding gradient.  Next, the receiver 
is turned on and the frequency-encoding gradient is applied, exciting a specific 
bandwidth (BW) based on the spatial location along the frequency or x-direction.  At a 
time t = TE/2 following the 180° RF pulse, the echo formation reaches a maximum (i.e., 
the nuclei are in phase with one another).  The total acquisition time (AT) is based on the 
receiver bandwidth (BW) and the number of sampling points (Npoints) dependent on 
Nyquist’s theorem.   In order to obtain all of the spatial information for the phase-
encoding direction, the pulse sequence is iterated Nphase times, equivalent to the total 
number of phase-encoding steps.  The time for each of these iterations is termed the 
repetition time (TR); therefore, the total experiment time is Nphase × TR. 
Carr-Purcell-Meiboom-Gill (CPMG) 
Performing image acquisition (either single-slice or multi-slice) according to the HSE 
method for a single TE value takes a reasonable amount of time.  Difficulty in 
maintaining good temporal resolution arises when multiple images of varying TE value 
are desired for determination of T2.  This may be overcome using the Carr-Purcell-
Meiboom-Gill (CPMG) method (13,14) characterized by a single 90° RF pulse followed 
by a train of 180° RF pulses (Nechoes).  The 90° and first 180° RF pulses are separated by 
a time t = TE/2, with each additional 180° spaced at time intervals t = TE.  Multiple spin-
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echoes occur (one after each 180° RF pulse) that are modulated by a T2-relaxation 
envelope.  Application of the slice-select gradients, frequency- and phase-encoding 
gradients, and the rephasing gradients are diagrammed in Fig. 1-24.  SE imaging via the 
HSE, CPMG, or fast imaging methods (to be discussed in the latter portion of Section 
1.5) is of particular interest for identifying abnormalities from healthy tissue based on 
differences in T2 relaxation. 
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TE TE
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Figure 1-24: Carr-Purcell-Meiboom-Gill (CPMG) pulse sequence diagram.  Individual components 
include: the 90° and 180° slice-selective RF pulses, the slice-select gradients, the phase-encoding gradients, 
the frequency-encoding (readout) gradients, the rephasing gradients (shaded gray), and receiver channels 
(with the resultant signal acquisition periods for individual spin-echoes).     
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1.5.2 Gradient-Echo (GE) Imaging 
The mechanisms of gradient-echo (GE) formation involve application of a single RF 
pulse having a flip angle θ that is usually less than 90°.  This partially flips the 
longitudinal magnetization into the transverse plane.  Over time, dephasing from B0 field 
inhomogeneities, magnetic susceptibility effects, and molecular diffusion effects induces 
decay of the transverse magnetization.  This decay, termed T2*, was mentioned briefly in 
Section 1.3.2.  After a time t = TE, echo formation is at a maximum.  Similar to the HSE 
and CMPG sequences, the GE pulse sequence is repeated Nphase times, with a repetition 
time (TR) for each increment.  Again, the total experiment time is Nphase × TR.  Since GE 
imaging uses a reduced-flip-angle RF pulse, it may be performed using much shorter TR 
values than the HSE or CPMG methods, significantly reducing the experiment time.  GE 
imaging is of particular interest for applications using contrast-enhancement, such as 
vascular and perfusion imaging.  The GE pulse sequence is diagrammed in Fig. 1-25. 
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TE 
Gfreq 
Gphase 
Figure 1-25: Gradient-echo (GE) 
pulse sequence diagram. 
Individual components include: 
the slice-selective RF pulse of flip 
angle θ, the slice-select gradient, 
the phase-encoding gradients, the 
frequency-encoding (readout) 
gradients, the rephasing gradients 
(shaded gray), and receiver 
channel (with the resultant signal 
acquisition period).     
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Optimization of Flip Angle θ 
The SNR may be optimized for the GE sequence by employing the Ernst angle 
relationship.  For a given TR and T1 value, the maximum signal will be obtained using a 
flip angle equivalent to the Ernst angle (θE): 
 1TR/TE eθcos
−=  (1.37) 
where TR is the repetition time and T1 is the spin-lattice relaxation.  For long T1’s, the 
maximum signal will occur at low flip angles (~ 30°). 
1.5.3 Echo-Planar Imaging (EPI) 
Prior to introduction of fast-imaging techniques, experiment times were on the order of  
5-25 minutes depending on the FOV, number of slices, user-specified TR/TE values, and 
the number of averages (NEX) desired.  In 1977, Peter Mansfield introduced a method 
now commonly known as echo-planar imaging, or EPI (10).  Because of hardware 
limitations, it wasn’t until the late 1980s that EPI became technically feasible, 
transforming it into the standard that exists today. 
Single-shot EPI 
Conventional MRI methods acquire k-space data on a line-by-line basis separated by a 
TR period (usually 10msec-3000msec), resulting in experiment times on the order of 
several minutes.  In contrast, EPI acquires the k-space data in a single acquisition (one 
TR period).  Since a single TR period is used, it is important to make sure that the total 
spatial encoding process is completed in the shortest time possible (i.e., using a short TE) 
in order to minimize effects of T2/T2* decay.  The EPI pulse sequence begins with 
application of the slice-select RF pulses and slice-select gradients, similar to the SE and 
GE methods described in Sections 1.5.1 and 1.5.2, respectively.  The primary difference 
is the method of frequency-encoding and phase-encoding employed for fast imaging.  
The frequency-encoding gradient is applied in an alternating fashion (by switching the 
gradient polarity) for traversing k-space.  In terms of the phase-encode gradients, two 
methods are common, one using a blipped gradients, the second using a ramped gradient.  
Application of the blipped phase-encode gradient occurs between the alternating 
application of the frequency-encode gradient, adding a small phase increment for each 
step.  This is analogous to the approach used for phase-encoding in conventional MRI 
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(Fig. 1-26).  For the ramped phase-encode gradient, constant gradient amplitude is 
applied during the alternating application of the frequency-encode gradient, permitting a 
‘zig-zag’ pattern of traversing k-space (Fig. 1-27).   
Optimizing EPI Image Quality 
Imaging artifacts could potentially present a problem depending on the EPI sequence 
used.  Although this is the case, the choice of parameters, image orientation, and 
hardware help in producing consistent image quality.  Some sources of artifacts are: 
sensitivity to field inhomogeneities (particularly important in GE-EPI), phase-encode 
blurring, and ghosting.  For SE-EPI, the latter two issues should be kept in mind.  Phase-
encode blurring occurs from T2/T2* signal decay during readout.  This may be minimized 
through reduction in the acquisition time (AT) by using a higher bandwidth (BW) for a 
given number of points sampled (Nfreq).  A shorter TE value should also be used to 
increase the overall SNR.  Ghosting occurs from problems in collection of the echoes 
during readout.  This is because odd and even echoes are acquired with alternating 
gradient polarity; therefore, any mismatch between them will result in a duplicate image 
of the object.  These are referred to as N/2 or Nyquist ghosts.  In order to reduce the 
potential of having Nyquist ghosts, gradient stability is important as well as minimized 
eddy currents.  The analog-to-digital converter (ADC) rate should also match the rate of 
data collection (i.e., centering the echoes in the acquisition window). 
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Figure 1-26: Spin-echo, echo-planar imaging (SE-EPI) pulse sequence diagram with blipped phase-encode 
gradient.  Individual components include: the 90° and 180° slice-selective RF pulses, the slice-select 
gradients, the phase-encoding gradients, the frequency-encoding (readout) gradients, the rephasing 
gradients (shaded gray), and receiver channel (with the resultant signal acquisition period).  
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Figure 1-27: Spin-echo, echo-planar imaging (SE-EPI) pulse sequence diagram with a ramped phase-
encode gradient.  Individual components include: the 90° and 180° slice-selective RF pulses, the slice-
select gradients, the phase-encoding gradients, the frequency-encoding (readout) gradients, the rephasing 
gradients (shaded gray), and receiver channel (with the resultant signal acquisition period).  
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1.5.4 Diffusion-Weighted Imaging 
What is Diffusion? 
Diffusion is the process of random molecular motion (termed Brownian motion) driven 
by the inherent thermal energy of a system.  For unrestricted self-diffusion, as is the case 
in bulk-water, Einstein showed that the mean squared displacement is related to the 
elapsed time t (i.e., the diffusion time, tdif): 
 ( ) dif02 t2nDr-r =′  (1.38) 
where n is the number of dimensions and D0 is the free diffusion coefficient.  With an 
increase in tdif there is a corresponding increase in the mean-squared displacement.  In 
other words, there is a larger displacement based on initial (r) and final (r’) positions 
because of the increased time allotted for diffusion.  Because diffusion is limited in 
biological tissue (from presence of macromolecules, organelles, cell membranes, etc), 
measurement of the true diffusion coefficient D0 is not possible.  Instead, the apparent 
diffusion coefficient (ADC) is used to characterize the water mobility in tissue. 
Isotropic and Anisotropic Diffusion 
In the case of isotropic diffusion the ADC is independent of spatial orientation, meaning 
it may be measured along any direction and the same value will be obtained.  Generally, 
the restrictions imposed in biological tissue introduce a dependence of the ADC on the 
spatial orientation.  This is known as diffusion anisotropy.  In this case, the directional 
dependence is described using a 2nd-rank tensor known as the diffusion tensor: 
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DDD
DDD
D  (1.39) 
Six of the nine elements of this 3 × 3 matrix represent an independent measure of 
diffusion.  The elements along the diagonal are measurements of diffusion along the three 
principal axes (x, y, and z in Cartesian coordinates).  The off-diagonal elements represent 
the degree of correlation between random motion along two of the principal directions.  
Using Eq. 1.38 and the diffusion values along the principal axes, displacement values for 
each direction may be obtained.  These are diagrammed in Fig. 1-28 for the cases of 
isotropic diffusion and anisotropic diffusion.  For isotropic diffusion (i.e., in CSF) the 
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diffusion tensor in Eq. 1.38 reduces to a single diffusion coefficient where Dxx = Dyy = 
Dzz = D with all off-diagonal elements equal to zero.  For anisotropic diffusion, at least 
one of the diffusion values along the principal axes is unequal to the remaining two.   
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Figure 1-28: Isotropic and anisotropic diffusion described by a diffusion sphere and diffusion 
ellipsoid, respectively.  The semiaxes are equal to the amplitude of the diffusion tensor 
eigenvalues D1, D2, and D3, with the directions of the three axes coincident with the 
eigenvectors λ1, λ2, and λ3.  For isotropic diffusion, D1 = D2 = D3 = D.  For anisotropic 
diffusion, at least one of the diffusion values (D1, D2, D3) differs from the remaining two. 
 
Indices of Isotropy and Anisotropy 
In order to eliminate the diffusion dependence based on sample placement with respect to 
the applied magnetic-field gradients, measurement of the average ADC may be 
performed.  The average ADC, also termed the mean diffusivity, is calculated using the 
trace of the diffusion tensor: 
 
3
DDD
3
)DTr(D 321
++==  (1.40) 
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with D1 = Dxx, D2 = Dyy, and D3 = Dzz (D1, D2, and D3 are often referred to as the 
principal diffusivities).  This provides a scalar measure for isotropic diffusion.  In 
addition, two indices of anisotropy, relative anisotropy (RA) and fractional anisotropy 
(FA), permit estimation of diffusion anisotropy and, therefore, a measure sensitive to 
tissue fiber orientation and connectivity (15).  The RA index provides a ratio between the 
anisotropic and isotropic components: 
 ∑
=
−=
3
1i
2
i )DD(D3
1RA  (1.41) 
The RA index is a dimensionless quantity that yields values between 0 and 2 , 
representing purely isotropic diffusion and purely anisotropic diffusion, respectively.  
The FA index is similar to the RA index in the respect that it is based on the standard 
deviations of the principal diffusivities from the mean diffusivity, but differs by method 
of normalization: 
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The FA index is a dimensionless quantity that yields values between 0 and 1, 
representing purely isotropic diffusion and purely anisotropic diffusion, respectively.   
Diffusion-Imaging 
The method of diffusion-weighted imaging (DWI) was first introduced by Stejskal and 
Tanner in the 1960s (16), with in vivo DWI coming into practice in the 1980s (17).  It 
involves the application of a pair of gradient pulses of particular amplitude (G) and 
duration (δ) separated by a time ∆, resulting in an effective diffusion time tdif equal to ∆-
δ/3 and ∆-δ/4 for rectangular-shaped and sine-shaped gradients, respectively.  The 
application of the first gradient imparts phase (φ) to the nuclei: 
 [ ])0(x)T(xGdt)t(xGdt T
0
T
0
1 −γ=γ=ω=φ ∫∫  (1.39) 
where ω is the precessional frequency, dt is the time derivative, γ is the gyromagnetic 
ratio, G is the gradient applied (usually along the x,y, or z axes, but potentially any 
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direction), x0 is the initial position of the nuclei, and x(t) is the position of the nuclei at a 
time t.  Next, the nuclei are allowed to diffuse for a time tdif, after which a second 
gradient is applied. This gradient removes the phase imparted by the first gradient:   
 [ ])T2(x)T(xGdt)t(xGdt T2
T
T2
T
2 −γ=γ−=ω−=φ ∫∫  (1.40) 
If the nuclei did not move, the phase accumulation would be zero:    
 [ ] [ ] 0)T2(x)T(xG)T(x)0(xG21 =−γ+−γ=φ+φ   (1.41) 
With no movement, x(0) = x(2T), and all terms cancel.  If the nuclei do move, there will 
the two phase terms φ1 and φ2 will not cancel.  This net phase accumulation is equivalent 
to the following: 
 [ ] 0)T2(x)0(xG21 =/−γ=φ+φ   (1.42) 
Any phase accumulation resulting from the movement of the nuclei yields exponential 
attenuation of the MRI signal: 
 Dt)G(0
bD
0
dif
222
eMeMM δγ−− ==   (1.43) 
where M and M0 are the signal intensities with and without diffusion, respectively, D is 
the diffusion coefficient along the direction of the applied diffusion gradient, b is the b-
value or b-factor that controls the diffusion-weighting in individual images, and tdif is the 
diffusion time.  The b-value is user-defined by the gyromagnetic ratio γ, the gradient 
strength G, the duration of the diffusion gradients δ, and the diffusion time tdif.  A spin-
echo, diffusion-weighted imaging (SE-DWI) pulse sequence is diagrammed in Fig. 1-29.  
Diffusion weighting may be incorporated into any imaging technique, although it is 
mainly used with spin-echo imaging methods (such as HSE and SE-EPI).  In the SE-DWI 
method, there is additional signal decay based on T1 and T2 effects; therefore, the signal 
intensity M will be weighted to some degree based on the chosen TR and TE values.  To 
reduce these effects a long TR and short TE are generally used.  
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Figure 1-29: Spin-echo, diffusion-weighted imaging (SE-DWI) pulse sequence 
diagram.  Individual components include: the 90° and 180° slice-selective RF pulses, 
the slice-select gradients, the phase-encoding gradients, the frequency-encoding 
(readout) gradients, the rephasing gradients (shaded gray), and receiver channel 
(with the resultant signal acquisition period).  The diffusion gradients (highlighted 
red) of amplitude G and duration δ are separated by a time ∆, resulting in an 
effective diffusion time tdif (equal to δ-∆/3 and δ-∆/4 for rectangular-shaped and sine-
shaped gradients, respectively).  Although they are diagrammed along the slice 
direction, the diffusion gradients may be applied along any direction.     
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1.5.5 Dynamic Contrast-Enhanced Perfusion Imaging 
What is Perfusion? 
Perfusion refers to the blood flow of a system (i.e., a specific tissue or organ).  Changes 
in vascular morphology within that system induce alterations in blood flow and may be 
characterized using contrast enhancement.  Rosen et al. (18,19) employed T2*-weighted 
EPI for dynamic contrast-enhanced perfusion imaging using a gadolinium chelate.  NMR 
contrast agents such as gadolinium-based chelates cause reductions in T1 and T2 through 
alterations in the local magnetization following bolus-injection via the bloodstream.  
Based upon the relaxivity R2 and concentration [Gd] of the contrast agent, the T2 changes 
in the following manner: 
 [ ]GdR
T
1
T
1
20
22
×+=   (1.44) 
where T20 is the transverse relaxation time of blood in the absence of contrast agent.  
Rapid acquisition of images both pre- and post-contrast injection (i.e., using EPI) permit 
tracer kinetic analysis and estimations of parameters such as relative cerebral blood 
volume (rCBV) and vascular transit time (VTT).  These two parameters, rCBV and VTT, 
allow calculation of a cerebral blood flow index (CBFi). 
Extraction of Tracer Kinetic Parameters 
Following acquisition of a series of EP images during bolus administration of the contrast 
agent, the changes in the T2 relaxation rate, ∆R2(t), may be obtained: 
 ( ) ( )

×−=
0
2 M
tMln
TE
1t∆R   (1.45) 
where M(t) is the signal intensity at a time t during bolus passage of the contrast agent 
and M0 is the signal intensity value at baseline pre-contrast.  Fitting the data using a 
gamma-variate function and non-linear regression (20), integration of the ∆R2(t) curve 
yields a measure of rCBV over the course of the entire experiment (in time T):  
 ( )∫+= Tτ
τ
2 dtt∆RrCBV   (1.46) 
Further estimation of VTT is obtained from the first moment of the ∆R2(t) curve: 
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 ( )∫+= Tτ
τ
2 dtt∆RtrCBV    (1.47) 
Per previous discussion by Hamberg et al. (21), the perfusion-weighted image series, 
along with Eqs. 1.46 and 1.47, are used to calculate the CBF index: 
 
VTT
rCBVCBFi =    (1.48) 
Perfusion Imaging 
For rapid acquisition of an image series, either SE-EPI or GE-EPI may be employed.  
Although contrast agents alters both T2 and T2*, SE-EPI for T2-weighted imaging has the 
advantage of increased SNR without the problem of magnetic field inhomogeneities or 
susceptibility effects (as is the case in GE-EPI for T2*-weighted imaging).  The SE-EPI 
method has been diagrammed previously in Fig. 1-27.  The number of repetitions (Nrep) 
may be specified such that the total experiment time is equal to the Nrep multiplied by the 
TR value, with an image taken at every TR increment. 
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2.1 Background  
The formation and progression of cancer (i.e., carcinogenesis) is generally accepted as a 
multi-stage process, involving four major steps: initiation, promotion, malignant 
conversion, and tumor progression (1).  Once malignancy is present, the likelihood of the 
cancer becoming invasive and metastatic increases dramatically, decreasing the potential 
for long-term patient survival.  With this in mind, early diagnosis previous to any 
infiltration into the surrounding normal tissue is necessary.  Hand in hand with early 
diagnosis are treatment provision and determination of efficacy.  Current therapeutic 
options include surgery, fractionated radiotherapy, chemotherapy, anti-angiogenic 
therapy, photodynamic therapy, gene-specific therapy, or combination therapy.  
Therapeutic assessment of solid tumors is generally performed through noninvasive 
monitoring of tumor volume by ultrasound, CT, or MRI.  Unfortunately, changes in 
tumor volume are generally slow and do not necessarily indicate tumor viability.  
Methods investigating physiologic-based changes that precede a change in tumor volume 
while also addressing the issue of tumor heterogeneity should aid in patient management.   
Rapid identification of the therapeutic response would permit both optimization of drug 
dose and delivery and the replacement of ineffective treatment with alternative measures.  
Since 1971 and Damadian’s (2) discovery of tumor detection using nuclear magnetic 
resonance, MRI has come to serve as a powerful diagnostic tool in clinical oncology.  In 
order to understand the applicability of MRI methods to tumor tissue characterization and 
the determination of therapeutic efficacy, a discussion of the pathophysiology of cancer 
progression and the inherent heterogeneity intra- and inter-tumorally is required.  
Additionally, a discussion of viable tissue versus formation of necrosis and well-
oxygenated versus radioresistant hypoxic tissue as they pertain to the cytotoxic response 
will be covered.  This chapter should provide sufficient background for the research 
presented in Chapters 3 and 4.   
2.1.1 Pathophysiology of Cancer Progression 
Initiation, promotion, and malignant conversion are necessary for a benign growth (i.e., 
adenoma) to become malignant (i.e., carcinoma).  Initiation involves genetic changes 
such as DNA strand breaks that lead to sequence additions or deletions, altered 
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nucleotides, or frameshift mutations.  The genetic replication of such errors is dependent 
on the dynamic between cell replication and standard DNA repair processes—if 
replication is faster than the repair process, the error may become permanent.  Following 
such a mutation, specific promoters stimulate cell proliferation and hasten the movement 
from a benign to hyperplastic lesion.  One group of promoters are the growth regulatory 
proteins, including fibroblast growth factor (FGF), epidermal growth factor (EGF), 
platelet-derived growth factor (PDGF), and vascular endothelial growth factor (VEGF) to 
name a few (1).  The up-regulation of these proteins, along with the loss of tumor 
suppressor genes (i.e., p53) leads to malignant conversion and ultimate tumor 
progression. 
The Angiogenic Switch 
Tumors can grow to approximately 1-2 mm in diameter and remain quiescent for years.  
It isn’t until the switch to an angiogenic phenotype (i.e., vascularization), first 
hypothesized by Folkman in 1971 as a potential therapeutic target (3), that further growth 
occurs. This was confirmed by subsequent studies following identification of the first 
angiogenic factor, VEGF (4), and the anti-tumor effects of VEGF inhibition (5).  Tumor 
angiogenesis may be stimulated by various mechanisms: neovascularization in adjacent 
vascular beds, fibroblast/macrophage overexpression of angiogenic factors (i.e., VEGF), 
or incorporation of pre-existing vessels.  The regulation of these mechanisms is 
controlled by promoters (i.e., proto-oncogenes) and inhibitors (i.e., suppressor genes), 
and may be further modified by the tumor physiologic state (6).       
Surrounding Tissue Infiltration and Metastatic Cascade 
Concomitant with the angiogenic switch is tumor metastasis.  Several studies have shown 
a strong correlation between intra-tumoral microvessel density (MVD) in primary tumors 
and the formation of local (lymph nodal) or distant metastasis (7-9).  Additionally, 
O’Reilly et al. (10) demonstrated that removal of the primary tumor, and therefore, the 
removal of natural angiogenic inhibitors produced by that tumor, induces rapid growth of 
distant metastasis.  These studies indicate a specific role of angiogenic factors, both 
stimulatory and inhibitory, to the cascade of events required for secondary tumor 
formation.  Because newly formed capillary vessels often have gaps between endothelial 
cells and a discontinuous or absent basement membrane (11), they are structurally weak 
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and the resulting increase in vascular permeability promotes the migration of cancer cells 
into the circulation.  The overall metastatic cascade is diagrammed in Fig. 2-1. 
 
 
Figure 2-1.  Metastatic cascade of events.  A primary tumor contains cells able to give rise to 
metastatic colonies, which must bind and disrupt the basement membrane, invade the 
extracellular matrix, penetrate the vascular system, circulate, arrest themselves at a distant site 
by adhesion to the basement membrane, and finally exit the vessel (extravasation) for 
formation of metastasis [Reprinted from Coltran RS, Kumar V, Robbins SL. Pathological 
Basis of Cancer, 5th ed. Philadelphia: W.B. Saunders Co., 1994.] 
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2.1.2 Tissue Hypoxia and the Formation of Necrosis 
Tumor vessels are structurally and functionally abnormal.  The tumor vasculature, in 
contrast to normal vessels, is chaotic and tortuous.  Its vessels have endothelial fenestrae, 
widened interendothelial junctions, and a discontinuous or absent basement membrane, 
resulting in vascular hyperpermeability (12-14).  As a tumor increases in size, there is an 
increase in interstitial pressure from plasma buildup—a direct result of the inherently 
leaky tumor vasculature and a non-functional lymphatic system.  This increase in 
pressure is greatest at the tumor center, and may lead to compression of local 
microvessels (15) and restricted oxygen delivery (16).  As all cells require oxygen and 
nutrients for their survival, and since the mean oxygen diffusion distance is only 50 to 
200µm, regions lacking local blood vessels within this proximity are likely to develop 
tissue hypoxia.  Regions of chronic hypoxia many generally result in formation of 
necrosis.  Necrotic cell death (17) is a process whereby cells lose their ability to maintain 
membrane integrity, leading to Ca2+ influx, increased enzymatic activity, and failed 
energy metabolism.  The cells then swell and burst, releasing enzymes such as lipases, 
proteases, and nucleases as well as reactive oxygen species (ROS) into the extracellular 
(EC) space, extending the damage to neighboring cells.  An inflammatory response is 
initiated to clean up the dead cells, but further damage is caused from neutrophils and 
macrophages recruited to the area.  For this reason, the central region of necrosis that 
forms usually extends radially from the site of origin, with a region of semi-necrosis at its 
edge surrounded by viable tissue that is hypoxic, and well-oxygenated, well-vascularized 
tissue at the periphery.   
2.1.3 Apoptotic Cell Death  
Any cellular injury can result in apoptotic cell death.  Apoptosis, otherwise known as 
programmed cell death, is a response to specific stimuli whereby a cell decides to die 
rather than repair itself (Fig. 2-2).    
Bcl-2 and Bax: Their Respective Roles in Apoptosis 
Following cellular damage, if the Bcl-2 gene family is underexpressed or absent, 
channels can form in mitochondria (termed permeability transition (PT)), resulting in ion 
gradient failure, ROS production, and oxidative injury (18).  In addition, the release of 
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Ca2+ and proteins (cytochrome c and apopotic inducible factor (AIF)) into the cytoplasm 
leads to caspase activation, a group of enzymes that cleave structural proteins and DNA.  
Loss of membrane integrity ultimately yields cellular collapse and phagocytosis by 
neighboring viable tumor cells or macrophages.   If instead Bcl-2 is overexpressed, it 
prevents the cleavage and activation of various caspases, dysregulating the apoptotic 
pathway.  In contrast, if Bax is overexpressed it promotes PT transition in mitochondria 
and the processing and activation of various caspases, aiding continuation of the 
apoptotic cascade.   
p53 and Apoptosis 
Besides Bcl-2 and Bax, p53 also plays an important role in apoptosis.  Stimulated 
expression of p53 can cause cell-cycle arrest and DNA-damage-induced apoptosis (19).  
Since p53 deficiency in mice leads to spontaneous tumors (20), and as p53 inactivation 
by mutation exists in a variety of tumor types, p53 is a target of particular interest for 
gene-specific therapies. 
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Figure 2-2.  Mechanisms of cell death: apoptosis and necrosis.  Following a major insult such as hypoxia or 
genotoxic injury (i.e., from therapeutic intervention), cellular damage occurs.  Several mechanisms are 
involved in the decision to survive or to proceed along the pathway to cell death.  Bcl-2 expression 
dysregulates apoptosis and necrosis through inhibition of caspase processing and activation.  In contrast, 
Bax expression triggers caspase activation and subsequent apoptotic death.  p53 on the other hand, has a 
dual role.  The downregulation or absence of p53 permits cell repair, survival, and tumor progression.  The 
upregulation of p53 triggers further processes that induce cell-cycle arrest, DNA damage-induced 
apoptosis, and necrotic cell death.   
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2.1.4 Necrosis and Apoptosis 
Since there are two modes of cell death, namely necrotic cell death and apoptotic cell 
death, it is important to be able to differentiate between them.  In the case of necrosis, 
cells have critically damaged membranes and organelles and exhibit a high degree of 
swelling prior to bursting their contents into the EC space.  The cellular debris is then 
phagocytosed by local macrophages and neutrophils, leaving an acellular zone (Fig. 2-3, 
light pink region labeled ‘N’ for necrosis).  As necrosis and the inflammatory response 
induce further damage to neighboring cells, apoptosis in proximity to regions of necrotic 
formation is not uncommon, leading to a region of semi-necrosis (Fig. 2-3, between the 
solid white arrows).  During apoptosis, cells shrink, condense, and detach themselves 
from their viable neighbors prior to phagocytosis by lysosomes and/or local 
macrophages.  The identification of cells undergoing various stages of apoptosis, whether 
proximal or distal to regions of necrosis, is possible by staining for differences in genetic 
expression (i.e., levels of Bcl-2 or p53 expression), or changes in morphology (i.e., 
nuclear fragmentation using the TUNEL assay).  Apoptotic cells may be identifiable via 
hematoxylin-eosin (H&E) staining, although this method is much more cumbersome for 
quantitative versus qualitative analyses. 
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Figure 2-3.  Patterns of cell death for a RIF-1 tumor.  Hematoxylin-Eosin staining of 6µm sections (10×).  
A zone of necrosis (N) is visible, surrounded by a region of multi-focal necrosis (between the solid white 
arrows) at the interface with viable tissue (V).  Some regions of hemorrhage (H) within the neoplastic 
proliferation were also present. Scale bar = 100µm. 
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2.2 Current Therapeutic Targets 
Current therapeutic measures are generally directed at one of two cellular targets: the 
tumor cells, or the endothelial cells of the vasculature supplying the tumor with oxygen 
and nutrients for continued proliferation.  Radiotherapy and chemotherapy are mainly 
directed at tumor cells.  Anti-angiogenic therapy combats the blood supply by directly or 
indirectly attacking vascular endothelial cells.  The standard therapies (i.e., radiotherapy, 
chemotherapy) will be discussed in detail, with a brief coverage of anti-angiogenic 
therapy and gene-specific therapy.  The overall therapeutic goal is to induce tumor 
clonogenic death, regression and remission.  This is usually done via total or partial 
tumor resection, followed by fractionated treatment over a period of several weeks to 
months. 
2.2.1 Radiotherapy 
Roentgen’s discovery of x-rays in the late 19th century was and still remains the 
cornerstone of radiotherapy as a form of cancer treatment.  Following irradiation, the 
majority of cellular damage is caused by the formation of free radicals from x-ray 
interaction with the target tissue (21): 
 )radicalfreehydroxy(OHHOHraysX 2 +=+−  (2-1) 
 )radicalfreeyhydroperox(HOOH 22 =+  (2-2) 
 OH)organic(ROHRH 2+=+  (2-3) 
 )radicalfreeperoxy(ROOR 22 =+  (2-4) 
The free radicals formed in Equations 2-1 through 2-4 are the hydroxy, hydroperoxy, 
organic, and peroxy free radicals.  Since free radicals contain unpaired electrons, they are 
highly reactive and can interact via oxidation-reduction processes, damaging DNA, 
proteins, and membrane integrity.  It is important to note that hydroperoxy and peroxy 
free radical production are oxygen-dependent processes.  For this reason, well-
oxygenated tissue generally responds well to radiotherapy, whereas hypoxic tissue does 
not (22). 
Tumor Hypoxia and Radioresistance 
Tumor hypoxia contributes to both tumor progression and radioresistance (22-27).  
During hypoxia, hypoxic-inducible-factor-1α (HIF-1α) protein is upregulated in order for 
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cell adaptation to oxygen deficiency (28).  Increased HIF-1α triggers production of 
various growth factors (i.e., VEGF and FGF), stimulating angiogenesis for enhanced 
oxygen delivery, glucose transport, and a switch to anaerobic glycolysis via changes in 
gene expression.  In addition, HIF-1α overexpression enhances radioresistance through 
suppression of apoptosis (25).  In light of these findings it is not surprising that, 
depending on the severity of tissue hypoxia and the extent of HIF-1α overexpression, 
radiotherapy may be ineffective (i.e., in terms of tumor regression and patient survival).  
Burri et al. (24) reported a signification correlation between HIF-1α expression and 
outcome following radiotherapy in cervical cancer.  Additional clinical studies report 
HIF-1α as a prognostic marker of therapeutic efficacy (23,26,27).  Further studies 
investigating the role of HIF-1α in tumor progression should aid in the development of 
hypoxic-specific targets, making non-invasive imaging methods monitoring HIF-1α 
expression important for determining therapeutic response. 
2.2.2 Chemotherapy 
The development of novel chemotherapeutics, termed cytotoxic drugs, act by disrupting 
the genetic integrity of cells.  They may or may not be directed against the cell cycle.  
Those that act against the cell cycle target DNA replication (S-phase or synthesis) and 
cell division (M-phase or mitosis), the two main processes within the cell cycle itself.  
Several drugs in prevalent use today are cyclophosphamide (Cp), 5-Fluorouracil (5-FU), 
bischloroethylnitrosourea (BCNU), and Paclitaxel.   Cp and BCNU are cell-cycle non-
specific. In contrast, 5-FU and Paclitaxel are cell-cycle specific, most sensitive during S-
phase and M-phase, respectively.  It is important to note that chemotherapy agents are 
unable to distinguish between normal healthy cells and malignancy, making them more 
toxic than radiotherapy with a higher incidence of unwanted side effects.  For this reason, 
fractionated-drug delivery is usually given to prevent or, at a minimum, diminish any 
potential adverse effects.  
Hypoxia and chemotoxic resistance 
Cells experiencing either chronic or intermittent hypoxia may exhibit resistance to anti-
cancer drugs.  First, anti-cancer drugs are targeted at rapidly dividing cells.  Second, anti-
cancer drugs must traverse the chaotic tumor vasculature to reach the tumor cells.  Since 
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most hypoxic cells have retarded cell division and are located distal to capillary beds, 
therapeutic efficacy will decrease as a function of distance from the vasculature (29).  
Recent studies have reported that overexpression of HIF-1α, a hypoxic marker, 
contributes to chemotoxic resistance (30),  and that high levels of HIF-1α are associated 
with more aggressive tumors and treatment failure (31).  For this reason, investigation of 
anti-cancer drugs that are toxic only under hypoxic conditions (i.e., Tirapazamine (TPZ)) 
may be desirable.  
2.2.3 Anti-angiogenic Therapy  
Since conventional cancer therapy and current anti-cancer drugs fail to cure 
approximately 50% of cancers, it is extremely important to develop novel therapeutic 
approaches that are more effective, less toxic, and less susceptible to failure.  One 
particular avenue of research that has emerged over the last decade is anti-angiogenic 
therapy, therapies specifically targeted at destroying the tumor blood supply.   
Direct versus Indirect Inhibitors 
Angiogenesis inhibitors are either direct or indirect.  Direct anti-angiogenic therapies 
specifically target endothelial cells and tend to induce little or no drug resistance (32,33).  
Two examples are angiostatin and endostatin, both manufactured by EntreMed.  Indirect 
anti-angiogenic therapies, in contrast, target the tumor cell’s production of an angiogenic 
factor or block its receptor on endothelial cells.  Because tumor cells have high mutation 
rates, there is a high risk of relapse for indirect versus direct methods.  Two examples are 
Interferon-alpha (commercially available) and Avastin (anti-VEGF; Genentech), which 
inhibit bFGF production and VEGF production, respectively.   
2.2.4 Gene-specific Therapy  
In addition to anti-angiogenic therapy, gene-specific therapy has raised a great deal of 
interest.  The transfer or replacement of a gene offers the possibility of a “magic bullet”, 
in which cell death may be induced or a genetic mutation may be reversed.  This type of 
therapy would spare normal host cells, but current methods of delivery require further 
optimization and testing.  In general, a gene is transferred to recipient cells by agents 
called vectors.  These vectors may be viral (i.e., adenoviruses or retroviruses) or non-viral 
(i.e., liposomes).  Since p53 is the most frequently mutated gene in human cancers, gene 
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replacement therapy of p53 has been under investigation in several cancer cell lines (34-
36).  These studies have identified that replacement of p53 in combination with 
chemotherapy is more efficacious than either alone, reinforcing the importance of p53 
regulation of apoptosis and other anti-tumor mechanisms. 
 
2.3 Current MRI Methods 
MRI techniques such as DWI, dynamic contrast-enhanced (DCE) MRI, and metabolic 
imaging permit the rapid identification of tumor morphological features such as cellular 
density (for differentiation between viable tissue versus necrosis) as well as physiologic-
based parameters, namely tumor blood flow, vascular permeability, oxygenation, pH, and 
lactate accumulation.  These methods are not only useful in investigating the 
pathophysiology of tumor progression, but also in monitoring therapeutic efficacy and 
optimizing drug dose and delivery. 
2.3.1 Diffusion-weighted Imaging 
With the development of DWI methods and their utility in cerebral ischemia (37), 
researchers over the past decade have been investigating the application of DWI in the 
study of experimental tumor models (38-45) and in the clinical setting (46,47).  
Identifying Tumor Heterogeneity  
Variations in ADCs, caused by differences in cellular density, permit tumor tissue 
characterization and volumetric analysis.  Lyng et al. (43) reported that viable tissue and 
necrosis could be delineated from one another based on ADCs.  The authors also noted a 
strong correlation between ADC values and cellular density, similar to previous reports 
(40,46).  Although studies employing T2-weighted MRI are able to identify tumor tissue 
from surrounding healthy tissue, conventional imaging is unable to accurately subdivide 
the tumor into various regions based on morphological characteristics.  This is because 
T2-weighted MRI, which detects alterations in tissue water content, is less sensitive than 
DWI.  T2 changes may not be readily apparent until sufficient formation of necrosis or 
during therapeutically-induced vasogenic edema.  DWI, on the other hand, is able to 
detect evidence of small changes in cellular density, providing a tool for addressing the 
issue of tumor heterogeneity.  Carano and coworkers (45) reported the delineation 
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between viable tissue, necrotic tissue, and subcutaneous adipose tissue using a 
multidimensional feature space (ADC, T2, M0) and cluster analysis.  Comparison of MR 
parameter maps with histology indicates that regions with elevated ADCs and T2 values 
denote regions of necrosis (zones that are generally acellular), whereas regions with 
normal to moderately elevated ADCs and normal T2 values denote viable tissue.  
Although previous studies have employed similar methods for assessing the temporal 
evolution of cerebral ischemia (48-51), as well as in breast (52) and brain cancer (47),  
this was the first study to report multispectral analysis for quantification of tumor tissue 
populations. 
Predicting Therapeutic Efficacy Based on ADC Changes   
In 1996, Zhao et al. (39) reported a significant increase in ADC previous to any change in 
tumor volume, indicative of the cytotoxic response following Cp treatment.  The authors 
suggested that ADC changes might serve as a marker for monitoring treatment response, 
based on changes in cellularity and the integrity of cellular membranes.  Soon after, 
Chenevert et al. (46) demonstrated the utility of DWI for determining therapeutic 
efficacy in both an experimental 9L glioma model and the clinical setting.  Individuals 
who were responsive to therapy showed significant increases in ADCs post-therapy, 
whereas non-responders showed little to no change in ADCs.  Galons et al. (42) reported 
similar ADC changes in human breast cancer tumor xenografts following paclitaxel 
treatment.  These results indicate that DWI may serve as an early noninvasive indicator 
of therapeutic response for a variety of tumors.  Therefore, multispectral analysis that 
includes ADC may provide further information into the physiological mechanisms 
involved, as well as the morphological changes that take place, post-therapeutic 
intervention.     
2.3.2 Dynamic Contrast-Enhanced (DCE) MRI 
Since the emergence of anti-angiogenic therapies, methods for the non-invasive 
monitoring of changes in the tumor vasculature were needed.  Dynamic contrast-
enhanced MRI, described in the latter part of Chapter 1, permits measurement of mean 
transfer time (MTT), relative tumor blood volume (rTBV), relative tumor blood flow 
(rTBF), vascular permeability (PS), and a tortuosity index.  The quantitative assessment 
of these metrics should help assess the role of the vasculature in maintaining tumor 
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viability, determine any changes induced following therapeutic intervention, and 
potentially aid in prediction of therapeutic response. 
Identifying Tumor Heterogeneity 
Because tumoral angiogenesis is chaotic, the tumor vasculature itself is tortuous with 
non-functional and immature vessels, abrupt shunting, and increased permeability due to 
large endothelial cell gaps or fenestrae.  These result in intermittent or unstable flow in 
areas of low vascular density and the potential for transient episodes of hypoxia and 
upregulation of angiogenic factors.  Since tumor vascularity is spatially heterogeneous, 
rTBF, rTBV, and PS measurements may permit differentiation between benign growths 
versus malignancy.  Knopp et al. (53) reported a significantly lower exchange rate (k21) 
in benign versus malignant breast cancer, with a dependence on VEGF expression.  A 
subsequent study by van Dijke and coworkers (54) demonstrated that these tumors may 
be subclassified into slow-growing and fast-growing (aggressive) based on PS.  The 
authors noted a strong correspondence between PS and histologic MVD, the current 
standard of measure for angiogenesis.   
Predicting Therapeutic Efficacy Based on DCE-MRI Changes   
Pham et al. (55) demonstrated the utility of DCE-MRI measurements of PS in monitoring 
the response to anti-VEGF treatment in implanted human breast cancer line MDA-MB-
435 in rats.  The authors reported significant reductions in tumor growth rate and PS 
values following administration of anti-VEGF, indicative of reduced angiogenic activity.  
Gossmann et al. (56) reported similar results in a xenograft model of glioblastoma 
multiforme.  Since the level of angiogenic activity pre-treatment has been shown to be a 
prognostic indicator of therapeutic response, the non-invasive assessment of rTBF, rTBV, 
and PS using DCE-MRI would permit tumor diagnosis and grading, providing the 
clinician with a tool for patient management and treatment planning.  In addition to its 
diagnostic utility, DCE-MRI may serve as an early noninvasive indicator of tumor 
response to antiangiogenic therapy.     
2.3.3 Metabolic Imaging 
Besides changes in cellular density and hemodynamic parameters such as rTBF, rTBV, 
and PS, tumor oxygenation and metabolism play an important role in tumor progression 
and individual responsiveness to therapy.  Tumors tend to have high interstitial fluid 
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pressure from plasma buildup in the interstitial space and a non-functional lymphatic 
system.  This increase in pressure leads to compression of the blood vessels at the tumor 
interior, resulting in zones of chronic or acute hypoxia.  Concomitant with tumor hypoxia 
is a transition to anaerobic glycolysis, tissue acidosis, and lactate accumulation.  Accurate 
assessment of these processes (oxygenation, glycolysis, and lactate accumulation) should 
provide a method for noninvasively monitoring the early response to therapy.   Poptani 
and coworkers (57,58) employed MR spectroscopic methods and DCE-MRI for the 
investigation of tumor oxygenation, glycolytic rates, and lactate levels following Cp 
treatment in a RIF-1 tumor model.  In these two studies, the authors noted a significant 
decrease in glycolysis, tissue pO2, and lactate levels, and a significant increase in Gd-
DTPA uptake kinetics at 24-hours post-treatment.  The authors also suggested that these 
changes are indicative of increased aerobic metabolism and lactate clearance, owing to an 
increase in tumor perfusion and subsequent tumor reoxygenation.  These results suggest 
that MRS methods monitoring tumor metabolism, in combination with DCE-MRI, may 
be used for early assessment of therapy. 
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Abstract 
Accurate assessment of therapeutic efficacy is confounded by intra- and inter-tumor 
heterogeneity.  Variable pre-treatment tissue composition, tumor size, and growth 
kinetics, as well as post-treatment cell kill and tumor regrowth, complicate dose-
optimization and comparative treatment regimens in animal oncological studies.  In order 
to address this issue, multispectral (MS) analysis using ADC, T2, and M0 and the k-means 
(KM) clustering algorithm was employed for identification of multiple compartments 
within both viable and necrotic tissue in a radiation-induced fibrosarcoma (RIF-1) tumor 
model receiving single-dose (1000cGy) radiotherapy.  Optimization of the KM method 
was performed through histological validation via hematoxylin-eosin (H&E) staining and 
hypoxic-inducible factor-1α (HIF-1α) immunohistochemistry.  The optimum KM 
method was determined to be a 2-feature (ADC, T2) and 4-cluster (two regions each of 
viable tissue and necrosis) segmentation.  KM volume estimates, both viable (r = 0.94, p 
< 0.01) and necrotic (r = 0.76, p < 0.01), were highly correlated with their H&E 
counterparts.  Comparison of HIF-1α immunohistochemistry and standard H&E showed 
that HIF-1α expression tended to be concentrated in peri-necrotic regions, correlating to 
viable 2 and supporting the subdivision of the viable tissue into well-oxygenated (viable 
1; V1) and hypoxic (viable 2; V2) regions.  Since both necrosis and hypoxia have been 
implicated in poor treatment response and reduced patient survival, the quantification of 
the amount of necrosis and the severity of hypoxia may aid in assignment of a more 
aggressive treatment regimen.  This method may potentially provide a tool for therapeutic 
monitoring, assessment of treatment efficacy, and optimization of drug-dose and timing 
schemes, particularly in pre-clinical animal models of disease.   
  
 
Keywords: RIF-1, tumor, diffusion, multispectral analysis, HIF-1 
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3.1 Introduction 
Accurate assessment of therapeutic efficacy is confounded by intra- and inter-tumor 
heterogeneity.  Variable pre-treatment tissue composition, tumor size, and growth 
kinetics, as well as post-treatment cell kill and tumor regrowth, complicate dose-
optimization and comparative treatment regimens in animal oncological studies.  This 
chapter will address the application of multispectral (MS) analysis using ADC, T2, and 
M0 and the k-means (KM) clustering algorithm for identification of multiple 
compartments within both viable and necrotic tissue.  Histological validation was 
performed via hematoxylin-eosin (H&E) staining and hypoxic-inducible factor-1α (HIF-
1α) immunohistochemistry.  The optimum KM method determined here was applied in 
Chapter 4 for an in-depth investigation of the radiotherapeutic response. 
3.1.1 Tumor Heterogeneity 
Tumors are inherently heterogeneous, and tend to be characterized by a chaotic 
vasculature with intermittent and/or reduced blood flow (1,2).  These perfusion 
abnormalities result in inefficient cellular delivery of oxygen and nutrients, thereby 
inducing regions of either transient or chronic hypoxia.  Cellular hypoxia triggers a 
physiological cascade leading to one of two outcomes: 1) cellular repair (if necessary) 
and survival; or 2) cell death (apoptotic or necrotic) and a reduction in cellular density.  If 
a cell ‘chooses’ to survive, it is generally through altered gene expression mediated by 
HIF-1α, or hypoxic-inducible factor (3).  This protein, upregulated during hypoxia, 
induces the transcription of a variety of genes specific to glucose uptake and metabolism 
(4), iron metabolism (5), and vascularization (6-8) in order to adapt to a low oxygen 
environment . 
Tumor Hypoxia and Radioresistance 
Tumor hypoxia has been long been implicated in the non-responsiveness of tumors to 
radiotherapeutic intervention (9).  Reduced oxygen availability decreases the generation 
of reactive oxygen species (ROS) following irradiation and the damage caused by free 
radicals (10).  Several clinical studies in cervical (11-13), head and neck (14), and 
esophageal (15) cancers have shown good correlation between hypoxia and poor 
prognosis, specifically in terms of radiation response and tumor relapse.  Additional 
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studies in experimental tumor models (16,17) indicate similar results of hypoxia-induced 
radioresistance.  Cerniglia et al. (16) reported a significant increase in radiation 
sensitivity following carbogen breathing, based on an increase in tissue oxygen tension 
(pO2) from ranges of 1-8 Torr to 5-15 Torr, well above the 5 Torr limit for radiation 
sensitivity.  Zips et al. (17) demonstrated that tumors under clamp hypoxia, versus 
normal physiological conditions, required a higher dose (tumor control dose TCD50 of 
40% versus 29%) for local tumor control.  These studies confirm the importance of tissue 
oxygenation to radiosensitivity and the overall prognostic outcome following 
radiotherapeutic intervention.   
Tumor Hypoxia, Drug Resistance, and Tumor Progression 
Besides its contributions to radioresistance, hypoxia may play an important role in drug 
resistance (18,19), and has recently been suggested as a major contributor in malignant 
progression (20,21).  In instances of hypoxia, HIF-1 tends to be upregulated, promoting 
cell proliferation, tumor progression, and the formation of metastasis (22,23).  Zhong et 
al. (24), in a study of 19 different tumor types, found a significant correlation between 
HIF-1 upregulation, p53 accumulation, and cell proliferation.  The authors also noted the 
strongest HIF-1 expression in glioblastoma multiforme, the most malignant tumor of the 
central nervous system. Since cell acclimatization to hypoxia requires HIF-1 
upregulation, and because increased HIF-1 activity is concomitant with tumor 
progression, HIF-1 may serve as a prognostic marker as well as a potential therapeutic 
target. 
Formation of Necrosis and Tumor Progression 
Necrotic cell death or the formation of necrosis, a direct result of chronic hypoxia, has 
been shown to correlate with tumor aggressiveness and, therefore, results in poor 
prognosis.  Chia et al. (25) and Vleugel et al. (26) reported similar results of carbonic-
anhydrase-9 (CA-9) expression in peri-necrotic regions, with strong correlation to tumor 
necrosis, tumor grade, and a higher relapse rate in invasive breast cancer.  Vleugel et al. 
(26) also showed an association between HIF-1 expression and CA-9, an expected result 
as CA-9 is a hypoxic-regulated marker.  A similar study by Giatromanolaki and 
coworkers (27) employing CA-9 in non-small cell lung cancer also reported a strong 
association between chronic hypoxia, necrosis, and poor patient outcome.  These results 
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indicate that assessment of necrosis, for certain types of cancer, may aid in patient 
management and the assignment of a more aggressive treatment regimen.   
3.1.2 Tumor Tissue Characterization with DWI 
Because hypoxia and necrosis are interrelated, and based on their respective roles in 
tumor progression and/or resistance to therapy, the delineation between well-oxygenated 
and hypoxic tissue, as well as the identification of viable tissue versus necrotic formation, 
would aid in patient management.  At this time, standard methods for assessing hypoxia 
and necrotic fraction are performed invasively using Eppendorf needle electrodes (28,29).  
Unfortunately, this method is extremely invasive, is limited to more superficial tumors, 
and has reduced reliability at low pO2 values (< 10 Torr).  Non-invasive methods able to 
quantify tumor morphology and oxygenation status, without the shortcomings of current 
invasive methods, would provide a safer alternative.    
DWI Assessment of Tumor Morphology 
Over the past decade, diffusion imaging has emerged as a powerful contrast mechanism 
for tissue characterization in both experimental tumor models (30-35) and the clinical 
setting (36,37).  Diffusion, based on the random translational motion of molecules due to 
thermal energy (termed Brownian motion), permits the differentiation between viable and 
necrotic tissue based on changes in cellular density.  In regions with high cellularity (i.e., 
viable tissue) diffusion will be restricted by barriers such as cell membranes, organelles, 
etc.  In regions with low cellularity (i.e., necrosis), diffusion is less restricted and can be 
close to that of bulk water.  Therapeutically-induced changes in cellular density and/or 
vasogenic edema may therefore, be detected using DWI and/or quantitative ADC 
measurements, permitting treatment monitoring (38-43) and the potential for prediction 
of therapeutic efficacy (44-46). 
DWI Identification of Necrosis 
Following the seminal study by Zhao et al. (38), reporting an early post-treatment 
increase in tumor spectroscopic ADC, Chenevert and coworkers (44,45) investigated the 
contribution of tumor physiology to this ADC change by comparison of the temporal 
evolution of the therapy-induced ADC increase with histological examination on a 
timepoint-by-timepoint basis.  The authors reported a strong correlation between the 
mean ADC of the total tumor volume and cellular density calculations derived from 
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histological examination of hematoxylin-eosin (H&E) stained sections in a rat 9L glioma 
model.  They concluded the early ADC increase was a result of reduced cellular density 
concomitant with formation of necrosis.  This is diagrammed in Fig. 3-1.  Lyng et al. (32) 
confirmed this correlation between ADC, cellular density, and necrotic fraction in four 
human xenograft lines, although the degree of correlation was dependent on the size of 
the necrotic fraction.  The authors reported a significant correlation between total tumor 
ADC and necrotic fraction in the D-12 line that tended to form a large central region 
necrosis, but not with the other three lines that tended to form areas of point necrosis.  
They suggested this lack of correlation was likely a result of partial volume effects and 
inclusion of viable tumor in the small regions of necrosis characteristic of these lines.  
ADC parameter maps and the corresponding H&E sections for two of the xenografts are 
diagrammed in Fig. 3-2.   
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Figure 3-1.  Evolution of tumor ADC and the corresponding changes in 
cellular density.  (a) dose dependence of BCNU, given at 6.6 (0.5 × 
LD10, solid square), 13.3 (1.0 × LD10, solid triangle), and 26.6 (2.0 × 
LD10, solid circle) mg/kg and the corresponding change in ADC.  (b) 
through (g) correspond to histopathological changes seen on H&E 
stained sections at days 2, 4, 8, 16, and 20 post-treatment.  (h) cell 
density measurements for the 2.0 × LD10 dose of BCNU. (i) correlation 
plot of ADC versus cell density (r = 0.78).  Figure reproduced from 
reference (45). 
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Figure 3-2.  Left: ADC parameter maps (a, c) and the corresponding H&E stained sections (b, d) of a D-12 
(a, b) and U-25 (c, d) human melanoma xenograft tumor.  Red pixels represent ADCs below 0.70 × 10-3 
mm2s-1, whereas purple pixels represent ADCs above 1.25 × 10-3 mm2s-1.  Arrows indicate regions of 
necrosis.  Right: Total tumor ADC versus necrotic fraction for D-12 and U-25 human melanoma xenograft 
tumors.  Each point represents the ADC of an individual MR slice and the corresponding necrotic fraction 
on H&E.  Figure adapted from reference (32). 
 
3.1.3 Limitations of a Single Parameter Approach 
Although these reports provide strong evidence that a significant ADC increase correlates 
with changes in cellular density and formation of necrosis, mean ADC calculations based 
on total tumor volume do not address or identify tissue heterogeneity, and therefore mask 
the underlying changes in tumor tissue viability.  Helmer et al. (47) reported a correlation 
between ADC and necrotic fraction in a radiation-induced fibrosarcoma (RIF-1) tumor 
model, but only used tissue regions clearly viable or clearly necrotic in the analysis.  
Regions of mixed tissue were excluded from further analysis.  The authors suggested that 
multiple MR parameters should increase the ability to identify these regions, although 
success will depend on both the size of necrotic regions and image resolution.      
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3.1.4 Multispectral Tissue Characterization 
Intra- and inter-tumor heterogeneity complicate tumor tissue characterization and 
comparison of treatment regimens for drug dose optimization in pre-clinical cancer 
models.  With this in mind, a multispectral (MS) approach that can identify tissue 
heterogeneity should provide greater power than previous single-parameter studies.  
Recent multiparametric studies in brain (48,49) show promise in their ability to separate 
tumor from surrounding healthy tissue and in potential tumor grading (i.e., level of 
malignancy).   A similar MS approach used in breast cancer (50) was able to distinguish 
benign lesions from malignancy and surrounding adipose tissue.  Following these studies, 
a novel method combining multispectral (MS) analysis using ADC, T2, and M0 parameter 
maps was shown to aid in the differentiation between viable and necrotic tissue, as well 
as in the identification of multiple compartments within necrotic tissue (51).    Example 
results from (51) have been reproduced in Fig. 3-3.  Because T2 is based on the 
interaction between water molecules and macromolecules, regions characterized by 
hemorrhage, upregulated angiogenesis, or an inflammatory response should have shorter 
T2 values.  In the case of hemorrhage and/or upregulated angiogenesis, T2 shortening is 
caused by local inhomogeneities in the magnetic field from presence of paramagnetic 
molecules (i.e., deoxyhemoglobin).  If inflammation is present, slow exchange between 
water molecules and proteins (i.e., a result of neutrophil action) lengthens the correlation 
times (τc), also reducing T2.  Although the addition of T2 permitted subdivision of the 
necrotic tissue population, Carano and coworkers (51) reported that the extraction of the 
MS viable volume provided a more stable efficacy endpoint than total necrotic fraction.  
The authors suggested that the similarities in percent necrosis seen by day 10 between 
groups, regardless of the presence or type of therapeutic intervention, may be 
characteristic of the COLO205 cell line used—these types of tumors tend to grow 
rapidly, exceeding their blood supply and forming large regions of necrosis.  
Nevertheless, this study provides a foundation for future methods employing an MS 
approach to tumor tissue characterization.  
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Figure 3-3.  Multispectral (MS) tissue characterization using the KM clustering procedure and 
a feature space containing ADC, T2, and M0.   Figure reproduced from reference (51). 
 
3.1.5 MS Analysis with Histological Validation 
In order to gain insight into the various processes whose combination yield the total ADC 
response over time, as well as the contribution of tissue heterogeneity (viable, necrotic) to 
the treatment response, we performed MS analysis using ADC, T2, and M0 using the KM 
clustering algorithm (52)  for identification of multiple compartments within both viable 
and necrotic tissue.  The KM clustering algorithm is an unsupervised classification 
technique that has been utilized in past studies of cerebral ischemia (53,54) and tumor 
chemotherapeutic response (51).  In order to use KM, the number of clusters, k, is 
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determined a priori.  In this study, the number of clusters was determined based on 
reproducibility and the correlation between KM parameter maps and the corresponding 
histology.  The utility of adding T2 and M0 for more accurate identification of individual 
tissue populations, versus ADC alone, was assessed based on minimization of the sum of 
squared differences (SSD) for KM volume estimates and their corresponding histological 
volumes.  Hematoxylin-eosin (H&E) staining was performed for identification of viable 
tissue (broken into two sub-regions; V1, V2) versus regions of necrosis (broken into two 
sub-regions; N1, N2).  Immunohistochemical staining for hypoxic-inducible factor-1 
alpha (HIF-1α) was performed to validate the subdivision of viable tissue into well-
oxygenated (V1) and hypoxic (V2) regions.  MS tissue characterization was performed 
accordingly following optimization of method. 
 
3.2 Methods 
3.2.1 Animal Preparation 
The present study was approved by the Institute Animal Care and Use Committee 
(IACUC) of the University of Massachusetts Medical School (IACUC protocol A-544).  
Twenty-nine 6-8 week-old female C3H mice (20-25g; Taconic Farms, Germantown, NY) 
were initially anesthetized with an intraperitoneal injection of ketamine/zylazine (100 
mg/kg:10 mg/kg).  All mice were inoculated with 1 × 106 RIF-1 cells (0.15 ml), delivered 
through a subcutaneous injection into the right hind leg.  Tumors were allowed to 
develop for 3-4 weeks, yielding an approximate 1.0 cc starting volume.  Tumor volume 
was determined from caliper measurements, taken 2-3 times per week, of the three 
perpendicular axes (length, width, height) and the equation for calculating the volume of 
an ellipsoid, where V = (π/6) (l × w × h).  Animals were subsequently divided into two 
groups: a control group (N = 16) and a treatment group (N = 13).  For the control group 
(N = 16), tumors of varying volumes (1.0 cc to 2.0 cc) were imaged at a single timepoint 
and then extracted for histological examination.  For the treatment group (N = 13), 
tumors of an approximate 1.0 cc starting volume were irradiated with 1000 cGy at a rate 
of 300 cGy/min (Siemens Mevatron 77, 6 MeV electrons, Tufts University School of 
Veterinary Medicine, North Grafton, MA).  Imaging for the treatment group was 
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performed at 1d pre-treatment, 5 hr, 1d, 2d post-treatment, and every 2d thereafter until 
tumor doubling (maximum 14d post-treatment) or until tumors reached a 2.0 cc volume 
(considered a burden for the animal). 
3.2.2 Radiotherapy 
Prior to radiotherapy, animals were anesthetized with an intraperitoneal injection of 
ketamine/zylazine (100 mg/kg:10 mg/kg).   Animals were placed prone on a plastic 
board, with movement restricted by securing the forepaws and hindlegs using medical 
tape (Fig. 3-4a).  The right hind leg was pulled away from the body in preparation for the 
procedure.  First, a 0.5-cm-thick bolus of tissue-substitute (Bolx-II, MED-TEC, Inc., 
Orange City, IA), with the center cut out, was placed around the tumor and filled with gel 
(Fig. 3-4b).  In order to deliver the desired dose to the tumor center without exposing the 
underlying tissue and bone, an additional 0.5-1.0 cm thick bolus of tissue-substitute was 
placed over the top, depending on the measured tumor height (Fig. 3-4c).  Based on 
tumor length and width, custom-made cutouts from 2.0-3.0 cm in diameter were used for 
the cone size in order to limit the radiation to the tumor versus the surrounding tissue 
(Fig. 3-4d).  Following preparation, tumors were irradiated with 1000 cGy at a rate of 300 
cGy/min (Siemens Mevatron 77, 6 MeV electrons, Tufts University School of Veterinary 
Medicine, North Grafton, MA).  At the conclusion of single-dose radiotherapy, animals 
were returned to their cage where they recovered from anesthesia and were provided with 
food and water. 
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Figure 3-4.  Animal preparation for receipt of single-dose radiotherapy. (a) The animal’s 
right hind leg was pulled away from the body and secured with medical tape. (b) The 
tumor was surrounded by a 0.5-cm-thick-bolus of tissue-substitute (Bolx-II; MED-TEC, 
Inc., Orange City, IA) (c) An additional 0.5-1.0-cm-thick bolus of tissue-substitute was 
added, depending on the tumor height, in order to deliver the desired radiation dose to 
the tumor center. (d) Custom-made cutout (arrow) and positioning of setup for tumor 
irradiation. 
 
3.2.3 MRI Measurements 
MRI experiments were performed with a Bruker Biospin 2.0T/45cm imaging 
spectrometer operating at 85.56 MHz for 1H and equipped with ±20 G/cm self-shielded 
gradients (Fig. 3-5).  The experiments involved multi-slice image acquisition along the 
coronal plane [matrix size = 128 × 128, FOV = 3cm × 3cm, slices = 8, slice thickness = 
1mm].  The imaging plane was referenced to the boundary between the tumor and 
underlying muscle.  A diffusion-weighted, spin-echo (SE) sequence was used to acquire 
the images at six b-values (b = 15, 60, 140, 390, 560, 760 mm2 s-1) with diffusion 
sensitization applied along the read (x) direction.  Other acquisition parameters were:  
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TR/TE = 2000.0/53.0 ms, diffusion gradient duration δ = 4.0 ms, diffusion gradient 
separation ∆ = 35 ms, resulting in an effective diffusion time tdif = 33.7 ms. A T2-
weighted, spin-echo (SE) sequence was used to acquire images at six echo times (TE = 
12.2, 20, 35, 50, 65, 90 ms) with TR = 2000.0 ms. The experiment times were 25 min for 
diffusion and 5 min per TE value for T2, yielding a total imaging time of 55 min.  During 
imaging, animals were placed prone in a home-built animal holder with a 4-turn 1H 
solenoid coil around the tumor (Fig. 3-6).  Multiple coils of variable diameter were 
constructed (0.95, 1.35, 1.75 cm) to account for tumor volume changes in repeated 
measures experiments.  Animals were anesthetized with 1.5% isoflurane at a rate of 1.5 
L/min in breathing quality air.  Body temperature was maintained by circulating warm air 
at 34.0° ± 1.0°C using a T-type thermocouple and a double-point feedback control 
system. 
 
 
Figure 3-5. Bruker Biospin 2.0T/45cm imaging spectrometer equipped with ±20 G/cm self-shielded 
gradients.  Current software: Paravision 2.1.1. 
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Figure 3-6.  Home-built animal holder for murine RIF-1 tumor imaging. (a) Angled-
view. (b) Dual-fitted head for delivery and removal of anesthetic (c) Side-view.  
Thermocouple and circulating tube for warm air and maintenance of body 
temperature  (d) Positioning of solenoid coil to encompass the tumor during imaging. 
 
3.2.4 Data Analysis 
Parameter Map Production 
Image reconstruction was performed using Paravision’s Image Processing and Display 
Software (Xtip).  Image analysis and parameter map production was performed using 
routines written in IDL (Research Systems Inc., Boulder, CO).  ADC, T2, and M0 
parameter-map production was performed on a pixel-by-pixel basis based on the 
relationship between the natural log of the signal intensity and b-value (Eq. 3-1) or signal 
intensity and echo time (Eq. 3-2), respectively: 
 bD0eMM(t)
−=  (3-1) 
 2TE/T0eMM(t)
−=  (3-2) 
where M/M0 is the signal intensity at a particular b-value or TE value; D is the diffusion 
along a single direction, and T2 is the spin-spin or transverse relaxation time.  A linear 
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fitting procedure based on the minimization of the chi-square statistic was employed for 
extraction of MR parameters.  Underlying muscle, remaining in the lower imaging slices 
for (N = 9) animals, was removed by delineation between tissue boundaries using T2-
weighted contrast images (TE = 90ms).   
Correction of M0 Maps 
M0 map correction was performed on a pixel-by-pixel basis using homomorphic unsharp 
masking (55) and global mean fixation using the following equation:   
 ( ) ( )ji,M
µ
µ
ji,M 0
roi
global
0 =′  (3-3) 
where M0(i,j) is the individual pixel value (i,j), µroi is the mean for a 23 × 23 ROI 
centered about (i,j), µglobal is the global mean (i.e., a user-defined ‘mean’ applied to all 
tumor datasets), and M0’(i,j) is the corrected M0.  Homomorphic unsharp masking (HUM) 
(23 × 23 kernel) was applied to correct the M0 maps for distortions due to B1-field 
inhomogeneities from tumor extension beyond coil boundaries (55). The global mean of 
each of the M0 maps was set to the same arbitrary constant in order to remove temporal 
variations in M0, permitting tissue classification based on regional differences in M0.       
3.2.5 K-means Clustering 
A 3D feature vector, containing the ADC, T2, and M0 parameter maps, was generated for 
each pixel.  KM clustering was performed on a pixel-by-pixel basis using the Euclidean 
distance measure (52): 
 ( ) ( )iti µxµxD −−=    (3-4) 
where x ε R3 is the feature vector and µi is the cluster mean, both determined from all of 
the data (N = 88 datasets, all animals, all timepoints).  Prior to KM clustering, feature 
normalization (mean µ = 0, standard deviation s = 1) was performed for removal of 
potential scaling differences.  Tissue classification was then performed using KM in a 
hierarchical manner.  In the first step of the classification algorithm, KM was applied to 
separate the data into two clusters (k = 2) of tumor tissue and background noise based on 
variations in M0.  All voxels classified as noise were set to zero and removed from further 
processing.  In the second step, KM was applied for a varying number of clusters using 
between one and three features, where f = 1 (ADC), f = 2 (ADC and T2), f = 3 (ADC, T2 
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and M0), to segment the data into the following: one region each of viable tumor (V1) 
and necrosis (V2) (k = 2); one region of viable tumor (V1) and two regions of necrosis 
(N1, N2) (k = 3), two regions each of viable tumor (V1, V2) and necrosis (N1, N2) (k = 
4).  For KM with 3 features (f = 3; ADC, T2, and M0), an additional cluster was added in 
order to compensate for residual M0 inhomogeneities missed by HUM correction (i.e., 
induced by solenoidal coil contact with the tumor edge).  All KM methods were then 
compared with histology in order to determine the optimum number of clusters (k) and 
features (f). 
3.2.6 Histological Analysis 
For the control group following imaging, as well as for the radiotherapy group following 
the final imaging timepoint, animals were euthanized by an overdose of 
ketamine/zylazine (400 mg/kg:40 mg/kg).  The RIF-1 tumors were extracted based on the 
intersection between the tumor and muscle and frozen for 30 minutes.  Sections were 
taken every 2 mm starting from the base of the tumor, stored in individual tissue cassettes 
(Microcassettes, VWR International, NJ), and placed in 10% neutral buffered formalin 
(Fisher Scientific, Pittsburgh, PA).  Following fixation, a standard paraffin embedding 
procedure was used.  Tissue cassettes were marked L-R in order to preserve orientation 
for later correlative analysis between imaging and histology. 
Hematoxylin-Eosin (H&E) Histochemistry 
For all tumors, three 6µm sections, approximately 300µm apart, were taken every 1-mm 
for a total of 24 sections per tumor.  Sections were mounted on Poly-L-lysine coated 
slides (VWR International, West Chester, PA) and dried overnight on a slidewarmer at 
37°C.  Slides were then stored at room temperature until further processing.  
Hematoxylin-Eosin (H&E) staining was performed for all sections with digital images 
(1×) taken on a section-by-section basis using a Hewlett-Packard Scanner (Model #3970) 
at a resolution of 1200dpi.  Image analysis and delineation between individual tissue 
regions (viable, necrotic) was performed using KM clustering and a feature space (f = 4) 
based on the R,G,B image values and texture analysis (56) using the Hurst transform, an 
image operator used in fractal analysis for the characterization of surface roughness (57).  
The Hurst transform or coefficient was calculated on a pixel-by-pixel basis using a 7-
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pixel-wide neighborhood, and pixel labels identifying groups with the same distance from 
the central pixel (Fig. 3-7).  A linear fitting procedure of log of the distance and versus 
log of the maximum brightness range between groups in the neighborhood and the central 
pixel permitted calculation of the Hurst coefficient.  In this case, the Hurst coefficient is 
equivalent to the slope based on the best-fit line and minimization of the chi-square 
statistic.  Additional images were taken at higher resolution (2×, 10×, 20×, and 40×) for 
correspondence with HIF-1 immunohistochemistry using an upright Nikon Eclipse E400 
phase contrast microscope (Nikon, Melville, NY) equipped with an RT Color Spot 
camera (Diagnostic Instruments, Inc., Sterling Heights, MI) for image capture.  Spot 
Analysis 4.0.9 (Diagnostic Instruments, Inc., Sterling Heights, MI) software was 
employed for optimization of image quality and image acquisition. 
Hypoxic Inducible Factor 1α (HIF-1a) Immunohistochemistry 
For (N = 9) tumors (N = 5 radiotherapy, N = 4 control), additional 6µm sections were 
taken at the approximate 600um mark.  Sections were mounted on Poly-L-lysine coated 
slides (VWR International, West Chester, PA) and dried overnight on a slidewarmer at 
37°C.  Slides were then stored at room temperature until further processing.  
Immunohistochemical staining for HIF-1α was performed using a 1:75 dilution of the 
mouse monoclonal antihuman HIF-1α antibody (ab463, ABCam Inc., Cambridge, MA).   
Optimization of method and immunohistochemical staining was performed by Mass 
Histology Service (Worcester, MA).  Sections were deparaffinized and peroxidase was 
quenched with 3% H2O2 for 15 min. Slide preparation for staining was performed with 
heat-mediated antigen retrieval (Vector #H-3300 for 20 min.).  After rinsing with PBS, 
slides were incubated overnight at 2°C with the primary antibody.  Sections were again 
rinsed with PBS and incubated with a 1:250 dilution of the secondary antibody (biotin 
goat anti-mouse IgG, Vector #BA2000) for 1 hr.  After rinsing with PBS, detection was 
performed using a streptavidin-biotin-horseradish peroxidase system (Vector Elite 
#PK6100 for 1 hr).  Sections were again rinsed with PBS and color was developed by a 
15-min incubation with 3,3’-diaminobenzidine solution (DAB). Slides were lightly 
counterstained with hematoxylin.  For negative controls, the primary antibody was not 
applied.  Tumor samples with strong cytoplasmic and/or nuclear expression were 
considered to be positive. 
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Figure 3-7.  Method of analysis using the Hurst operator.  Left: 7-pixel-wide neighborhood (37 pixels total) 
used for calculation of the Hurst coefficient.  Pixel labels identify groups with the same distance from the 
central pixel. Right: Table of pixel classes and their distance from the center pixel. 
 
3.2.8 Statistical Analysis 
Data are reported as mean ± SEM.  MS estimates of individual cluster volumes 
(V1,V2,N1,N2) as well as viable volume (V1+V2) and necrotic volume (N1+N2) were 
compared with H&E histological volumes through computation of Pearson’s correlation 
coefficient to provide the degree of linear association between imaging and histological 
volume estimates.  Histology slices at the 600µm point for 1-mm sections from N = 16 
tumors were analyzed (all other H&E sections had considerable tissue loss).  
Determination of the best combination of features and clusters was established by finding 
the method with the best correlation and one-to-one correspondence between KM- and 
histologically derived tissue-volume estimates.   For each cluster/feature combination, the 
SSD of the data from the model x = y line was calculated (58): 
 ∑ −= 2KM%TTV)%TTVcal(HistologiSSD    (3-5) 
providing a method for assessment of goodness-of-fit.  The cluster/feature combination 
minimizing the SSD was chosen as the optimum with provision of good correspondence 
to histology.  All subsequent analysis was performed using the optimal cluster/feature 
combination.  The temporal evolution of individual cluster volumes and feature means 
(ADC, T2, M0), as well as total volume and feature mean, were compared on a timepoint-
by-timepoint basis between pre-irradiation and post-irradiation by Student’s t-tests 
assuming unequal variances.  The relationship between tumor size and percent necrosis, 
as well as percent necrosis for control and radiotherapy groups was investigated using 
Pearson’s correlation coefficient to provide a measure of the degree of linear correlation 
between parameters. 
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3.3 Results 
3.3.1 Optimization of KM Method 
KM segmentation was applied to divide the data into individual tissue classes based on 
the Euclidean distance measure (Eq. 3-4).  Fig. 3-8a-f shows correlation plots of KM 
percent necrotic fraction estimated using the following combinations: 1 feature (ADC) 
and 2 clusters (V1, N1); 1 feature (ADC) and 3 clusters (V1, N1, N2); 2 features (ADC 
and T2) and 3 clusters (V1, N1, N2); 2 features (ADC and T2) and 4 clusters (V1, V2, N1, 
N2); 3 features (ADC, T2, and M0) and 4 clusters (V1, N1, N2, edge); and 3 features 
(ADC, T2, and M0) and 5 clusters (V1, V2, N1, N2, edge).  Note that the addition of an 
‘edge’ cluster in the KM segmentations including M0 is necessary in order to account for 
B1 field inhomogeneities missed by HUM correction (i.e., generally from the tumor 
touching the coil edge).  The sum of squared differences (SSD) for the KM method with 
two features (ADC, T2) and four clusters (V1, V2, N1, N2) for subdivision of both viable 
and necrotic tissue yielded the minimum SSD, indicating this particular KM tissue 
segmentation approach was optimal.  A quantitative summary of the SSD values for KM 
percent necrotic fraction versus histologically-derived percent necrotic fraction, as well 
as the correlation between KM tissue volumes estimates and their corresponding 
histological volumes are provided in Table 3-1.  Although Pearson’s correlation 
coefficient for KM versus histologically-derived necrotic volumes was the best for using 
a single feature (ADC) and two clusters (r = 0.76), the SSD was the lowest for where two 
N1, N2).  Pearson’s correlation coefficient for KM versus histologically-derived viable 
volumes was identical for the two methods (r = 0.94).    In addition, there was a strong 
correlation between KM versus histologically-derived viable volumes (r = 0.80) and a 
moderate-to-strong correlation between KM and histologically-derived necrotic volumes 
(r = 0.61) as determined on a slice-by-slice basis (Fig. 3-9).  These results indicate that 
the addition of T2 permits more accurate identification of the total necrotic fraction of the 
tumor with good slice-by-slice correspondence between KM and histologically-derived 
necrotic slice volumes; and similar reliability in total viable tissue estimates to ADC 
alone.   
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Figure 3-8.  Correlation plots of histologically-derived percent-tumor-necrotic fraction (%TNF) versus 
KM-derived estimates.  The x = y line provides a visual reference for the distribution of the data relative to 
the optimal model, i.e., a one-to-one correspondence.  KM feature assignments are labeled on individual 
plots with designations as follows: f = feature, k = cluster, V1 = viable 1, V2 = viable 2, N1 = necrosis 1, 
N2 = necrosis 2, and edge = tumor edge (this cluster was added in order to compensate for low M0 values 
introduced by the tumor edge touching the coil.  The optimum KM method (d) exhibits the smallest 
deviations from the model x = y line, and therefore, the smallest sum of squared differences (SSD). 
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Table 3-1.  Correlative Summary Between Various KM Methods and Histologically-Derived 
Estimates of Percent Tumor Necrotic Fraction, Viable Tumor Volume, and Necrotic Volume. 
Features Clusters SSD (%TNF) 
r-value 
(Viable) 
r-value 
(Necrotic) 
ADC 2 1119 0.94 0.76 
ADC 3 19441 0.82 0.72 
ADC, T2 3 3306 0.93 0.75 
ADC, T2 4 588 0.94 0.69 
ADC, T2, and M0 4 1053 0.94 0.75 
ADC, T2, and M0 5 713 0.92 0.68 
SSD = sum of squared differences 
 %TNF = Tumor Necrotic Fraction 
r-value = Pearson’s correlation coefficient 
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Figure 3-9.  Correlation plot of KM volume estimates (f = 2, k = 4) on a slice-by-slice basis for viable and 
necrotic tissue populations versus histologically-derived estimates.  There was a strong correlation between 
estimates for viable tissue (r = 0.80) and a moderate-to-strong correlation between estimates of necrosis (r = 
0.61) per determination on a slice-by-slice basis.  The non-zero y-intercepts correspond to an overstimation 
of KM volume versus that of the histologically-derived volume.  This overestimation is most likely from 
tissue shrinkage during histological preparation.   
   
3.3.2 KM Segmentation Results 
Based on the optimal KM approach using two features (ADC and T2) and four clusters, 
tissue segmentation was performed in a hierarchical manner according to Fig. 3-10.  
Representative ADC and T2 parameter maps, their normalized values, and the 
corresponding KM segmentation map and histological H&E sections are shown in Fig. 3-
11.   For the KM segmentation map (Fig. 3-11, 5th column), individual tissue regions 
have been color-coded such that: red = necrotic 1, blue = necrotic 2, green = viable 1, and 
yellow = viable 2.  Mean feature values for individual tissue populations, obtained via 
clustering of all datasets together (N = 88 datasets, over all timepoints), are summarized 
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in Table 3-2.  These results indicate the existence of two unique subpopulations within 
both viable and necrotic tissue.  Both necrotic regions were characterized by high ADC 
values, but differed based on T2.  Necrosis 1 had both high ADCs and long T2 values, 
whereas necrosis 2 had shorter T2 values.  The viable tissue regions differed in both ADC 
and T2. Viable 1 had both low ADCs and low T2 values, whereas viable 2 had 
intermediate ADCs and T2 values lower than that of viable 1.  These KM tissue volume 
estimates, as described in Section 3.3.1, are well correlated with their corresponding 
histological estimates.  The KM viable volume estimates (746 ± 320 mm3) were strongly 
correlated (r = 0.80, p < 0.01) with the histologically-derived viable volumes (496 ± 237 
mm3), and the KM necrotic volume estimates (226 ± 129 mm3) were moderately to 
strongly correlated (r = 0.61, p < 0.01) with the histologically-derived necrotic volumes 
(111 ± 62 mm3).  The average KM total tumor volume was 972 mm3, in comparison to 
the average histological volume of 607 mm3.   
 
 
Viable 1 Viable 2 Necrosis 1 Necrosis 2
Tumor Background
All MS Pixels
 
 
Figure 3-10.  Organizational chart diagramming the hierarchical method of 
KM clustering performed for multiparametric segmentation of tumor into four 
tissue populations.  In the first step (k = 2), KM clustering was applied for 
segmentation of the tumor from background noise voxels based on differences 
in M0.  Following removal of the background (by setting values to zero), the 
remaining tumor voxels were segmented into four tissue populations (k = 4), 
two each for viable tissue and necrosis using a 2-dimensional feature space 
including ADC and T2.  
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Figure 3-11.  KM segmentation results for a representative tumor with corresponding histology via 
H&E histochemistry.  ADC and T2 parameter maps are shown in the 1st and 2nd columns, with their 
corresponding normalization maps in the 3rd and 4th columns.  These normalization maps were used for 
MS analysis using KM clustering and the Euclidean distance, with k = 4 clusters and f = 2 features, 
namely ADC and T2.  The final KM segmentation map is shown in the 5th column, with color 
designations such that red = necrosis 1, blue = necrosis 2, green = viable 1, yellow = viable 2.  The 
corresponding H&E histological sections are given in the last column on the right. 
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Table 3-2.  Mean feature values (ADC and T2) for individual tissue populations following 
KM segmentation using k = 4 clusters.   
Features 
ADC 
(× 10-5 cm2s-1) 
T2 (ms) 
total number 
of voxels % of total 
Viable 1 0.76 ± 0.05 60 ± 20 627227 56 
Viable 2 1.11 ± 0.05 50 ± 20 374936 34 
Necrosis 1 2.2 ± 0.4 139 ± 15 11896 1 
Necrosis 2 1.8 ± 0.1 68 ± 6 103951 9 
Parameters were derived on an animal-by-animal basis based on the clustering of all 
datasets together (N = 29 animals, 88 total datasets over all timepoints).  Data are 
presented as mean ± SD.   
 
3.3.3 Correlation with Histology 
KM Segmentation and H&E Staining of Tumor Morphology 
Fig. 3-12 shows the KM segmentation map (Fig. 3-12a) and the corresponding H&E 
stained section (Fig. 3-12b) for a single-slice, with high-power (20×) images for 
identification of morphological features contributing to the ADC and T2 values measured 
in individual regions (Fig. 3-12c-f) labeled as: 1 = necrosis 1, 2a,b = necrosis 2; 3 = 
viable 1; 4 = viable 2.  Necrosis 1 was generally acellular in nature, whereas necrosis 2 
had a sparse population of cells intermixed with intact red blood cells (RBCs).  Viable 1 
was very cell-dense, whereas viable 2 had a slightly reduced cell density with greater 
vascularity.  Fig. 3-13 shows higher power (40×) images corresponding to the (20×) 
images in Fig. 3-12c-f.  Necrosis 1 (Fig. 3-13a) shows evidence of inflammation, 
indicated by the presence of neutrophils (blue arrows) recruited to the area to remove 
residual cellular debris (red arrows).  In addition, the remaining structure post-cell death 
appears to have begun to degrade, and the few remaining cells in the region are in the 
process of nuclear fragmentation, termed karyorrhexis (yellow arrows).  Necrosis 2 (Fig. 
3-13b), in contrast to necrosis 1, has a sparse population of cells undergoing apoptotic 
cell death intermixed with RBCs that have accumulated in the interstitial space either  
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Figure 3-12.  KM segmentation map for a single-slice from a representative RIF-1 tumor with 
corresponding histology.  (a) KM map based on segmentation using 2 features (ADC, T2) and 4 
clusters.  Individual tissue populations are color-coded such that: red = necrosis 1; blue = necrosis 2; 
green = viable 1, and yellow = viable 2.  (b)  H&E stained section.  Regions of interests were chosen 
for investigation of the underlying morphological contribution to the measured ADC and T2 values, 
with: 1 = necrosis 1; 2 = necrosis 2; 3 = viable 1; 4 = viable 2.   These regions correspond to the 20x 
images in (c) through (f).  Scale bar = 50µm. 
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Figure 3-13.  H&E images taken at 40× magnification, corresponding to the regions specified in 
Fig. 3-12.  (a) Necrosis 1.  This region is generally acellular in nature.  (b) Necrosis 2.  This 
region is characterized by a sparse population of cells intermixed with red blood cells.  (c) 
Viable 1.  This region is fairly cell-dense, with blood vessels around 10µm in diameter.  (d) 
Viable 2.  This region has a slightly lower cell density than (c), and is characterized by dilated 
blood vessels of an approximate 25µm-diameter.  Morphological identification of enzymatic 
actions and repair mechanisms concomitant with apoptosis and/or necrosis are labeled by 
arrows:  green = pyknosis, yellow = karyorrhexis, blue = neutrophil invasion, red = nuclear 
dusting.  Scale bar = 25µm. 
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from hemorrhage or a leaky vasculature.  This accumulation of RBCs leads to 
inflammation, indicated again by the presence of neutrophils (yellow arrows).  Cells in 
this region are undergoing nuclear karyorrhexis (yellow arrows) or pyknosis (green 
arrows).  Pyknotic nuclei exhibit degradation of both nuclear DNA and cytoplasmic 
RNA, resulting in nuclear shrinkage.  Unlike the necrotic regions, Viable 1 (Fig. 3-13c) is 
extremely cell-dense, with no evidence of inflammation or RBC accumulation.  Viable 2 
(Fig. 3-13d), on the other hand, has a slightly reduced cell-density over that of viable 1, 
with an abundance of dilated blood vessels.  These blood vessels are approximately 
25µm in diameter in comparison to 10µm for viable 1.   
HIF-1α Immunohistochemistry and Identification of Hypoxia 
Fig. 3-14 shows high power (10×, 20×, and 40×) images for control slides receiving only 
the secondary antibody (i.e., no anti HIF-1α).  Note that viable tissue (V) and necrosis 
(N) showed neither positive staining nor any residual background staining.  Fig. 3-15 
shows high power (10×, 20×, and 40×) images for HIF-1α immunostaining and the 
corresponding H&E stained regions.  Nuclei staining an intense brown (Fig. 3-15e, black 
arrows) indicate upregulated HIF-1α expression specific to hypoxia.  Cells with 
overexpression of HIF-1α were generally located in peri-necrotic regions, although some 
cells in areas more distal to necrosis did have some HIF-1α activity.  These cells stained 
a faint brown (Fig. 3-15e, brown arrow), and likely had HIF-1α expression unrelated to 
hypoxia.  This is reiterated in Fig. 3-16.  The first image (Fig. 3-16a) shows the viable 
tumor region for a control slide receiving only the secondary antibody (i.e., no anti HIF-
1α).  The next image (Fig. 3-16b) shows the viable tumor region, which is presumably 
non-hypoxic, with a diffuse light brown staining of cells with some HIF-1α activity.  The 
cells with light staining have no characteristic spatial pattern.  Fig. 3-16c, unlike the 
diffuse staining in Fig. 3-16b, exhibits cells with intense brown staining located 
specifically in peri-necrotic regions.   This HIF-1α activity is specific to hypoxia.   
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Figure 3-14.  Negative control slides for HIF-1α immunostaining with corresponding H&E 
histochemistry.  (a) HIF-1α negative control image (10×) denoting viable tissue (V) and necrosis (N).  
(b) Corresponding H&E stained section. (c) HIF-1α negative control image (20×).  (d) HIF-1α 
negative control image (40×).  Scale bar = 100µm for (a) and (b), 50µm for (c), and 25µm for (d).   
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Figure 3-15.  HIF-1α immunostaining with corresponding H&E histochemistry.  (a) HIF-1α image (10×) 
denoting viable tissue (V) and necrosis (N).  (b) Corresponding H&E stained section. (c) HIF-1 image 
(20×) from inset in (a).  (d) Corresponding H&E stained section.  (e) HIF-1α image (40×) from inset in (c).  
(f) Corresponding H&E stained section.  HIF-1α positive nuclei in peri-necrotic regions stain an intense 
brown (black arrows), HIF-1α negative nuclei stain light blue (from the hematoxylin counterstain, brown 
arrow), and nuclei with non-specific HIF-1α activity (i.e., unrelated to hypoxia) stain a faint brown (red 
arrow).  Scale bar = 100µm for (a) and (b), 50µm for (c) and (d), and 25µm for (e) and (f).     
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3.3.4 Temporal Evolution of KM Volume 
Fig. 3-17 illustrates the temporal evolution of individual KM volume estimates pre- as 
well as post-irradiation.  The overall trend of the total KM volume is a volume decrease 
to day 2, followed by tumor regrowth from day 2 to day 8.  Changes in KM viable 
volume mirror the changes in total KM volume.  In contrast, KM necrotic volume 
consistently increases out to 2d post-irradiation, at which point it levels off.  With the 
decrease in viable 1 out to day 2 there was a concomitant increase in viable 2.  After day 
2, both viable 1 and viable 2 slowly but steadily increased.  In terms of individual 
necrotic regions, necrosis 1 remained unchanged with time, whereas necrosis 2 increased 
in volume to day 4, after which it leveled off.  This trend for necrosis 2 followed very 
closely to that of the total volume, not surprising as the majority of the necrotic volume 
was necrosis 2 versus necrosis 1. 
 
 
Figure 3-16.  Delineation between HIF-1α
activity specific or non-specific to hypoxia. 
(a) HIF-1α negative control slide in viable 
tissue.  (b) HIF-1α activity in viable tissue, 
non-specific to hypoxia (c)  HIF-1α activity 
in peri-necrotic regions, specific-to hypoxia.  
Note the intensity differences for stained 
nuclei.  Images are 20×.   Scale bar = 50µm. 
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Figure 3-17.  Temporal evolution of individual KM cluster volumes pre- and post-irradiation.  
The overall volume decreases post-irradiation out to day 2, with subsequent tumor regrowth post 
day 2.  The underlying contributions to changes in tumor volume are visible by inspection of 
individual tissue populations (viable, necrotic), as well as the subpopulations within both viable 
and necrotic tissue.  Data are presented as mean ± SEM.  Values for each timepoint are based on 
the radiotherapy animals (n = 11, 12, 9, 8, 9, 8 for 5h, 1d, 2d, 4d, 6d, and 8d respectively).  
Differences in number of animals per timepoint are based on tumors reaching 2.0cc, considered a 
burden for the animal. 
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3.4 Discussion 
3.4.1 Determination of Optimum KM Method 
In order to address the issue of tumor heterogeneity, MS analysis using ADC, T2, and M0 
parameter maps and the KM clustering algorithm was performed.  Subdivision into 
individual tissue populations was based on similarities in feature space using the 
Euclidean distance measure (Eq. 3-4).  The optimum number of clusters and features 
providing the best segmentation of tumor tissue is unknown a priori.  Since the 
number(s) of clusters are chosen by the user, it is extremely important to identify the 
optimum number of clusters for tissue segmentation before further analysis.  Selection of 
too few or too many clusters will result in reduced sensitivity to tissue heterogeneity 
and/or poor correspondence with histology.  For this reason, both the number of clusters 
and the number of features were varied in order to determine the optimal KM method for 
addressing intra- and inter-tumor heterogeneity.  The results for individual cluster/feature 
combinations are diagrammed in Fig. 3-8.  Correlation plots of KM Volume presented as 
percent-tumor-necrotic fraction (%TNF) versus histologically-derived %TNF show that 
the option using 2 features (ADC, T2) and 4 clusters minimized the sum of squared 
differences (SSD) to a value of 588 over all other methods (Table 3-1).  The addition of 
T2 over that of segmentation using ADC alone reduced the SSD from 1119 to 588, 
permitting more accurate division between viable and necrotic tissue.  Both segmentation 
methods, ADC alone or ADC with T2, showed the same correlation between viable-
volume estimates (r = 0.94) and similar values for necrotic-volume estimates (r = 0.76 for 
ADC alone and r = 0.69 for ADC with T2).  Although Pearson’s correlation coefficient 
was slightly lower with the addition of T2, the 2-feature method provided a better 
estimate for the necrotic fraction (i.e., less overestimation) than ADC alone (Fig. 3-8a 
versus Fig. 3-8d).  For segmentation with ADC and T2, besides a strong total volume 
correlation between viable and necrotic tissue estimates (Fig. 3-8d), there was also a good 
slice-by-slice correlation between KM viable (r = 0.81, p < 0.01) and necrotic (r = 0.61, p 
< 0.01) estimates and their corresponding histologically-derived volume estimates (Fig. 
3-9).  These values were generally overestimated (~38%), probably a result of tissue 
shrinkage from histological preparation using formalin fixation versus section loss.  
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Formalin is known to cause tissue shrinkage and deformation (59).  The addition of M0 
didn’t change the SSD or correlation values by a significant amount.  Since segmentation 
including M0 required an additional cluster to compensate for reduced M0 values at the 
tumor edge (i.e., from B1 field inhomogeneities), it was concluded that M0 only added 
potential variability in the segmentation process and would compromise the ability to 
translate this technique to other oncological models.       
3.4.2 KM Delineation Between Viable Tissue and Necrosis 
Following methological optimization, analysis of results from the 2-feature, 4-cluster 
method (ADC and T2 with subdivision into two regions each of viable tissue and 
necrosis) was performed.  The final KM segmentation according to normalized ADC and 
T2 values and the corresponding histology via H&E is shown in Fig. 3-11, with a 
quantitative summary of the data in Table 3-2.   
KM Subdivision of Necrosis 
Superior to ADC alone, the addition of T2 to the MS feature space permitted 
segmentation of both viable tissue (well-oxygenated vs. hypoxic) and necrosis (acellular 
vs. mixed).  Using ADC alone for division between viable and necrotic tissue tended to 
overestimate the size of the necrotic region (Fig. 3-8a), and attempts at further 
subdivision of the necrotic region failed, resulting in gross overestimation of %TNF (Fig. 
3-8b).  With the addition of T2, two necrotic regions were identifiable.  Because necrosis 
1 is generally acellular (Figs.3-12c and 3-13a), the T2 values tend to be relatively long 
due to short correlation times (τc) and a homogeneous environment with properties close 
to that of bulk water.  Necrosis 2 (Figs.3-12d and 3-13b), on the other hand, is 
characterized by a sparse population of cells intermixed with RBCs.  The intact RBCs, 
present from hemorrhage and/or a leaky vasculature (60), recruit neutrophils to the area 
(Fig. 3-13b, blue arrows).  Most likely, this combination of RBCs, protein accumulation 
from neutrophil action, and the presence of a small cellular population leads to shorter T2 
values.  RBCs with a high deoxyhemoglobin/methemoglobin (Hb/MHb) content are 
paramagnetic; therefore, they induce small local changes in the magnetic field, dephasing 
the transverse magnetization and shortening T2 (61,62). Neutrophil accumulation and the 
remainder of cells both increase the amount of protein and macromolecules in the area, 
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which, when complexed with water, lengthen the correlation times and also shorten T2.  
Both necrotic regions had higher ADC values than regions characterized as viable tissue. 
KM Subdivision of Viable Tissue 
Employment of both ADC and T2 permitted subdivision of the viable tissue as well.  
Viable 1 (Fig. 3-12e and 3-13c), presumably well-oxygenated tissue, was extremely cell-
dense, free of any inflammation or RBC accumulation.  This high cellular density results 
in increased diffusion restriction through the greater presence of cellular membranes and 
organelles, leading to ADC values of ∼0.76 × 10-5 cm2s-1 (Table 3-2).  Viable 2 (Fig. 3-
12f and 3-13d), on the other hand, differs from viable 1 in both ADC and T2.  Viable 2 
has a slightly reduced cellular density from that of viable 1, with a greater abundance of 
dilated blood vessels (Fig. 3-13d) than viable 1 (Fig. 3-13c).  The viable 2 region of some 
tumors also showed evidence of RBC accumulation in the interstitial space either from 
hemorrhage or a leaky vasculature (60), and through cross-sections of vessels present in 
the area (data not shown).  The reduced cellular density and the presence of RBCs 
account for the elevated ADCs and reduced T2 values, respectively, in contrast to viable 1 
(Table 3-2). Previous reports by Ryschich and coworkers (63,64) show vessel dilation as 
the first detectable stage of ongoing angiogenesis, prior to vessel sprouting.  The authors 
concluded that vessel dilation permits an increased endothelial diffusion surface for 
delivery of O2 to surrounding tissue.  This suggests that the presence of vessel dilation in 
viable 2 to approximately 25µm from normal values around 10µm to 15µm is a 
compensatory response to a reduced oxygen environment. 
3.4.3 KM Identification of Hypoxic Tissue 
HIF-1, or hypoxic-inducible factor, is upregulated during hypoxia, inducing transcription 
of a variety of genes in order to adapt to a low oxygen environment (4-8).  HIF-1 itself is 
composed of two subunits, HIF-1α and HIF-1β.   In a normal, well-oxygenated setting, 
these are separate and inactive.  Under hypoxic conditions, HIF-1α upregulation leads to: 
1) dimerization with HIF-1β to form an active transcription factor, 2) interaction with 
hypoxia response elements (termed HREs), and 3) subsequent genetic transcription (65). 
 
 
MS QUANTIFICATION OF TISSUE TYPES IN A RIF-1 TUMOR MODEL 109
Peri-Necrotic Expression of HIF-1α 
In order to help validate subdivision of the viable tissue into subpopulations, namely 
well-oxygenated versus hypoxic tissue, HIF-1α immunohistochemistry was performed.  
Initial verification of HIF-1α-specific staining of the nuclei versus non-specific 
background staining was performed via negative control slides (Fig. 3-14a, no anti-HIF-
1α) with comparison to H&E (Fig. 3-14b) of the same region.  No staining of nuclei was 
observable in viable (V) or necrotic (N) regions (Fig. 3-14c,d).  Fig. 3-15 shows images 
of HIF-1α expression and the corresponding H&E stained section.  HIF-1α expression 
was highest in peri-necrotic regions, exhibited by nuclei staining an intense brown (Fig. 
3-15e, black arrows), versus normal cells (Fig. 3-15e, brown arrow) or cells with non-
specific HIF-1α activity (Fig. 3-15e, red arrow).  Fig. 3-16 further demonstrates the non-
specific HIF-1α expression in comparison to regions adjacent to necrosis (i.e., viable 2). 
These results are consistent with previous studies reporting concentrated HIF-1α 
expression in peri-necrotic regions and a heterogeneous distribution of expression 
throughout the tumor area (15,24,26,66).  Expression throughout the tumor distal to 
regions of necrosis could potentially be from small hypoxic microenvironments, but HIF-
1α activity in these areas is more likely from genetic upregulation of HIF-1α rather than 
hypoxic-mediated expression.  Since HIF-1α expression in viable 1 was either non-
existent or heterogeneously distributed (Fig. 3-16b) versus that of the concentrated 
expression in viable 2 (Fig. 3-16d), the HIF-1α expression in viable 2 is likely an indirect 
measure of hypoxia.  These results support the delineation between viable 1 and viable 2, 
as well as the identification of viable 1 as well-oxygenated tissue and viable 2 as hypoxic.  
Because tumors have varying viability, with well-oxygenated and hypoxic viable tissue 
and regions of necrosis, by subdividing major regions (viable, necrotic) some of the 
complexity may be addressed.  Although the correspondence between regions of HIF-1α 
and KM volume estimates was analyzed in a more qualitative manner, these results 
suggest that the subdivision of viable tissue into well-oxygenated and hypoxic regions is 
plausible.  Further study at higher resolution using this methodology and the addition of 
pO2 and lactate concentration to the feature space should permit a more accurate 
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assessment of well-oxygenated versus hypoxic tumor tissue and the exact correspondence 
between KM regions and areas of HIF-1α expression. 
3.4.4 Temporal Evolution of KM Volume 
Following radiotherapy, the temporal evolution of individual tissue regions and their 
overall contribution to tumor regression and regrowth was investigated.  Fig. 3-17 
diagrams the temporal evolution of total tumor volume, viable and necrotic volume, and 
the subpopulations within both viable and necrotic tissue.  The overall response of the 
tumors was a reduction in total volume out to day 2, followed by tumor regrowth.  
Underlying this change, there was a general reduction in viable volume out to day 2, 
followed by tumor regrowth—this trend for viable tissue followed that of the total tumor 
response.  In addition, the necrotic volume increased post-treatment out to day 4, 
followed by a plateau.  In terms of the subpopulations within viable tissue, there was a 
decrease in viable 1 volume post-irradiation concomitant with an increase in viable 2 out 
to day 2.  After day 2, both viable 1 and viable 2 increased, although the change in viable 
1 was significantly more pronounced.  At day 4 viable 2 plateaued, but viable 1 continued 
to increase.  These results indicate tumor regression via a transition from well-
oxygenated to hypoxic tissue induced by radiotherapeutic intervention and the formation 
of necrosis out to day 4, followed by tumor regrowth.  The overall change in necrosis 
from pre- (9%) versus post-irradiation (15%) was substantial, approximately a 67% 
increase in necrosis following single-dose radiotherapy.  
3.4.5 Utility of the KM Method 
Advantage of MS Analysis over Single Parameter Approaches 
Although several studies have shown that increases in total tumor ADC prior to any 
change in tumor volume are indicative of a positive-treatment response (40,44-46), the 
evaluation of the tumor in this manner confounds ones ability to address intra-tumor 
variability.  With a reduction in tumor necrotic fraction, the total tumor ADC approaches 
ADC values consistent with that of viable tissue.  If small sub-populations of necrosis are 
present, changes in the overall necrosis may be small and would show little to no change 
in total tumor ADC.  In addition, regions of mixed viability exist.  Tissue may not 
necessarily be clearly viable or clearly necrotic.  A single feature such as ADC, although 
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a fairly good estimate for regions that are viable or necrotic, lacks the sensitivity to 
identify these regions of mixed viability. 
Combating Tumor Heterogeneity 
Overall, these results indicate that MS analysis using the KM method with ADC and T2 
provides a way of addressing inter- and intra-tumor heterogeneity through identification 
of individual tumor tissue populations.  This particular method was able to identify 
subpopulations within both viable and necrotic tissue, and more importantly, the 
delineation between well-oxygenated versus hypoxic tissue.  Since both necrosis and 
hypoxia have been implicated in poor treatment response and reduced patient survival, 
the quantification of the amount of necrosis and the severity of hypoxia may aid in 
assignment of a more aggressive treatment regimen.  Additionally, through identification 
of individual tissue regions, their relative contributions to the overall therapeutic response 
may be investigated, permitting a method for therapeutic monitoring and optimization of 
drug-dose and timing schemes in pre-clinical animal models.   
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Abstract  
Assessment of therapeutic efficacy is confounded by intra-tumor and inter-tumor 
heterogeneity.  Variable pre-treatment tissue composition, tumor size, and growth 
kinetics, as well as post-treatment cell kill and tumor regrowth complicate dose-
optimization and comparative treatment regimens in animal oncology studies.  In 
addition, the roles of various processes (vasogenic edema, reduced cell density, formation 
of necrosis, and tumor regrowth) with potential contribution to the temporal evolution of 
the total apparent diffusion coefficient (ADC) are not fully understood.  In order to 
address these issues, a multi-spectral (MS) approach, combining ADC and T2 parameter 
maps with k-means (KM) clustering, was employed for estimation of multiple 
compartments within both viable tumor tissue and necrosis following single-dose (1000 
cGy) radiotherapy in a radiation-induced fibrosarcoma (RIF-1) tumor model.  The 
individual contributions of cell kill and tumor growth kinetics (tumor doubling time 
(TDT) pre- and post-irradiation, tumor growth delay (TGD), cell kill) to the radiotherapy-
induced response were investigated.  A moderate-to-strong correlation was found 
between the change in KM total viable volume and the resultant TGD (r = 0.62) and cell 
kill (r = 0.65).  An increase in pre-treatment viable 1 correlated with a decrease in both 
TGD (r = 0.68) and cell kill (r = 0.71).  There was no correlation between pre-treatment 
viable 2 volume and TGD or cell kill.  These results suggest that viable 2 is well-
oxygenated, radiosensitive tissue, while viable 2 is hypoxic, and therefore, radioresistant.  
The roles of therapeutically-induced vasogenic edema and formation of necrosis to the 
early ADC response post-treatment, as well as the role of individual tissue components to 
the ADC response during tumor-regrowth were investigated.  The trend in increased total 
ADC was observed prior to an increase in necrotic fraction (visible beyond day 4 post-
treatment).  This trend is driven by the increase in total viable tissue ADC, specifically 
that of viable 1.  Because there are no changes in T2, which would be indicative of edema 
based on changes in water content, these observations suggest that the early increase in 
total ADC is in fact based on a slight reduction in cell density, and not that of radiation-
induced vasogenic edema.  This method should be helpful in monitoring the range of 
tissue viability as a function of time post-treatment, as well as understanding the 
underlying mechanisms contributing to the temporal evolution of the total ADC response.  
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Quantitative assessment of individual tissue regions, tumor growth rates (TDT and TGD), 
and cell kill should provide a more accurate method for therapeutic monitoring and 
optimization of drug-dose and timing schemes in pre-clinical animal models by 
eliminating the issue of inter-tumoral variability. 
 
Keywords: RIF-1, tumor, diffusion, multispectral analysis, radiotherapy 
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4.1 Introduction 
Early increases in ADC post-treatment have been hypothesized to indicate a decrease in 
cell density and formation of necrosis, indicative of a positive treatment response.  At this 
time, the underlying mechanisms that contribute to the total ADC response are not fully 
understood.  This chapter addresses the application of multispectral (MS) analysis using 
ADC and T2 parameter maps and the k-means (KM) clustering algorithm to follow the 
tumor response to radiotherapeutic intervention.  The role of individual tissue regions to 
the total ADC response and their correlation with tumor growth kinetics should provide a 
better understanding of the physiological dynamics of pre- versus post-treatment tumor 
response.   
4.1.1 DWI Assessment of Treatment Response 
Clinical assessment of therapeutic efficacy is generally based on changes in tumor 
volume.  Unfortunately, changes in tumor volume are generally slow, preventing early 
assessment and modification of therapy based on individual responsiveness.  The ability 
to predict therapeutic response on an individual basis would minimize potentially harmful 
side-effects and toxicity issues, especially for patients with non-responsive tumors who 
should be reassigned to an alternative form of treatment.  Over the past decade, diffusion 
imaging has emerged as a powerful contrast for tissue assessment following 
chemotherapeutic and/or radiotherapeutic treatment in experimental tumor models (1-5), 
as well as in clinical oncology (6-8).  The first major study showing a substantial increase 
in the tumor apparent diffusion coefficient (ADC) of water post-treatment was done by 
Zhao et al. (1).  The authors reported a significant increase in ADC (approximately 30-
40% by day 2 for both 150mg/kg and 300mg/kg cyclophosphamide treatment) previous 
to a reduction in tumor volume using diffusion-weighted 1H-NMR spectroscopy, likely a 
result of tumor cytotoxic response.  These results, reproduced from reference (1) are 
diagrammed in Fig. 4-1.   
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Figure 4-1.  Evolution of tumor volume (left) and spectroscopic ADC (right) following chemotherapy in a 
RIF-1 tumor model.  Symbol designations are: diamonds = control tumors; squares = tumors receiving a 
single dose of 150mg/kg cyclophosphamide (Cp); and circles = tumors receiving 300 mg/kg Cp.  A 
significant increase in ADC was seen previous to any change in tumor volume (day 2), with ADC reversal 
upon tumor regrowth (post-day 4).  Figure reproduced from reference (1).   
 
Changes in ADC Correlate with Changes in Cellular Density 
Subsequent studies by Chenevert et al. (6,7) investigated the contribution of tumor 
physiology to this ADC change by comparing the temporal evolution of the therapy-
induced ADC increase to histology at each timepoint.  The authors reported a strong 
correlation between the mean ADC of the total tumor volume and values of cellular 
density, obtained from histological examination of hematoxylin-eosin (H&E) stained 
sections in a rat 9L glioma model.  They concluded that the early ADC increase was a 
result of reduced cellular density concomitant with the formation of necrosis.  Lyng et al. 
(9) confirmed this correlation between ADC, cellular density, and necrotic fraction in 
four human xenograft lines, although the degree of correlation was dependent on the size 
of the necrotic region.   
Limitations of ADC Calculations Based on Whole-Volume Measurements 
Although these reports provide strong evidence that a significant ADC increase correlates 
with therapeutically-induced changes in cellular density and formation of necrosis, 
increased ADCs at early timepoints post-treatment may also result from other 
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therapeutically-induced changes in ADC such as vasogenic edema.  Spectroscopic ADCs 
or mean ADC calculations based on total tumor volume do not assess tissue 
heterogeneity, and therefore mask the complex tissue response.  Helmer et al. (10) 
attempted to address this issue of heterogeneity by analyzing tissue that was either clearly 
viable or clearly necrotic, determined from H&E-stained sections.  Tissue having a 
mixture of viable cells and acellular regions was excluded from analysis.  The authors 
suggested that multiple MR parameters should increase the ability to identify these 
regions, although success would depend on their size as well as image resolution.    
4.1.2 Multispectral Tissue Characterization 
Variable pre-treatment tissue composition, tumor size, and growth kinetics, as well as 
post-treatment cell kill and tumor regrowth complicate dose-optimization and comparison 
of treatment regimens in animal oncological studies.  With this in mind, a multispectral 
(MS) approach using multiple MR parameters should provide greater power than 
previous single-parameter studies.  Recent multiparametric studies in brain (11,12) and 
breast (13) cancer provide promising results for pathological assessment.  Subsequent to 
these studies, Carano et al. (14) reported on a multispectral (MS) analysis approach using 
ADC, T2, and M0 parameter maps for identification of viable versus necrotic tissue in 
COLO205 tumor xenografts in immuno-compromised mice.  The authors reported that 
ADCs permitted differentiation between viable tissue and necrosis; and with the addition 
of T2, further subdivision of necrotic tissue was possible. They noted that although their 
MS estimates of viable and necrotic volumes correlated well with the corresponding 
histological estimates, the MS viable volume provided a more stable efficacy endpoint.  
Their KM volume results are reproduced in Fig. 4-2.  There was a significant reduction in 
MS viable volume by day 10 for two of the treatment groups, but similar values of 
necrotic fraction regardless of the presence or type of therapeutic intervention.  Carano 
and coworkers suggested that the necrotic fraction results might be merely a 
characteristic of the cell line, as these types of tumors tend to grow rapidly and form large 
regions of necrosis.   
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Figure 4-2.  The temporal evolution of mean MS estimates of viable tumor 
volume (a) and percent necrosis (b) in response to Apo2L/TRAIL and CPT-11 
therapy.  Animals were treated with 60mg/kg Apo-2/TRAIL (circle) on days 
1-4 and 6-10.  80mg/kg CPT-11 (square) was administered on days 1, 5, and 
9.  *p < 0.05, ** p < 0.01, significant difference relative to control (diamond) 
based on Dunnett’s test of multiple comparisons.  Figure reproduced from 
reference (14).  
 
4.1.3 Tumor Growth Kinetics 
Previous tumor growth studies in experimental animal models (14-19) and the clinical 
setting (20,21) have demonstrated that serial MRI measurements permit the non-invasive 
evaluation of tumor growth kinetics and a method for monitoring treatment response.   
Ross et. al. (16) provided a model for assessment of tumor doubling time (TDT), tumor 
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growth delay (TGD), and log cell kill without the requirement that the rate of tumor 
regrowth be identical to the pretreatment growth rate.  The authors concluded that MRI 
quantification of these three parameters provides a non-invasive way of accounting for 
inter-animal variability.  With this in mind, combining MS methods for tissue 
characterization with tumor growth kinetics and cell kill measurements should provide a 
better understanding of the physiological dynamics of treated tumors.  In addition, 
subdivision of individual tissue types should also permit investigation of the relative 
contributions of each tissue population to the response pre- versus post-treatment.   
4.1.4 Monitoring Response to Radiotherapy  
There were two goals of this study.  First, in order to gain insight into the various 
processes whose combination yield the total ADC response over time; second, to identify 
the contribution of tissue heterogeneity (viable, necrotic) to the treatment response and 
changes in tumor growth kinetics and cell kill.  To this end, we performed MS analysis 
using a 2-dimensional feature space (ADC, T2) and the k-means clustering algorithm (22) 
for identification of multiple compartments within both viable and necrotic tissue.  
Hematoxylin-eosin (H&E) staining was performed for identification two types of viable 
tissue (V1, V2) and two types of necrosis (N1, N2).  Immunohistochemical staining for 
hypoxic-inducible factor-1 alpha (HIF-1α) was performed for differentiation of viable 
tissue into well-oxygenated (V1) and hypoxic (V2) regions.  This method, a 2-feature, 4-
cluster segmentation using k-means clustering and the Euclidean distance, was found to 
be optimal following analysis of the correlation between KM parameter maps and the 
corresponding histology (details provided in Ch. 3).  The temporal evolution of individual 
tissue populations was investigated in order to understand the underlying mechanisms of 
treatment response pre- versus post-radiotherapeutic intervention.  
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4.2 Methods 
4.2.1 Animal Preparation 
The present study was approved by the Institute Animal Care and Use Committee 
(IACUC) of the University of Massachusetts Medical School (IACUC protocol A-544).  
Twenty-nine 6-8 week-old female C3H mice (20-25g; Taconic Farms, Germantown, NY) 
were initially anesthetized with an intraperitoneal injection of ketamine/zylazine (100 
mg/kg:10 mg/kg).  All mice were inoculated with 1 × 106 RIF-1 cells (0.15 ml), delivered 
through a subcutaneous injection into the right hind leg.  Tumors were allowed to 
develop for 3-4 weeks, yielding an approximate 1.0 cc starting volume.  Tumor volume 
was determined from caliper measurements, taken 2-3 times per week, of the three 
perpendicular axes (length, width, height) and the equation for calculating the volume of 
an ellipsoid where V = (π/6) (l × w × h).  Animals were subsequently divided into two 
groups: a control group (N = 16) and a treatment group (N = 13).  For the control group 
(N = 16), tumors of varying volumes (1.0 cc to 2.0 cc) were imaged at a single timepoint 
and then extracted for histological examination.  For the treatment group (N = 13), 
tumors of an approximate 1.0 cc starting volume were irradiated with 1000 cGy at a rate 
of 300 cGy/min (Siemens Mevatron 77, 6 MeV electrons, Tufts University School of 
Veterinary Medicine, North Grafton, MA).  Imaging for the treatment group was 
performed at 1d pre-treatment, 5 hr, 1d, 2d post-treatment, and every 2d thereafter until 
tumor doubling (maximum 14d post-treatment) or until tumors reached a 2.0 cc volume 
(considered a burden for the animal). 
4.2.2 Radiotherapy 
Prior to radiotherapy, animals were anesthetized with an intraperitoneal injection of 
ketamine/zylazine (100 mg/kg:10 mg/kg).   Animals were placed prone on a plastic 
board, with movement restricted by securing the forepaws and hindlegs down using 
medical tape (Fig. 3-4a).  The right hind leg was pulled away from the body for 
preparation.  First, a 0.5-cm-thick bolus of tissue-substitute (Bolx-II, MED-TEC, Inc., 
Orange City, IA), with the center cut out, was placed around the tumor and filled with gel 
(Fig. 3-4b).  In order to deliver the desired dose to the tumor center without exposing the 
underlying tissue and bone, an additional 0.5-1.0-cm-thick bolus of tissue-substitute was 
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placed over the top, depending on the measured tumor height (Fig. 3-4c).  Based on 
tumor length and width, custom-made cutouts from 2.0-3.0 cm in diameter were used for 
the cone size in order to limit the radiation to the tumor versus the surrounding tissue 
(Fig. 3-4d).  Following preparation, tumors were irradiated with 1000 cGy at a rate of 300 
cGy/min (Siemens Mevatron 77, 6 MeV electrons, Tufts University School of Veterinary 
Medicine, North Grafton, MA).  At the conclusion of single-dose radiotherapy, animals 
were returned to their cage where they recovered from anesthesia and were provided with 
food and water. 
4.2.3 MRI Measurements 
MR experiments were performed with a Bruker Biospin 2.0T/45cm imaging spectrometer 
operating at 85.56 MHz for 1H and equipped with ±20 G/cm self-shielded gradients (Fig. 
3-5).  The experiments involved multi-slice image acquisition along the coronal plane 
[matrix size = 128 × 128, FOV = 3cm × 3cm, slices = 8, slice thickness = 1mm].  The 
imaging plane was referenced to the boundary between the tumor and underlying muscle.  
A diffusion-weighted, spin-echo (SE) sequence was used to acquire the images at six b-
values (b = 15, 60, 140, 390, 560, 760 mm2 s-1) with diffusion sensitization applied along 
the read direction.  Other acquisition parameters were:  TR/TE = 2000.0/53.0 ms, 
diffusion gradient duration δ = 4.0 ms, diffusion gradient separation ∆ = 35 ms, resulting 
in an effective diffusion time tdif = 33.7 ms. A T2-weighted, spin-echo (SE) sequence was 
used to acquire images at six echo times (TE = 12.2, 20, 35, 50, 65, 90 ms) with TR = 
2000.0 ms. The experiment times were 25 min for diffusion and 5 min per TE value for 
T2, yielding a total imaging time of 55 min.  During imaging, animals were placed prone 
in a home-built animal holder with a 4-turn 1H solenoid coil around the tumor (Fig. 3-6).  
Multiple coils of variable diameter were constructed (0.95, 1.35, 1.75 cm) to account for 
tumor volume changes in repeated measures experiments.  Animals were anesthetized 
with 1.5% isoflurane at a rate of 1.5 L/min in breathing quality air.  Body temperature 
was maintained by circulating warm air at 34.0° ± 1.0°C using a T-type thermocouple 
and a double-point feedback control system. 
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4.2.4 Data Analysis 
Parameter Map Production 
Image reconstruction was performed using Paravision’s Image Processing and Display 
Software (Xtip).  Image analysis and parameter map production was performed using 
routines written in IDL (Research Systems Inc., Boulder, CO).  ADC, and T2 parameter-
map production was performed on a pixel-by-pixel basis based on the relationship 
between the natural log of the signal intensity and b-value (Eq. 4-1) or signal intensity 
and echo time (Eq. 4-2), respectively: 
 bD0eMM(t)
−=  (4-1) 
 2TE/T0eMM(t)
−=  (4-2) 
where M/M0 is the signal intensity at a particular b-value or TE value; D is the diffusion 
along a single direction, and T2 is the spin-spin or transverse relaxation time.  A linear 
fitting procedure based on the minimization of the chi-square statistic was employed for 
extraction of MR parameters.  Underlying muscle, remaining in the lower imaging slices 
for (N = 9) animals, was removed by delineation between tissue boundaries using T2-
weighted contrast images (TE = 90ms).   
4.2.5 K-means Clustering 
A 2D feature vector, containing ADC and T2 parameter maps, was generated.  KM 
clustering was performed on a pixel-by-pixel basis using the Euclidean distance measure 
(22): 
 ( ) ( )iti µxµxD −−=    (4-3) 
where x ε R3 is the feature vector and µi is the cluster mean, both determined from all of 
the data (N = 88 datasets, all animals, all timepoints).  Prior to KM clustering, feature 
normalization (µ = 0, s = 1) was performed for removal of potential scaling differences.  
Tissue classification was then performed using KM in a hierarchical manner.  In the first 
step of the classification algorithm, KM was applied to separate the data into two clusters 
(k = 2) of tumor tissue and background noise based on variations in M0.  All voxels 
classified as noise were set to zero and removed from further processing.  In the second 
step, KM was applied (k = 4) to segment the data into the following two regions each of 
viable tumor (V1,V2) and necrosis (N1,N2). 
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4.2.6 Kinetic Modeling 
Growth kinetic calculations and cell kills were determined using an exponential model of 
tumor growth (23) and the mathematical model proposed by Ross et al. (16).  In this 
model (Fig. 4-3), tumor volumes, V(t), are plotted versus time post-cell implantation, t,  
using the natural log of the following equation: 
 ( ) tTd2ln0eVtV −=    (4-4)  
where Td is the volumetric doubling time and V0 is the initial viable tumor volume (at 
first measurement).  To determine the pre-treatment and post-treatment doubling times of 
the tumors, Tdpre and Tdpost, Eq. 4 was fit to the initial exponential growth curve and the 
regrowth curve of the total tumor evolution plot.  By inserting the Tdpre into the equations 
determined by the fits for exponential growth and regrowth, the difference in time will be 
equivalent to the tumor growth delay, or TGD.  The effective volume of tumor surviving 
immediately after treatment, Vpost, was derived by extrapolation of the regrowth curve to 
the day of treatment.  This permits calculation of the ratio of the volumes pre- and post- 
treatment, and subsequent determination of log cell kill: 
    


=
post
pre
10 V
V
logKillCellLog    (4-5) 
This approach does not have the constraint requiring that the rate of tumor regrowth be 
identical to the pre-treatment growth rate, thereby making it more applicable to situations 
with inherent heterogeneity such as the case in animal oncological models. 
4.2.7 Histological Analysis 
For the control group following imaging, as well as for the radiotherapy group following 
the final imaging timepoint, animals were euthanized by an overdose of 
ketamine/zylazine (400 mg/kg:40 mg/kg).  The RIF-1 tumors were extracted based on the 
intersection between the tumor and muscle and frozen for 30 minutes.  Sections were 
taken every 2 mm starting from the base of the tumor, stored in individual tissue cassettes 
(Microcassettes, VWR International, NJ), and placed in 10% neutral buffered formalin 
(Fisher Scientific, Pittsburgh, PA).  Following fixation, a standard paraffin embedding 
procedure was used.  Tissue cassettes were marked L-R in order to preserve orientation 
for later correlative analysis between imaging and histology. 
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Figure 4-3.  Demonstration of the mathematical analysis of tumor growth 
and treatment.  Data points are actual values obtained for a 9L tumor treated 
with BCNU.  The line marked A is the least-squares fit of the pre-treatment 
growth points according to Eq. 4-4.  The line marked C is the fit of the post-
treatment growth points.  Line C is extrapolated back to the time of 
treatment to give Vpost.  Log cell kill is the log of the ratio Vpre/Vpost (Eq.4-
5).  The line marked B is the theoretical tumor regrowth curve assuming 
Tdpost = Tdpre.  The relative contributions of cell kill and tumor growth rates 
are related to the calculated repopulation intervals, Trapre and Trapost (these 
are not included in our analysis).   Figure reproduced from reference (16). 
 
Hematoxylin-Eosin (H&E) Histochemistry 
For all tumors, three 6µm sections, approximately 300µm apart, were taken every 1-mm 
for a total of 24 sections per tumor.  Sections were mounted on Poly-L-lysine coated 
slides (VWR International, West Chester, PA) and dried overnight on a slidewarmer at 
37°C.  Slides were then stored at room temperature until further processing.  
Hematoxylin-Eosin (H&E) staining was performed for all sections with digital images 
(1×) taken on a section-by-section basis using a Hewlett-Packard Scanner (Model #3970) 
at a resolution of 1200dpi.  Image analysis and delineation between individual tissue 
regions (viable, necrotic) was performed using KM clustering and a feature space (f = 4) 
based on the R,G,B image values and texture analysis (24) using the Hurst transform, an 
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image operator used in fractal analysis for the characterization of surface roughness (25).  
The Hurst transform or coefficient was calculated on a pixel-by-pixel basis using a 7-
pixel-wide neighborhood, and pixel labels identifying groups with the same distance from 
the central pixel (Fig. 3-8).  A linear fitting procedure of log of the distance and versus 
log of the maximum brightness range between groups in the neighborhood and the central 
pixel permitted calculation of the Hurst coefficient.  In this case, the Hurst coefficient is 
equivalent to the slope based on the best-fit line and minimization of the chi-square 
statistic.  Additional images were taken at higher resolution (2×, 10×, 20×, and 40×) for 
correspondence with HIF-1 immunohistochemistry using an upright Nikon Eclipse E400 
phase contrast microscope (Nikon, Melville, NY) equipped with an RT Color Spot 
camera (Diagnostic Instruments, Inc., Sterling Heights, MI) for image capture.  Spot 
Analysis 4.0.9 (Diagnostic Instruments, Inc., Sterling Heights, MI) software was 
employed for optimization of image quality and image acquisition. 
Hypoxic Inducible Factor 1α (HIF-1a) Immunohistochemistry 
For (N = 9) tumors (N = 5 radiotherapy, N = 4 control), additional 6µm sections were 
taken at the approximate 600um mark.  Sections were mounted on Poly-L-lysine coated 
slides (VWR International, West Chester, PA) and dried overnight on a slidewarmer at 
37°C.  Slides were then stored at room temperature until further processing.  
Immunohistochemical staining for HIF-1α was performed using a 1:75 dilution of the 
mouse monoclonal antihuman HIF-1α antibody (ab463, ABCam Inc., Cambridge, MA).   
Optimization of method and immunohistochemical staining was performed by Mass 
Histology Service (Worcester, MA).  Sections were deparaffinized and peroxidase was 
quenched with 3% H2O2 for 15 min. Slide preparation for staining was performed with 
heat-mediated antigen retrieval (Vector #H-3300 for 20 min.).  After rinsing with PBS, 
slides were incubated overnight at 2°C with the primary antibody.  Sections were again 
rinsed with PBS and incubated with a 1:250 dilution of the secondary antibody (biotin 
goat anti-mouse IgG, Vector #BA2000) for 1 hr.  After rinsing with PBS, detection was 
performed using a streptavidin-biotin-horseradish peroxidase system (Vector Elite 
#PK6100 for 1 hr).  Sections were again rinsed with PBS and color was developed by a 
15-min incubation with 3,3’-diaminobenzidine solution (DAB). Slides were lightly 
counterstained with hematoxylin.  For negative controls, the primary antibody was not 
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applied.  Tumor samples with strong cytoplasmic and/or nuclear expression were 
considered to be positive. 
 
4.2.8 Statistical Analysis 
Data are reported as mean ± SEM.  MS estimates of individual cluster volumes 
(V1,V2,N1,N2) as well as total viable volume (V1+V2) and total necrotic volume 
(N1+N2) were compared with H&E histological volumes through computation of 
Pearson’s correlation coefficient to provide the degree of linear association between 
imaging and histological volume estimates.  Histology slices at the 600µm point for 1-
mm sections from N = 16 tumors were analyzed (all other H&E sections had considerable 
tissue loss).  The temporal evolution of individual cluster volumes and feature means 
(ADC, T2), as well as total volume and feature mean, were compared on a timepoint-by-
timepoint basis between pre-irradiation and post-irradiation by two-tailed t-tests 
assuming unequal variances.  The relationship between tumor size and percent necrosis, 
as well as percent necrosis for control and radiotherapy groups was investigated using 
Pearson’s correlation coefficient to provide a measure of the degree of linear correlation 
between parameters. 
 
4.3 Results 
4.3.1 KM Segmentation Results 
Fig. 4-4 shows representative ADC and T2 parameter maps (Fig. 4-4a,b), the KM 
segmentation map (Fig. 4-4c), and the corresponding histological H&E section (Fig. 4-
4d).  For the KM segmentation map, individual tissue regions have been color-coded 
such that: red = necrotic 1, blue = necrotic 2, green = viable 1, and yellow = viable 2.  
Mean feature values for individual tissue populations, obtained via clustering of all 
datasets together (N = 88 datasets, over all timepoints), are summarized in Table 4-1.  
These results indicate the existence of two unique subpopulations within both viable and 
necrotic tissue.  Fig. 4-5 shows high-power images corresponding to the regions labeled 
on the H&E section in Fig. 4-4.  Necrosis 1 (Fig. 4-5a), characterized by high ADCs and 
high T2 values was generally acellular in nature. It showed some signs of inflammation, 
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indicated by the presence of neutrophils (blue arrows) recruited to the area to remove 
residual cellular debris (red arrows).  In addition, the remaining structure post-cell death 
appears to have begun to degrade, and the few remaining cells in the region are in the 
process of nuclear fragmentation, termed karyorrhexis (yellow arrows).  Necrosis 2 (Fig. 
4-5b), in contrast to necrosis 1, is characterized by low T2 values.  It has a sparse 
population of cells undergoing apoptotic cell death intermixed with red blood cells 
(RBCs) that have accumulated in the interstitial space either from hemorrhage or a leaky 
vasculature (26).  This accumulation of RBCs leads to inflammation, indicated again by 
the presence of neutrophils (blue arrows).  Cells in this region are undergoing 
karyorrhexis (yellow arrows) or pyknosis (green arrows).  Pyknotic nuclei exhibit 
degradation of both nuclear DNA and cytoplasmic RNA, resulting in nuclear shrinkage.  
Unlike the necrotic regions, viable 1 (Fig. 4-5c) is extremely cell-dense, with no evidence 
of inflammation or RBC accumulation.  Viable 2 (Fig. 4-5d), on the other hand, has a 
slightly reduced cell-density over that of viable 1, with an abundance of dilated blood 
vessels.  These blood vessels are approximately 25µm in comparison to 10µm for viable 
1.  Fig. 4-5e,f diagram the resultant HIF-1α expression via comparison of HIF-1α 
immunohistochemistry and H&E histochemistry for the same location.  HIF-1α 
expression, denoted by the intensely stained brown nuclei (black arrows), is hypoxic-
specific, whereas the lightly stained nuclei (red arrow) are from non-specific genetic 
upregulation of HIF-1α.  The regions with the most concentrated HIF-1α expression 
were located in per-necrotic areas. 
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Figure 4-4.  KM segmentation results for a single-slice of a representative tumor with 
corresponding histology via H&E histochemistry.  ADC and T2 parameter maps are shown in 
(a) and (b) respectively, with the corresponding KM segmentation map in (c), and the 
corresponding H&E stained section in (d).  Color designations for the KM map are: red = 
necrosis 1, blue = necrosis 2, green = viable 1, yellow = viable 2.  Regions of interest were 
chosen for investigation of the underlying morphology contribution to the measured ADC and 
T2 values, with: 1 = necrosis 1; 2 = necrosis 2; 3 = viable 1; 4 = viable 2.  High-power images of 
these regions are displayed in Fig. 4-5. 
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Table 4-1.  Mean feature values (ADC and T2) for individual tissue populations following 
KM segmentation using k = 4 clusters.   
Features 
ADC 
(× 10-5 cm2s-1) 
T2 (ms) 
total number 
of voxels % of total 
Viable 1 0.76 ± 0.05 60 ± 20 627227 56 
Viable 2 1.11 ± 0.05 50 ± 20 374936 34 
Necrosis 1 2.2 ± 0.4 139 ± 15 11896 1 
Necrosis 2 1.8 ± 0.1 68 ± 6 103951 9 
Parameters were derived on an animal-by-animal basis based on the clustering of all 
datasets together (N = 29 animals, 88 total datasets over all timepoints).  Data are 
presented as mean ± SEM.   
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Figure 4-5.  H&E images taken at 40× magnification (a-d) corresponding to the regions specified in Fig. 4-
4, and 20× magnification (e-f) for identification of hypoxic nuclei via HIF-1α immunohistochemistry.  (a) 
Necrosis 1.  (b) Necrosis 2.  (c) Viable 1.  (d) Viable 2.  Morphological identification of enzymatic actions 
and repair mechanisms concomitant with apoptosis and/or necrosis are labeled by arrows:  green = 
pyknosis, yellow = karyorrhexis, blue = neutrophil invasion, red = nuclear dusting.  (e) HIF-1α 
immunohistochemistry with the corresponding H&E stained region (f).  HIF-1α positive nuclei in peri-
necrotic regions stain an intense brown (black arrows), negative nuclei stain light blue (from hematoxylin 
counterstain, brown arrow), and nuclei with non-specific HIF-1α activity (i.e., unrelated to hypoxia) stain a 
faint brown (red arrow).  Scale bar = 25µm. for (a-d) and 50µm for (e-f). 
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4.3.2 Results: Control Group (Untreated)  
Fig. 4-6 shows various correlation plots for the control group of animals (N = 13, 3 
animals excluded from analysis because of misregistration between ADC and T2 
parameter maps).  There was a strong correlation between KM volume and caliper 
volume estimates (r = 0.70, Fig. 4-6a).  In terms of the relationship between total-tumor-
mean ADC and KM volume estimates, there was a weak correlation between the total-
tumor-mean ADC and KM total volume (r = 0.48, Fig. 4-6b) and total-tumor-mean ADC 
and KM viable volume (r = 0.43, Fig. 4-6c).  Fig. 4-6d shows a modest-to-strong 
correlation (r = 0.55) between total tumor ADC and KM percent-tumor-necrotic fraction 
(%TNF).  Table 4-2 provides a quantitative summary of mean feature values (ADC, T2) 
for individual tissue populations of the control group only.  From these results, the 
existence of two unique subpopulations within both viable and necrotic tissue is evident, 
consistent with the results in Table 4-1. 
4.3.3 Results: Radiotherapy Group (Treated) 
Table 4-3 gives a quantitative summary of mean feature values (ADC, T2) for individual 
tissue populations for the radiotherapy group pre-treatment (-1d) and at 8-days post-
treatment.   The pre-treatment values are very close to the values listed in Table 4-2 for 
the control group.  Both had comparable percentages of viable and necrotic tissue, with 
equally similar values of ADC and T2 on a population-by-population basis.  Note that 
both groups (control, pre-treatment) had 10% necrosis.  By 8-days post-treatment, there 
was an increase in necrotic fraction to an average of 16%, with a jump in volume by a 
factor of 2.  In addition to radiation-induced necrotic formation, there was an increase in 
viable 2 volume by 50%.  Viable 1 remained constant.  In terms of the ADCs and T2 
values pre- versus post-treatment, all values remained fairly constant except for necrosis 
1, there was an increase in ADC by approximately 24%.   
Temporal Evolution of KM Volume 
Fig. 4-7 illustrates the temporal evolution of individual KM volume estimates pre- as well 
as post-irradiation for the radiotherapy group.  The overall trend of the total KM volume 
is a volume decrease out to day 2, followed by tumor regrowth out to day 8.  Changes in 
KM viable volume mirror the changes in total KM volume.  In contrast, KM  
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Figure 4-6.  Correlation plots of KM volume versus caliper volume (a), total tumor ADC versus KM 
volume (b), ADC versus KM viable volume (c), and ADC versus percent-tumor-necrotic fraction, %TNF 
(d).  There is a strong correlation between KM and caliper volume estimates (r = 0.70).  There are relatively 
weak correlations between ADC and KM volume (r = 0.48) and ADC and KM viable volume (r = 43), with 
a moderate-to-strong correlation between ADC and %TNF (r = 0.55).  Data are plotted for 13 of the 16 
control animals.  The remaining three were excluded because of miregistration between ADC and T2 
parameter maps.   
   
a b
c d
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Table 4-2.  Control group mean feature values (ADC and T2) for individual tissue populations. 
Features 
ADC 
(× 10-5 cm2s-1) 
T2 (ms) Volume (mm3) % of total 
Viable 1 0.71 ± 0.01 64 ± 1 890 ± 60 63 
Viable 2 1.09 ± 0.04 50 ± 0.4 400 ± 60 28 
Necrosis 1 2.0 ± 0.1 137 ± 2 21 ± 4 2 
Necrosis 2 1.8 ± 0.11 73 ± 1 110 ± 15 8 
Parameters were derived on an animal-by-animal basis based on the clustering of all 
datasets together (N = 29 animals, 88 total datasets over all timepoints).  Data are 
presented as mean ± SEM.   
 
 
Table 4-3.  Radiotherapy group mean feature values (ADC and T2) for individual tissue populations at       
1-day pre-treatment (Pre-Tx) and 8-days post-treatment (8d). 
Timepoint Features 
ADC 
(× 10-5 cm2s-1) 
T2 (ms) Volume (mm3) % of total 
Viable 1 0.70 ± 0.02 62 ± 1 820 ± 60 60 
Viable 2 1.1 ± 0.01 50 ± 1 420 ± 70 31 
Necrosis 1 2.1 ± 0.06 144 ± 5 16 ± 6 1 
Pre-Tx     
(-1d) 
Necrosis 2 1.8 ± 0.02 68 ± 1 120 ± 30 9 
Viable 1 0.79 ± 0.04 63 ± 1 810 ± 150  47 
Viable 2 1.1 ± 0.01 52 ± 1 640 ± 40 37 
Necrosis 1 2.6 ± 0.06 146 ± 5 40 ± 10 2 
Post-Tx 
(8d) 
Necrosis 2 1.8 ± 0.01 72 ± 1 240 ± 60 14 
Parameters were derived on an animal-by-animal basis based on the clustering of all datasets together (N = 
29 animals, 88 total datasets over all timepoints).  Data are presented as mean ± SEM.   
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necrotic volume consistently increases out to day 2 post irradiation, after which point it 
levels off.  With the decrease in viable 1 out to day 2 there was a concomitant increase in 
viable 2.  After day 2, both viable 1 and viable 2 slowly but steadily increased.  In terms 
of individual necrotic regions, necrosis 1 remained unchanged with time, whereas 
necrosis 2 increased in volume to day 4, after which it leveled off.  This trend for necrosis 
2 followed very closely to that of the total necrotic volume, not surprising as the majority 
of the necrosis was necrosis 2 versus necrosis 1. 
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Figure 4-7.  Temporal evolution of individual KM cluster volumes pre- and post-irradiation.  The overall 
volume decreases post-irradiation out to day 2, with subsequent tumor regrowth post day 2.  The underlying 
contributions to changes in tumor volume are visible by inspection of individual tissue populations (viable, 
necrotic), as well as the subpopulations within both viable and necrotic tissue Values for each timepoint are 
based on the radiotherapy animals (n = 11, 12, 9, 8, 9, 8 for 5h, 1d, 2d, 4d, 6d, and 8d respectively).   
Differences in number of animals per timepoint are based on tumors reaching 2.0cc, considered a burden 
for the animal. 
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4.3.4 Tumor Growth Kinetics (Control vs. Radiotherapy) 
Fig. 4-8 shows the method of mathematical analysis of tumor growth and treatment for a 
representative animal from the radiotherapy group.  From this plot, the tumor doubling 
time (TDT) pre- and post-irradiation may be determined, as well as the tumor growth 
delay (TGD), and log cell kill.  For this animal, TDTpre = 2.7 days, TDTpost = 3.6 days, 
TGD = 5.6 days, and log cell kill = 0.46.  Fig. 4-9 shows the tumor growth curves for 
control versus radiotherapy animals as determined from caliper tumor volume 
measurements (Fig. 4-9a,b) and the corresponding TDT results (Fig. 4-9c,d).  The control 
group TDT was 3.7 ± 0.5 days.  In this group, one of the animal’s TDT was 10.2 days—if 
this is removed, the control group TDT = 3.1 ± 0.2 days.  For the radiotherapy group, the 
pre-treatment TDT was 2.3 ± 0.1 days, versus a post-treatment TDT of 6.5 ± 0.7, with a 
significant difference between the two (p < 0.001).  From these results, the single-dose 
(1000cGy) radiotherapy induced a 3-fold delay in tumor growth.   
 
 
Figure 4-8.  Sample plot for a representative RIF-1 tumor demonstrating the mathematical analysis 
employed for tumor growth and treatment.  The line marked (a) is the least-squares fit of the pre-
treatment growth points to Eq. 4-4.  The line marked (b) is the least-squares fit of the post-treatment 
growth points to Eq. 4-4.  (c) and (d) permit extrapolation of the Vt-pre and Vt-post, and subsequent 
calculation of the log cell kill according to Eq. 4-5.  Tr, the repopulation interval, is the time required 
for recovery of the cell population killed by treatment, i.e., the tumor growth delay (TGD). 
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Figure 4-9.  Tumor growth curves on an animal-by-animal basis for control (a) and radiotherapy (b) groups, 
with the corresponding tumor doubling time (TDT) plots.  (c) control group TDT = 3.7 ±  0.5  days.  One 
animal’s TDT was 10.2 days.  If this is removed, the group TDT = 3.1 ± 0.1.  (d) radiotherapy group TDTs 
on an animal-by-animal basis.  There was a significant difference (p < 0.001) between pre-treatment TDT 
(2.3 ± 0.1) versus post-treatment TDT (6.5 ± 0.7).  
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4.3.5 KM Volume and Treatment Response: TGD and Cell Kill 
Fig. 4-10 shows the relationship between the changes in tumor volume between day 0 
and the point at which the tumor volume reached a minimum (ranged between day 1 and 
4 post-irradiation) and the resultant tumor growth delay (TGD) and log cell kill.  For the 
total tumor volume, determined via caliper measurements, there was a strong correlation 
between an increase in volume and decreased TGD (r = 0.91) and decreased cell kill (r = 
0.85).  Similar correlations were found for the change in KM volume versus TGD and 
cell kill, although the correlations were to a lesser degree (r = 0.62 and r = 0.65, 
respectively).  In order to understand which viable regions are contributing to the TGD 
and cell kill, the relationships between changes in viable 1 and viable 2 versus TGD and 
cell kill were investigated.  There was a moderate-to-strong correlation between a change 
in viable 1 volume and both TGD (r = 0.68) and cell kill (r = 0.71), but there was no 
correlation between these kinetic parameters and viable 2.  In addition to the changes in 
total and/or individual volumes playing a role in the TGD and cell kill, the pre-treatment 
volumes of individual tissue populations may also play a role in the overall 
radiotherapeutic response.  Fig. 4-11 shows the relationship between pre-treatment values 
for viable 1 and viable 2 and the TGD and cell kill results.  A strong correlation was 
found between the pre-treament viable 1 volume and TGD (r = 0.81), with a moderate-to-
strong correlation between pre-treatment viable 1 and log cell kill (r = 0.55).  No 
correlation was found between pre-treatment viable 2 volume and TGD or log cell kill. 
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Figure 4-10.  The correlation plots for changes in KM volume at day 0 versus the timepoint resulting in a 
minimum volume (between day 1 and day 4 post-treatment depending on the animal). (a) Volume changes 
based on caliper measurements were highly correlated with both TGD (r = 0.91) and cell kill (r = 0.85).  (b) 
Changes in total KM volume were moderate-to-strongly correlated with TGD (r = 0.62) and cell kill (r = 
0.65).  Upon investigation of the subpopulations of the viable tissue, it was determined that decreases in 
viable 1 volume pre- versus post-irradiation correlate well with increased TGD (r = 0.68) and increased cell 
kill (r = 0.71).  There was no correlation between TGD, cell kill, and viable 2. 
 
 
 
 
MONITORING RESPONSE TO SINGLE-DOSE (1000cGy) RADIOTHERAPY 
 
144
0
1
2
3
4
5
6
7
0.4 0.5 0.6 0.7 0.8 0.9 1
Pre-treatment Viable 1 Volume (cm3)
TG
D
 (D
ay
s)
-0.4
-0.2
0
0.2
0.4
0.6
0.8
Lo
g 
C
el
l K
ill
 
Figure 4-11.  The correlation plot for pre-treatment viable 1 volume versus the tumor growth delay (TGD) 
and log cell kill induced by radiotherapeutic intervention.  A strong correlation was found between the pre-
treament viable 1 volume and TGD (r = 0.81), with a moderate-to-strong correlation between pre-treatment 
viable 1 and log cell kill (r = 0.55).  No correlation was found between pre-treatment viable 2 volume and 
TGD or log cell kill. 
 
4.3.6 KM Volume and Treatment Response: Evolution of ADC and T2 
Fig. 4-12 shows the temporal evolution of mean ADCs and mean T2 values for individual 
KM volumes for the radiotherapy group.  The total tumor ADC showed a significant 
increase by day 2, with a leveling off by day 4 post-treatment.  Underlying this change, 
the trend in KM viable volume followed closely with the total tumor values.  This was 
mainly driven by the change in viable 1 ADC, as viable 2 ADC did not change 
appreciably.  In terms of the necrotic tissue ADC, there was no significant change until 
day 8.  Based on these results, it seems that the early ADC increase (day 0 to 4) is due to 
changes in ADC in the viable tissue region, with the increase at later timepoints (post-  
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Figure 4-12.  Temporal evolution of ADC and T2 for individual tissue populations pre- versus post-
irradiation for the radiotherapy group.  Asterisks denote significance based on 2-tailed t-tests assuming 
unequal variances, for comparisons between values pre-irradiation and every timepoint thereafter.  * p < 
0.05. ** p < 0.01.  Data are presented as mean ± SEM. Values for each timepoint are based on the 
radiotherapy animals (n = 11, 12, 9, 8, 9, 8 for 5h, 1d, 2d, 4d, 6d, and 8d respectively).   
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day-4) from the increase in necrotic ADC.    The corresponding changes in T2 values 
(Fig. 4-12b) show no significant changes between timepoints pre-irradiation versus post-
irradiation for any of the individual KM volumes.  Since there are no significant changes 
in T2 at early timepoints post-irradiation, changes in ADC are likely a result of small 
changes in cellular density over that of radiation-induced vasogenic edema.          
 
4.4 Discussion 
4.4.1 KM Segmentation Results 
MS analysis using the KM clustering algorithm and a 2-dimensional feature space (ADC 
and T2) permitted subdivision of tumor tissue into two regions each of viable tissue (V1, 
V2) and necrosis (N1, N2) based on differences in mean ADC and T2 values using the 
Euclidean distance measure (Eq. 4-3).  These results are shown in Figs. 4-4 and 4.5.  This 
cluster/feature combination was determined to be the optimal method of correlation 
between KM and histologically-derived volume estimates (see Chapter 3 for details).  
Differences in T2 permitted subdivision of necrotic tissue into two regions (Fig. 4-5a,b), 
one generally acellular in nature (necrosis 1), and a second with a sparse population of 
cells intermixed with intact RBCs from hemorrhage or leaky vasculature (necrosis 2) 
(26).  Differences in both ADC and T2 permitted subdivision of viable tissue into two 
regions (Fig. 4-5c,d), one extremely cell-dense, free of inflammation or hemorrhage 
(viable 1), and a second with a slightly lower cellular density and abundance of dilated 
blood vessels in comparison to viable 1.  Vessel dilation, likely a compensatory 
mechanism to a reduced oxygen environment, precedes angiogenesis (27,28).  Following 
HIF-1α immunohistochemistry, HIF-1α expression (Fig. 4-5e) was found to be 
concentrated in peri-necrotic areas, generally corresponding to regions of viable 2 from 
KM segmentation (Fig. 4-4c, viable 2 = yellow).  These morphological characteristics, 
along with the ADC and T2 values and the peri-necrotic upregulation of HIF-1α support 
the contention that viable 2 is hypoxic, and the subdivision of viable tissue in general. 
4.4.2 KM Results: Control versus Radiotherapy 
In order to understand the effects of radiotherapy on individual tumor tissue populations, 
separate control and radiotherapy groups were employed.  In the control group, varying 
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tumor sizes between 1.0 cc and 2.0 cc were investigated in order to look at the correlation 
between tumor volume and various parameters, specifically the degree of necrosis and 
the corresponding ADC values.  A strong correlation was found between KM volume 
estimates and caliper volume estimates (Fig. 4-6a, r = 0.70), indicating that MRI provides 
an accurate non-invasive measure of tumor volume.  With an increase in KM volume 
there was an increase in tumor ADC (Fig. 4-6b, r = 0.48) based on increased percent-
tumor-necrotic fraction, %TNF (Fig. 4-6d, r = 0.55).  These results are consistent with 
those of Carano and coworkers (14).   
Radiation-induced Necrosis and Hypoxia 
Through comparison of the quantitative results for the control group (Table 4-2) and 
radiotherapy group (Table 4-3), a more detailed understanding of the radiotherapy-
induced changes in viable and necrotic tissue is possible.  The control group and the pre-
treatment timepoint (-1d) for the radiotherapy group had comparable ADCs, T2 values, 
and volume estimates for individual tissue populations.  Note that there was 10% necrosis 
in either case, with the remaining tumor volume mostly viable tissue.  By day-8 post-
treatment, there was an increase in necrosis from 10% to 16% with an increase in necrotic 
volume by a factor of two.  Along with radiation-induced necrotic formation, there was a 
50% increase in viable 2 volume and little or no change in viable 1 volume.  This 
increase in viable 2 indicates an increase in the amount of hypoxic tissue post-
irradiation—in other words, the selective survival of radioresistant tumor cells.  These 
results are consistent with previous studies reporting on a radiation-induced increase in 
the fraction of hypoxic cells (29-31).     
Temporal Evolution of KM Volume    
Fig. 4-7 diagrams the temporal evolution of individual KM volumes pre-irradiation 
versus post-irradiation.  The decrease in tumor volume out to day 2, mirrored by a 
decrease in viable 1, is consistent with radiation-induced cell killing.  Concomitant with 
this decrease is an increase in viable 2.  These trends indicate that viable 1, presumably 
well-oxygenated tissue, is radiosensitive and regresses following irradiation.  Viable 2, on 
the other hand, is radioresistant, and doesn’t respond to radiotherapy.  In fact, viable 2 
increases out to day 4 and then plateaus.  This persistent hypoxia may be related to the 
formation of necrosis, as the trend for viable 2 follows that of the necrotic fraction.   
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4.4.3 KM Contributions to TGD and Cell Kill 
In order to address the relative contributions of individual tissue populations to the 
overall response, the relationships between KM volume contributions and TGD and cell 
kill was investigated.   
Overall Tumor Growth Kinetics 
The overall growth kinetics for the control and radiotherapy groups are shown in Fig. 4-9.  
Fig. 4-9a,b show the tumor growth curves obtained via caliper measurements for the 
control and radiotherapy groups, respectively.  These plots show the existence of inter-
tumoral variability, even though all animals received the same injection of RIF-1 cells for 
development of the tumor model.  The control group TDT was 3.7 ± 0.5 days, consistent 
with previously reported TDTs within this particular tumor model.  For the radiotherapy 
group, there was a significant difference between pre-treatment TDT (2.3 ± 0.1) and post-
treatment TDT (6.5 ± 0.7).  These results indicate that a single-dose of 1000cGy induces 
an approximate 3-fold increase in TDT.  
KM Viable Volume Changes and the Radiotherapeutic Response 
Changes in volume between day 0 versus the timepoint resulting in a minimum tumor 
volume (between days 1 and 4 post-treatment depending on the animal) were compared 
with the resultant TGD and log cell kill on an animal-by-animal basis within the 
radiotherapy group (Fig. 4-10).  There was a moderate-to-strong correlation between the 
change in total KM volume and these kinetic parameters (r = 0.62 for TGD and r = 0.65 
for cell kill).  With a reduction in total KM volume, there was an increase in TGD and 
cell kill.  Changes in viable 1 showed similar levels of correlation, but there was no 
correlation between viable 2 and TGD or cell kill.  This reinforces the previous claim that 
viable 1 is well-oxygenated, radiosensitive tissue and that viable 2 is radioresistant, and 
therefore, hypoxic.  Because hypoxia induces radioresistance, the relative contributions 
of viable 1 and viable 2 pre-treatment to the radiotherapeutic response was investigated 
(Fig. 4-11).  There was a strong correlation between pre-treatment viable 1 volume and 
TGD (r = 0.81) and a moderate-to-strong correlation with log cell kill (r = 0.55).  Again, 
there was no correlation found between viable 2 and TGD or cell kill.   
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4.4.4 Underlying Contributions to the ADC Response  
In order to understand the underlying contributions whose combination yield the total 
ADC response following treatment, the temporal evolution of ADCs for individual tissue 
populations was investigated (Fig. 4-12a).  Following radiotherapy, there was an increase 
in total tumor ADC out to day 4 followed by a plateau.  The ADC for necrotic tissue 
remained constant out to day 4, followed by a significant increase (p < 0.05) at day 8.  
This is most likely from removal of cellular debris and the movement of the total necrotic 
fraction towards an acellular environment.  The ADC increase for viable tissue mirrored 
that of the total tumor ADC.  The underlying contribution to the ADC changes in viable 
tissue were attributed to the viable 1 fraction, not viable 2.  Although there was this slight 
increase in ADC for viable 1, because there was no corresponding change in T2 (Fig. 4-
12b), it could not be attributed to vasogenic edema.  This small change, approximately 
10% in magnitude, is most likely from a slight reduction in cellular density.  This change 
was not large enough for a transfer of classification from viable 1 to viable 2 [viable 1 
ADC = 0.76 ± 0.23 (mean ± SD, × 10-5 cm2s-1)].  No significant changes were seen in T2 
for any KM regions, indicating the absence of edema.   
4.4.5 Utility of the KM Method 
Advantage of MS Analysis over Single Parameter Approaches 
Although several studies have shown that increases in mean/volume-averaged tumor 
ADC prior to any change in tumor volume are indicative of a positive-treatment response 
(3,6-8), the evaluation of the tumor in this manner does not allow the determination of the 
origin of the ADC change.  With a reduction in tumor necrotic fraction, the mean tumor 
ADC approaches ADC values consistent with that of viable tissue.  If small sub-
populations of necrosis are present, changes in the overall necrosis may be small and 
would show little to no change in mean tumor ADC (9).  Because previous studies have 
also had difficulty in identifying regions of mixed viability (9,10,14), an MS approach 
aimed at subdividing individual tissue regions, specifically viable tissue, is needed. 
MS Analysis and Tumor Growth Kinetics 
Overall, these results indicate that the combination of MS analysis with tumor growth 
kinetics is superior to either approach alone.  MS analysis provides a way of addressing 
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inter- and intra-tumor heterogeneity through identification of individual tumor tissue 
populations.  This particular method was able to identify subpopulations within both 
viable and necrotic tissue, and more importantly, the delineation between well-
oxygenated versus hypoxic tissue.  Since both necrosis and hypoxia have been implicated 
in poor treatment response and reduced patient survival, the quantification of the amount 
of necrosis and the severity of hypoxia may aid in assignment of a more aggressive 
treatment regimen.  Quantitative assessment of individual tissue regions, tumor growth 
rates (TDT and TGD), and cell kill should provide a more accurate method for 
therapeutic monitoring and optimization of drug-dose and timing schemes in pre-clinical 
animal models by eliminating the issue of inter-tumoral variability.        
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5.1 Background  
Cessation of the cerebral circulation following stroke begins a cascade of physiological 
events ultimately leading to tissue ischemia and irreversible neuronal damage.  Arrested 
or critically-reduced blood flow is many times a result of vessel occlusion, although it 
can also be a result of vessel damage (i.e., from traumatic brain injury).  Clinically 
available therapeutic targets, such as standard rt-PA therapy, are limited to the treatment 
of patients with acute stroke (within 3-5 hours of onset).  Unfortunately, the majority of 
patients presents with symptoms long after this therapeutic window, excluding them from 
treatment and the potential for improved quality of life.  As this leaves clinicians to 
simple diagnosis and follow-up, methods investigating mechanistic aspects of ischemic 
progression are necessary in order to provide new therapeutic avenues with potential 
application at later timepoints from onset of stroke.  MRI techniques have been employed 
in the study of cerebral ischemia since the emergence of the diagnostic utility of DWI in 
the late 1980s (1) and early 1990s (2,3).  Further methods involving PWI and metabolic 
imaging followed, permitting a more in-depth analysis of the temporal evolution of 
cerebral ischemia.  In order to understand the applicability of MRI methods and the 
development of potential therapeutic targets for cerebral ischemia, a discussion of healthy 
versus ischemia brain tissue is required.  Additionally, lesion characterization into core 
and penumbra based on viability thresholds will be covered.  This chapter should provide 
sufficient background for the research presented in Chapters 6 and 7. 
5.1.1 Healthy versus Ischemic Brain Tissue 
The healthy brain depends on a constant supply of oxygen (O2) and glucose.  Constrained 
O2 supply impairs energy production, affecting energy-consuming processes in a 
sequential manner—impaired functioning is followed by metabolic failure and loss of 
structural integrity.  Depending on the level of perfusion deficit present in ischemic tissue 
the development of infarction may or may not occur.  Residual perfusion from collateral 
flow can temporarily maintain the limited energy stores in regions with loss of functional 
integrity but that are structurally intact.  These tissue regions are potentially salvageable 
and serve as a therapeutic target early after stroke onset.   
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5.1.2 Viability Thresholds in Cerebral Ischemia 
The existence of two major thresholds of hypoxia characteristic of cerebral ischemia were 
suggested by studies revealing that electroencephalographic (EEG) activity is disrupted at 
significantly higher flow rates than energy state deterioration and failure of ion 
homeostasis (4-6).  A diagram of the various flow thresholds with the corresponding 
breakdowns of function and metabolism is shown in Fig. 5-1, a modification of 
Hossmann’s (7).  Inhibition of protein synthesis (0.55 ml/g/min) is followed by a 
transition from aerobic to anaerobic glycolysis, with accumulation of lactate (<0.35 
ml/g/min) and subsequent reduction of tissue pH (8).   
Threshold of Electrical Failure 
At flow rates between 0.15 ml/g/min and 0.25 ml/g/min, the spontaneous EEG activity is 
suppressed.  Energy metabolism is moderately reduced from a failing O2 supply and 
declined ATP production.  Nevertheless, it remains functional and is able to maintain ion 
homeostasis via the sodium-potassium pump and the Na+-K+ ATPase enzyme.   It is 
important to note that this tissue region, although compromised, is recoverable because 
existing neurons are intact.  Reperfusion, or the restoration of normal blood flow, could 
potentially salvage this region’s viability. 
Threshold of Membrane Failure 
At flow rates below 0.15 ml/g/min there is complete failure of energy metabolism, 
leading to ion pump failure.  Unable to maintain existing ion gradients, cells experience a 
massive efflux of potassium (K+) concomitant with an influx of sodium (Na+), chloride 
(Cl-), and calcium (Ca2+).  In response to the massive movement of ionic species (K+, 
Na+, Cl-, Ca2+) across cellular membranes, a shift of extracellular (EC) water to the 
intracellular (IC) space results in cellular swelling, often referred to as cytotoxic edema.  
Stimulated release of excitatory neurotransmitters (i.e., glutamate) activates N-methyl-D-
aspartate (NMDA) receptors, opening ligand-gated Ca2+ channels for further Ca2+ influx.  
Without the necessary energy stores, membrane repolarization and restoration of ion 
gradients is not possible.  Therefore, terminal anoxic depolarizations are characteristic of 
this region.  Intracellular Ca2+ accumulation initiates enzymatic activity, the formation of 
free radicals, and subsequent degradation of cellular components such as DNA.  At this 
point, the loss of structural integrity results in permanent neuronal damage.      
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Figure 5-1.  Critical flow thresholds of ischemia.  Between 0.15 ml/g/min and 0.25 ml/g/min (shaded 
blue) spontaneous EEG activity is suppressed.  Within this flow range, the metabolism remains 
functional although the energy stores are limited.  Transient depolarizations may occur in this region.  
Below 0.15 ml/g/min (shaded red) there is complete energy failure and severe loss of ion homeostasis.  
Within this flow range, there is a combined loss of functionality and structural integrity.  Terminal 
anoxic depolarizations are characteristic of this region. CMRG = cerebral metabolic rate of glucose; 
PCr = phosphocreatine, ATP = adenosine triphosphate.  Figure adapted from reference (7).     
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5.1.3 Tissue Characterization: Core and Penumbra 
Defining Ischemic Penumbra 
The two critical flow rates, the threshold for electrical failure and the threshold for 
membrane failure, initiated the idea of a region of potentially viable tissue in which there 
was functional but not structural injury.  This region has been termed the ischemic 
penumbra (9).  An oversimplified model of focal ischemia is shown in Fig. 5-2.  Here, the 
penumbra surrounds a central core of irreversibly damaged tissue (i.e., infarct).  
Supported by flow from collateral vessels, partial perfusion of the penumbra temporarily 
maintains its viability in contrast to the core.  Lassen et al. (10) commented on a temporal 
dependence for tissue viability, supported by reports of similar lesion sizes in three hours 
of temporary ischemia versus that of permanent occlusion (11).  With this in mind, using 
a relative cerebral blood flow (rCBF) threshold for delineation between penumbra and 
core is tricky.  Over the years, the evolving definition of penumbra has come to include 
metrics of metabolism (ATP levels and tissue pH) as well as ionic changes (Ca2+ and 
water movement). 
 
 
 Penumbra
Core
 
     
Figure 5-2.  Visualization of the Penumbra and Core of Ischemia.  Left: ADC parameter map for a 
single 2-mm axial slice in a rat model of middle cerebral artery occlusion (MCAO).  The 
hypointense region represents the ischemic lesion.  The remainder is normal tissue.  Right:  
Cartoon of penumbra tissue (shaded blue) and core (shaded red).  The penumbra corresponds to 
the region of reduced blood flow in which energy metabolism (i.e., ATP production) and ion 
homeostasis (i.e., the Na+-K+ pump) are preserved.  This region is potentially salvageable via 
therapeutic intervention.  The core corresponds to the region of irreversible neuronal damage. 
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5.2 Current Therapeutic Targets 
Potentially salvageable tissue, the penumbra has been of interest for over a decade in the 
hopes of halting progression to infarct.  Current therapies concentrate on mechanisms for 
improved blood flow, neuroprotection, and anti-inflammation.  The overall therapeutic 
goal is to reduce the progression of cerebral ischemia and the resultant neuronal damage. 
5.2.1 Recombinant Tissue Plasminogen Activator (rt-PA) Therapy 
Thrombolytic therapy aids in the breakdown of blood clots (emboli) that are suppressing 
normal cerebral circulation.  One such example is recombinant tissue plasminogen 
activator, or rt-PA.  This agent cleaves plasminogen to plasmin, an endogenous substance 
responsible for fibrinolysis.  Although this methodology is effective in the restoration of 
cerebral blood flow, the high occurrence of intracranial hemorrhage requires extreme care 
in patient selection.  A comparison of intravenous and intraarterial studies in the delivery 
of rt-PA shows that hemorrhagic transformation results in neurological deterioration in 
approximately 10% to 15% of patients (12).  Despite these safety concerns, rt-PA 
remains the most successful thrombolytic agent in stroke therapy to date.   
5.2.2 Neuroprotective Therapy 
The investigation of drugs exhibiting neuroprotective effects is very important in 
combating failure of energy metabolism and cellular deterioration in cerebral ischemia. 
Ca2+ overload in neurons triggers apoptosis (programmed cell death) and the degradation 
of cellular components such as DNA, proteins, and phospholipids (13).  Wahlgren (14) 
diagrammed the chain of events resulting in the buildup of intracellular Ca2+, which has 
been reproduced in Fig. 5-3.  Since intracellular Ca2+ accumulation leads to permanent 
neuronal damage, methods aiming to reduce the level of Ca2+ influx are of particular 
interest. This makes Ca2+ channels (both voltage-gated and ligand-gated) a therapeutic 
target.   
NMDA Channel Antagonists 
The NMDA receptor is the most well known in the excitatory amino acid (EAA) receptor 
family (Fig. 5-4).  This receptor has several binding sites, but the phencyclidine (PCP) 
recognition site is of particular interest for noncompetitive NMDA channel antagonists 
such as dizocilpine (MK-801) (15).  As stated earlier, glutamate release activates NMDA 
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Figure 5-3.  Pathophysiological chain of events in cerebral ischemia.  These events 
resulting in a buildup of the intracellular calcium concentration and cell death. 
Abbreviations are: ATP = adenosine triphosphate, VSCC = voltage-sensitive Ca2+-
channels, NMDA = N-methyl-D-aspartate, AMPA = alpha-amino-3-hydroxy-5-methyl-4-
isoxazole propionate, IP3 = inositol 1,4,5-trisphosphate, DAG = diacylglycerol (1,2-
diacyl-sn-glycerol-3-phosphorylethanolamine).  Figure reproduced from reference (14). 
 
 
 
Figure 5-4.  Cartoon of the N-methyl-D-aspartate (NMDA) receptor.  
Individual binding sites (glutamate, glycine, polymine, and phencyclidine 
(PCP) are shown.  Figure reproduced from reference (14). 
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receptors, permitting Ca2+ influx.  Studies of focal cerebral ischemia in animal models 
have demonstrated significant reductions in infarct volume with MK-801 (16,17).  In 
terms of competitive NMDA channel antagonists (directly blocking the NMDA receptor 
site), the most extensively tested drug has been CGS-19755.  Studies providing CGS-
19755 treatment early after ischemic onset reported a significant decrease in Ca2+ influx, 
with differing levels of neuronal protection depending on drug dose and time of delivery 
(18-20).  Subsequent studies comparing the effects of a more recent competitive NMDA 
receptor antagonist, CGP-40116, with that of CGS-19755 and MK-801 have shown that 
CGP-40116 is more potent than CGS-19755 with comparable levels of neuroprotection 
as MK-801 (21-23).  
5.2.3 Anti-inflammatory Agents 
Although rt-PA therapy improves therapeutic outcome via restoration of blood flow, two 
retrospective studies performed by the NINDS rt-PA Stroke Study Group (24,25)  
reported that six percent of patients treated with rt-PA experienced symptomatic 
intracerebral hemorrhage. In addition, the authors found that the neurological benefit (i.e., 
minimal or no disability) at 3 months was only 30% better than patients receiving 
placebo, with similar mortality rates for the two.   
Reperfusion Injury and the Inflammatory Response 
Reperfusion of ischemic tissue has an associative inflammatory response that may 
contribute to the development of secondary neuronal damage.  Following transient 
cerebral ischemia, expression of cytokines such as tumor necrosis factor alpha (TNF-α) 
and interleukin-1 (IL-1) increase the recruitment and activation of leukocytes (26,27).  
These leukocytes, referred to as polymorphic neutrophils (PMNs), promote blood 
coagulation by adhesion to endothelial cells and the production of perfusion defects.  del 
Zoppo et al. (28) demonstrated that leukocyte accumulation in the microvasculature after 
reperfusion caused secondary occlusion (i.e., the “no-reflow” phenomenon).  Leukocyte 
accumulation also increases enzymatic activity and the production of oxygen free 
radicals.  These, as discussed earlier, lead to neuronal damage and apoptotic events.   
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Anti-inflammatory Agents 
Because inflammation is the major contributor to reperfusion injury, anti-inflammatory 
agents targeting adhesion molecules (ICAM-1) or cytokines (TNF-α, IL-1) could reduce 
the risk of symptomatic ICH following rt-PA therapy.  Treatment of cerebral reperfusion 
injury with anti-ICAM-1 was shown to increase the efficacy of rt-PA in a rabbit model of 
ischemia (29).  Additional studies in IL-1R1 null mice (30) and anti-TNF-α in rat brain 
(31) reported neuroprotection against reperfusion injury.   Further study of antibodies 
against adhesion molecules such as ICAM-1 and the cytokines listed above should aid in 
understanding the mechanisms of reperfusion injury and how to combat them.   
    
5.3 Current MRI Methods 
MRI techniques such as DWI, PWI, and metabolic imaging permit the rapid definition of 
ischemic territory and regions of perfusion deficit.  These methods are not only useful in 
investigating the pathophysiology of cerebral ischemia, but also in monitoring therapeutic 
efficacy and optimizing drug dose and delivery.   
5.3.1 Diffusion-weighted Imaging 
The emergence of DWI for early detection of ischemic injury, first detected by Moseley 
and coworkers (2,3), initiated subsequent quantitative assessment of ADCs in normal and 
ischemic brain tissue.  Reduced ADCs, caused by cellular swelling and energy driven 
processes, permit lesion identification and volumetric analysis.  Warach et al. (32) 
reported that ischemic injury was detectable on DWI as early as one hour after onset, 
previous to any visible hyperintensity on T2-weighted MRI.  A subsequent study by this 
group reinforced the fact that conventional imaging tends to underestimate the ischemic 
territory identifiable by ADCs (33).  This is because T2-weighted MRI, which detects 
alterations in tissue water content, is less sensitive than DWI.  T2 changes are not readily 
apparent until 4-6 hours after occlusion, when sufficient development of vasogenic 
edema has occurred.  DWI, on the other hand, is able to detect evidence of cytotoxic 
edema within minutes after occlusion.  DWI evaluation of the extent of injury in acute 
stroke, within 3-5 hours from initial onset, provides the clinician with a diagnostic tool 
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superior to pre-existing methods; a method for monitoring any therapeutic intervention 
provided on the patient’s behalf.   
Reversible versus Irreversible Damage 
The ability to differentiate reversible from irreversible damage is important in assessing 
the severity of stroke at the time of diagnosis and treatment.  Ischemic areas with slow 
diffusion denote permanent injury whereas regions with normal to moderately reduced 
diffusion suggest salvageable tissue.  Minematsu et al. (34) noted that MRI with heavy 
diffusion-weighting was able to differentiate reversible focal ischemic injury from 
permanent damage in a transient MCAO model in rats.  Similar results were reported in 
cerebral ischemia in gerbils (35).       
5.3.2 Perfusion-weighted Imaging 
Perfusion deficits due to vascular occlusion are measurable using dynamic contrast-
enhanced MRI, described in the latter part of Chapter 1.  Several hemodynamic 
parameters may be measured, such as VTT, rCBV, and CBFi.  Similar to DWI, 
quantitative assessment of these metrics with perfusion-weighted MRI should help assess 
the role of collateral circulation in maintaining viability within ischemic tissue.  Clinical 
studies have shown good correlation between reduced rCBV and acute infarcts (36), with 
a heterogeneous distribution of rCBV values across the lesion (37).  Higher rCBV values 
on the periphery of lesions may indicate less severe damage.  Schlaug et al. identified a 
reduction in rCBV (47% of normal) and CBFi (37% of normal) for the penumbral region, 
with more severe reductions for the core (19% of normal for rCBV, 12% of normal for 
CBFi).  These regions with somewhat reduced rCBV or CBFi and normal to moderately 
reduced ADCs, termed the “diffusion-perfusion mismatch”, may indicate a treatable area.    
Reversible versus Irreversible Damage 
Experimental animal studies have investigated changes in this mismatch region using 
concurrent DWI and PWI, as well as standard T2-weighted imaging.  Carano and 
coworkers (38,39) reported the delineation between normal and abnormal tissue, as well 
as penumbra and core, using a multidimensional feature space (ADC, CBF, T2, and M0) 
and cluster analysis.  Diffusion and perfusion heterogeneity within the lesion indicates 
that regions with severely reduced ADCs and CBFs denote the core, whereas regions 
with normal to moderately reduced ADCs and somewhat reduced CBF denote the 
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penumbra.  Subsequent clinical studies, in defining the diffusion-perfusion mismatch, 
have used this region as a guideline for therapeutic intervention, with moderate success 
(40-42).  It is important to note that this mismatch is a generalization of the penumbra, 
and that additional parameters indicative of energy metabolism would improve the 
delineation between reversible and irreversible injury. 
5.3.3 Metabolic Imaging 
In the acute stage the diffusion-perfusion mismatch may compromise tissue at both high 
and low risk.  Metabolic imaging offers a method for tracking changes in energy 
metabolism following ischemia—ATP depletion, tissue acidosis, and increased pH.  
Concurrent monitoring of these parameters with DWI and PWI should aid in delineating 
the fraction of mismatch tissue at high risk.  Takegami et al. (43) observed a region with 
increased lactate and normal ADC on the periphery of ischemia 20 minutes after MCAO.  
This region progressed to infarct without treatment.  Additional studies (44,45) showed a 
gradient of cellular metabolic injury; one region with increased lactate in line with the 
diffusion-perfusion mismatch, a second oligemic region with no change in lactate (both 
having relatively normal ADC/NAA levels).  Since acute lesions may reverse transiently 
or permanently, or potentially progress to infarct, multiparametric prediction maps are 
imperative.  By combining DWI, PWI, and lactate/NAA imaging, the pathophysiological 
complexity of ischemia may be elucidated. 
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Abstract 
Cortical spreading depression (CSD) was visualized using manganese-enhanced MRI 
(MEMRI) following topical application of KCl to the exposed rat cortex.  MEMRI signal 
increase in the ipsilateral cortex relative to the contralateral control region was 60% ± 
30% following two KCl applications.  MEMRI signal increase for a single (40%) versus 
double (80%) KCl application suggests an integration effect over successive CSD 
episodes.  CSD-induced MEMRI enhancement involved cortical layers containing dense 
regions of apical dendrites, supporting the contention that these neuronal structures are 
necessary for propagation of CSDs.  Sub-cortical enhancement was present in 
hippocampal and thalamic regions, most likely a result of neuronal connections with 
cortical layers 4 and 5.  These results are consistent with previous studies of CSD using 
diffusion-weighted MRI and T2*-weighted MRI and should be useful for investigating 
CSD itself and its role in other neurological disorders.   
 
 
Keywords: manganese-enhanced MRI, spreading depression, rat brain 
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6.1 Introduction 
The long hypothesized contribution of cortical spreading depression (CSD) to the 
pathophysiology of neurological disorders such as stroke, head trauma, epilepsy, 
hypoglycemia, and subarachnoid hemorrhage make it a potential therapeutic target.  This 
chapter will address application of a recently developed MRI method, manganese-
enhanced MRI, for the visualization of experimental CSD.  The utility of MEMRI for 
investigating the role of CSDs in the aforementioned conditions will be discussed briefly.  
The role of peri-infarct depolarizations, similar to CSDs, in the temporal evolution of 
cerebral ischemia will be covered in Chapter 7, using the methodology developed here.     
6.1.1 Pathophysiology of Cortical Spreading Depression 
Cortical spreading depression (CSD), a pathophysiological phenomenon of the central 
nervous system first described by Leao (1,2), is characterized by a spontaneous and 
reversible depression of electrical activity that spreads from the site of onset as a radial 
wave across the cortex with a speed of 2 to 5 mm/min.  Experimental induction of CSD 
relies on methods that increase the extracellular K+ concentration ([K+]o), leading to 
depolarization of adjacent presynaptic terminals, neurotransmitter release, and local 
failure of ion homeostasis (3).  The radial wave of depressed cortical electrical activity 
leads to depolarization of the cellular membrane, causing an abrupt negative shift in 
direct-current (DC) potential on the order of -5 to -15 mV, followed immediately by a 
smaller but more prolonged positive phase (4).  For the duration of the negative potential 
shift (approximately one minute), a large increase in [K+]o is accompanied by a drop in 
[Cl-]o, [Na+]o, and [Ca2+]o, suggesting that K+ leaving cells is exchanged against Na+ and 
Ca2+ that are entering (5).  The increase in [K+]o to levels of 10 to 60 mmol/L is sufficient 
to depolarize adjacent neurons in the path of the CSD wave, permitting its continued 
propagation.  Concomitant with the movement of Na+ and Cl- into the cell, there is an 
influx of water, subsequent cellular swelling, and a reduction in extracellular space by 
50% (6,7).  These transient cellular changes are accompanied by increased cortical 
perfusion and decreased tissue pO2, accounting for the local increase in oxygen 
consumption required to restore membrane ion gradients (8).  Upon passage of the CSD 
wave, cortical electrical activity renormalizes over the course of several minutes, 
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permitting additional episodes of CSD following an approximate 3-minute refractory 
period.   
6.1.2 Role of CSD in Neurological Disorders 
CSD is of interest because of its contribution to the pathophysiology of stroke, head 
trauma, epilepsy, hypoglycemia, and subarachnoid hemorrhage (3).  Unfortunately, the 
comprehensive evaluation of CSD in human subjects has not been done, largely in 
consideration of the challenges involved and the lack of appropriate measuring 
techniques.  The majority of studies investigating the role of CSDs in these conditions 
have been in animal models, specifically lissencephalic species (mouse, rat, rabbit), 
versus that of gyrencephalic species (cat, monkey) (5).  CSD, which can be elicited by 
direct chemical, mechanical, or electrical stimulation to the cortex, is produced more 
readily in lissencephalic species, and, although gyrencephalic species are relatively 
resistant to CSD propagation, they are by no means immune.  Further investigation of the 
dynamic physiologic changes of CSD could aid in understanding the underlying 
mechanisms of the aforementioned conditions. 
6.1.3 MRI of Experimental CSD 
Macroscopic Characterization of CSD  
Past studies have used MRI as a non-invasive tool for the characterization of CSD.  
Gardner-Medwin et al. (9) demonstrated the identification of experimentally-induced 
CSD in a rat model using T2*-weighted MRI.  The authors suggested that the observed 
increase in signal intensity (~10%) was a result of sensitivity to alterations in the 
oxygenation state of hemoglobin within the local cerebral vasculature (10).  CSD causes 
a local increase in cerebral blood flow and tissue oxygenation, yielding increased signal 
in gradient-echo images (Fig. 6-1).  Other studies present observations of a similar 
phenomenon in which experimentally-induced CSD is characterized by a transient 
decline in the apparent diffusion coefficient (ADC) of water (11-13).  Latour et al. (11) 
characterized the temporal evolution of CSD using DWI.  The authors observed a region 
of declined ADC (~35%) moving across the cortex with a uniform velocity of 
approximately 3 mm/min (Fig. 6-2).  The authors hypothesized that the induced 
depolarizations of the cellular membrane, resulting in cellular swelling and a decrease in 
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the extracellular volume fraction, account for the transient decrease in ADC.  In line with 
this study, Busch et al. (12) demonstrated the simultaneous recording of EEG, DC 
potential, and the temporal evolution of CSD using DWI.  Their results coincide with 
those of Latour et al. (11), but allow a method of obtaining electrophysiological 
recordings in the magnet during CSD imaging.  For a better understanding of the 
temporal relation between cell membrane depolarizations and the accompanying 
hemodynamic response, de Crespigny et al. (13) assessed both during CSD using T2*-
weighted MRI and DWI.  The authors found that the transient regional hyperperfusion 
following the ADC decrease was delayed, suggesting that the perfusion increase is a 
consequence of elevated ATP requirements for cellular repolarization. 
 
 
 
Figure 6-1.  Distribution of zones of increased MR signal intensity in successive images 
(at 12.2-s intervals) following induction of spreading depression.  White zones indicate 
areas with a minimum 5.5% signal increase relative to baseline.  A single raw gradient 
echo image (29) is shown in the top left panel.  Regions above the threshold are shown in 
the remaining images (30-44), superimposed on spin echo anatomical images.  
Subtraction maps for images 32, 36, 40, and 44 versus baseline are shown in the right-
hand column.  After application of 3M KCl, a hyperintense region (from decreased T2*), 
approximately 2 mm in size, is clearly visible moving away from the application site to 
the lower cortex.  Figure reproduced from reference (9). 
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Figure 6-2.  Left: Water apparent diffusion coefficient (ADC) maps of a single MRI slice though the rat 
brain exposed to physiological saline (NaCl) (left) or 3M KCl (right).  The gray-scale intensity is 
proportional to the water ADC and a nonlinear mapping, such that ADC values below 0.55 × 10-5 cm2s-1 
appear nearly black, was used to exaggerate the affected region.  The ADC maps acquired after NaCl 
application are unchanged, indicative of normal rat brain.  After application of 3M KCl, a region of 
decreased water ADC, approximately 2 mm in size, is clearly visible moving away from the application site 
to the lower cortex.  Right: A 3D intensity plot (top right) for the 30 cortical ROIs, with the corresponding 
2D contour plot (bottom right).  The slope of the trajectory, indicated by the dashed white line, provides an 
estimate of the propagation speed (~3 mm/min).  Figure reproduced from reference (11). 
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Limitations of Real-Time Imaging 
Although T2*-weighted MRI and DWI have been used to investigate CSD, these studies 
have limited their spatial resolution and signal-to-noise ratios in order to achieve a 
reasonable temporal resolution for monitoring the transient changes in ADC and T2* 
concomitant with CSD propagation.  T2*-weighted MRI also suffers from susceptibility-
induced artifacts from the interface between tissue boundaries, degrading image quality.  
Since DWI and T2* methods are based on macroscopic physiological changes (cell 
swelling and regional blood flow, respectively), they are limited in their ability to 
characterize the spatial extent of CSD.   An MRI method with a higher signal-to-noise 
ratio for whole-brain imaging of CSD, based on more microscopic physiological changes, 
would be helpful in order to overcome these limitations. 
6.1.4 Manganese as a Paramagnetic Calcium Analog 
Manganese and Neuronal Activation 
Recent studies have reported the use of manganese ions (Mn2+) as a membrane-
depolarization-dependent contrast agent for monitoring neuronal activation following the 
application of glutamate (14,15), as well as in the study of focal ischemia (16).  Mn2+ 
competitively enters cells through Ca2+-influx pathways such as voltage-gated Ca2+ 
channels (17,18).  Lin and Koretsky (14) first demonstrated the utility of paramagnetic 
Mn2+ in monitoring regional brain function using T1-weighted MRI.  The presence of 
extracellular Mn2+ during neuronal depolarization elicits Mn2+ influx through Ca2+ 
channels (Fig. 6-3).  Upon repolarization, Ca2+ channels close resulting in the 
‘permanent’ intracellular uptake of Mn2+.  Since Mn2+ remains sequestered in previously 
activated regions, it allows for ‘snapshot’ imaging of brain activation patterns in 
functional task paradigms performed outside the magnet (14). 
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Ca2+
 
Figure 6-3.  Schematic of a voltage-gated Ca2+ channel.  Following membrane depolarization, both gates 
open and Ca2+ may be exchanged between the intracellular and extracellular spaces.  With repolarization, 
Ca2+ channels close resulting in the ‘permanent’ intracellular uptake of Mn2+. 
 
 
Manganese and Cortical Spreading Depression 
Extracellular accumulation of K+, like glutamate, is believed to play a central role in the 
propagation of CSDs.  Whether pathophysiologically or experimentally induced, local 
increases in [K+]o lead to the depolarization of presynaptic terminals and the opening of 
Ca2+ channels.  Mirroring the rise in [K+]o, [Ca2+]o declines from its normal level of 1.2-
1.5 mM to less than 0.3 mM, indicating a Ca2+ shift to the intracellular compartment 
during CSD.  Since Mn2+ is transported into the cell in a manner similar to Ca2+, it should 
be possible to use Mn2+ to track the spatial distribution of CSD using manganese-
enhanced MRI (MEMRI).    The purpose of this feasibility study is to demonstrate the 
utility of Mn2+ as a paramagnetic Ca2+ analog in the visualization of CSD in the rat brain.  
MEMRI should be useful for investigating CSD itself as well as its role in the 
pathophysiology of other neurological disorders.  
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6.2 Methods 
6.2.1 Animal Preparation 
The present study was approved by the Institute Animal Care and Use Committee 
(IACUC) of the University of Massachusetts Medical School (IACUC protocol A-875).  
Male Sprague-Dawley rats (300-360 g; Taconic Farms, Germantown, NY) were divided 
into three groups: saline control (N = 4), glutamate (N = 2), and experimental CSD (N = 
5).  Rats were initially anesthetized with an intraperitoneal injection of chloral hydrate 
(400 mg/kg).  Polyethylene catheters (PE-50, Becton Dickinson, San Jose, CA) were 
placed in the left femoral vein (i.v.) and the right external carotid artery (ECA) for drug 
administration.  For catheterization of the right ECA, a ventral midline incision was made 
in the neck. The omohyoid muscle was separated longitudinally and retracted laterally to 
isolate and expose the right ECA.  Following ligation of the vessel, a small incision was 
made into which the catheter was inserted and secured in place.  Cannulation of the right 
ECA limited drug delivery to the right side of the brain, enabling the left side to serve as 
a control.  The common carotid artery (CCA) was kept intact and open in order to 
maintain blood flow to regions originally supplied by the right ECA (i.e., face and 
underlying muscle).  Rectal temperature was monitored continuously with a rectal probe 
and maintained at 37.0°C using a thermostatically-controlled heating lamp (Model 
73ATD, YSI Inc., Yellow Spring, OH) during preparation.   
6.2.2 MnCl2 Administration 
Physiologically-buffered saline containing 74.5 mM manganese chloride (MnCl2 • 4H2O; 
Sigma, St. Louis, MO) was infused through the left femoral vein at a rate of 3.97 
µmol/min (3.2 ml/hr) using a syringe pump (Model 11; Harvard Apparatus, Holliston, 
MA) for 32 min.  The total volume of infused MnCl2 solution was 1.71 ml (127 µmol).  
To open the blood-brain barrier (BBB), 25% D-mannitol solution (5 mg/kg; Sigma, St. 
Louis, MO) was bolus-injected via the right ECA 10 min after the start of the MnCl2 
infusion. 
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6.2.3 Glutamate Administration  
A glutamate administration group (N = 2) was evaluated to validate our use of the 
MEMRI method previously developed by Aoki et al (15), a modification of the original 
by Lin and Koretsky (14).  A solution of L-glutamic acid (0.2 ml of 10 mg/ml; Sigma, St. 
Louis, MO) was bolus-injected via the right ECA 22 min after the start of the MnCl2 
infusion (Fig. 6-4a).  For the corresponding controls (N = 2), physiologically buffered 
saline (0.2 ml) was injected through the right ECA in place of the glutamate. 
6.2.4 Experimental Cortical Spreading Depression 
Animal Preparation 
For the experimental CSD group (N = 5), rats were mounted prone on a homemade 
stereotaxic surgical board with a head holder and tooth bar.  The frontoparietal cranium 
was exposed by a midsagittal incision, and a burr hole, 2.0 mm in diameter, was made in 
the right parietooccipital cortex, 1 mm posterior and 1.5 mm lateral of bregma.  
Following careful excision of the dura using a 23-gauge needle, two syringes were 
prepared for cortical application of 4M KCl or 0.9% (w/v) NaCl, respectively. 
Single versus Double KCl Applications 
In order to evaluate the effects of single versus multiple applications of KCl on CSD-
induced MEMRI enhancement, animals were subdivided into two groups: a single 4M 
KCl application (N = 1) and two 4M KCl applications (N = 4).  For the single 4M KCl 
application, 22 min after the start of MnCl2 infusion, a 20µl volume of KCl solution was 
administered over the course of 3 min followed by a saline wash (Fig. 6-4b).  For two 4M 
KCl applications, a 40µl volume of KCl solution was administered in the following 
manner, 22 min after the start of MnCl2 infusion: 3-min 4M KCl exposure, saline wash 
→ 3-min waiting period → 3-min 4M KCl exposure, saline wash (Fig. 6-4c).  For the 
corresponding controls (N = 2), 40µl of 0.9% (w/v) NaCl was applied to the exposed 
cortex in place of the 4M KCl.   
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Figure 6-4.  Timing of Drug Administration for Glutamate (a), Experimental CSD with 
one KCl application (b), and Experimental CSD with two KCl applications (c).  The 
time points for starting the MnCl2 infusion, mannitol injection, glutamate injection, 
KCl applications, and saline washes are indicated by the labeled arrows.  For the 
corresponding controls, physiologically-buffered saline (NaCl) was applied in place of 
the glutamate or KCl. 
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6.2.5 MRI Measurements 
Data Acquisition and Parameter Setup 
MR experiments were performed with a Bruker Biospin 2.0T/45cm imaging spectrometer 
equipped with ±20 G/cm self-shielded gradients (Fig. 3-5). T1-weighted imaging was 
performed using the following acquisition parameters: TR/TE = 300.0/12.0 ms, FOV = 4 
cm × 4 cm, matrix size = 256 × 256.  The imaging plane was referenced to the rhinal 
fissure at the boundary of the olfactory bulb.  For the glutamate administration group and 
controls, six 3-mm slices were acquired with NEX = 2.  For the experimental CSD group 
and controls, eight 2-mm slices were acquired with NEX = 4.  The total experiment times 
were 2.6 min and 5.2 min for the glutamate and experimental CSD experiments, 
respectively.  
Imaging Setup and Physiological Monitoring 
During imaging, animals were placed supine in a home-built animal holder (Fig. 6-5a).  
The head of the animal was fixed inside a 2.0 cm x 3.5 cm rectangular 1H surface coil 
shaped to conform to the curvature of the skull (Fig. 6-5b).  Animals were anesthetized 
with 1.0% isoflurane delivered at 1.0 L/min in breathing-quality air (Fig. 6-5c).  Body 
temperature was maintained at 37.0 ± 1.0°C by circulated warm air using a T-type 
thermocouple and a double-point feedback control system (Fig. 6-5d).  
6.2.6 Data Analysis 
Image analysis, image reconstruction and region of interest (ROI) calculations were 
performed using Paravision’s Image Processing and Display Software (Xtip).  The spatial 
extent of MEMRI-enhanced regions (cortical, sub-cortical) were determined by 
correlation to a standard rat brain atlas (19) based on the slice location in terms of 
distance from bregma.  ROIs were user-defined to delineate between MEMRI-enhanced 
cortical regions and normal tissue.   Percent signal increase was calculated through 
comparison of the ipsilateral cortex to the equivalent contralateral control region on a 
slice-by-slice basis: 
100
SI
SISI(%) Increase Signal
CC
CCIC ×−=    (6-1) 
where SIIC is the signal intensity for the ROI in the ipsilateral cortex and SICC is the signal 
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intensity for the ROI in the contralateral cortex.  Data are presented as mean ± standard 
deviation (SD), with a separate term for the inter-slice signal variability (IS-SD). 
 
 
 
 
 
 
Figure 6-5.  Home-built animal holder for rat brain imaging studies.  (a) Angled view.  The holder is dual-
fitted with PVC tubing for delivery and removal of anesthetic, a cradle equipped with nose holder and tooth 
bar, a 2.0 cm × 3.5 cm rectangular curved surface coil for 1H imaging, and a heat tube for maintenance of 
body temperature using a T-type thermocouple.  (b) Side view.  The animal is placed supine in the holder 
such that the surface coil conforms to the curvature of the skull.  The nose holder and tooth bar maintain 
positioning of the animal’s head during imaging.  (c) Anesthetic Delivery.  Anesthetic is delivered to the 
animal via the PVC tubing in 1.0L/min breathing quality air.  A glove is used to restrict delivery of 
anesthetic to the animal’s face.  (d) Temperature Maintenance.  Body temperature is maintained at 37.0 ± 
1.0°C by circulated warm air using a T-type thermocouple and a double-point feedback control system. 
a b
c d
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6.3 Results 
6.3.1 MEMRI Enhanced Regions 
Regional Coverage of Cortical and Ventricular Enhancement  
Fig. 6-6 shows the multi-slice T1-weighted MEMRI for the glutamate group, 
experimental CSD group, and the corresponding controls at a single time-point 1.5 hours 
after the start of MnCl2 infusion.  Fig. 6-6a shows the signal enhancement from T1-
weighted MEMRI following neuronal activation via glutamate administration.  The 
average percentage increase in cortical signal intensity was 29% ± 3%, with a similar 
increase seen in the ventricles.  Cortical enhancement was visible across five of the six 
imaging slices, resulting in approximately 15 mm of coverage (4.5 mm anterior to 10.5 
mm posterior of bregma).  Fig. 6-6c shows the signal enhancement from T1-weighted 
MEMRI of experimental CSD following two applications of 4M KCl.  The region of 
MEMRI enhancement was confined to a 0.6-1.2-mm-thick cortical layer, appearing as a 
hyperintense streak extending radially from the CSD induction site (solid arrows).  The 
average percentage increase in cortical signal intensity was 60% ± 30%.  Cortical 
enhancement was visible across six of the eight imaging slices, resulting in 
approximately 12 mm of coverage (2.5 mm anterior to 9.5 mm posterior of bregma).    
Regional Coverage of Subcortical Enhancement 
In a few of the slices (Fig. 6-6b, open arrows), sub-cortical enhancement was present that 
did not match with the regional ventricular enhancement of the NaCl control (3.5 mm to 
9.5 mm posterior of bregma).  Areas of sub-cortical enhancement included hippocampal 
regions CA1-3, subiculum, and dendate gyrus, as well as the thalamic nucleus, superior 
and inferior colliculi, and geniculate nucleus.  No significant changes in cortical signal 
intensity were detected for the saline controls (Figs. 6-6b and 6-6d), but the same degree 
of ventricular enhancement was present. 
Comparison of Single versus Double KCl Applications 
Fig. 6-7 illustrates the effect of single versus multiple applications of KCl on CSD-
induced MEMRI enhancement.  Three representative axial images are shown for each 
animal (solid arrows indicate the image located coincident with the KCl application site).  
Fig. 6-7a shows the signal enhancement from T1-weighted MEMRI following a single 
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application of 4M KCl.  The average percentage increase in cortical signal intensity was 
40% for this particular animal.  Fig. 6-7b shows the signal enhancement from T1-
weighted MEMRI following two applications of 4M KCl.  The average percentage 
increase in cortical signal intensity was 80% for this particular animal (60% ± 30% for N 
= 4); double that of the single 4M KCl application.  Both animals had similar levels of 
ventricular enhancement.   
 
 
Figure 6-6. T1-weighted MEMRI following glutamate administration and experimental CSD.  a) Neuronal 
activation following glutamate administration.  Glutamate administration results in heterogeneous cortical 
enhancement (29% ± 3% signal increase) in five out of six images (solid arrows).  Slice thickness = 3 mm.  
b) Saline control for glutamate experiments.  c) Cortical signal enhancement following two 4M KCl 
applications.  Two 4M KCl applications result in a thin layer of cortical enhancement (60% ± 30% signal 
increase) in six out of eight images (solid arrows).  Slice thickness = 2 mm.  Only images exhibiting 
enhancement are shown. Signal enhancement following CSD in the presence of Mn2+ is clearly visible in 
the right cortex.  Regions of CSD-induced MEMRI enhancement appear as a hyperintense streak extending 
dorsolaterally from RSG (retrosplenial granular cortex) or FR2 (frontal cortex, area 2) to Pir (piriform 
cortex) or PRh (perirhinal cortex) depending on the location anterior-posterior with respect to bregma.  
Regions of sub-cortical enhancement (open arrows) include CA1-3 (Ammon’s Horn), the subiculum, and 
the dendate gyrus of the hippocampus, in addition to the thalamic nucleus, superior and inferior colliculi, 
and geniculate nucleus.  Sub-cortical enhancement is thought to be due to neuronal connections between 
these particular regions and the cortex.    d) NaCl control for experimental CSD.     
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Figure 6-7.  Effect of single versus double KCl applications on MEMRI appearance.  a) MEMRI 
enhancement following a single application of 4M KCl.  One KCl application results in a thin layer of 
cortical enhancement (40% signal increase for this particular animal).  b) MEMRI enhancement following 
two applications of 4M KCl.  Two applications of KCl induce multiple episodes of CSD, resulting in an 
integration of MEMRI cortical signal intensity (80% signal increase for this particular animal; 60% ± 30% 
for N = 4).  MEMRI enhancement was visible across six out of eight images for both the single and double 
KCl application.  Representative axial images coincident with and adjacent to the KCl application site are 
shown.  Solid arrows indicate the location of the KCl application site.  
 
6.3.2 Quantitative Summary 
Table 6-1 summarizes the average percentage signal intensity increase for different brain 
regions for the glutamate administration group, experimental CSD group, and the 
corresponding controls.  In the glutamate administration group, changes in signal 
intensity in the ipsilateral cortex were comparable to that of the ventricles.  Animals in 
the experimental CSD group that received two applications of 4M KCl exhibited no 
significant difference in percentage signal increase between the ipsilateral cortex and the 
ventricles (p > 0.32, N = 4).  A similar trend was seen for the single application of 4M 
KCl.  For both sets of controls, changes in cortical and ventricular signal intensity were 
comparable, indicating experimental reproducibility. 
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Table 6-1:  Average Signal Increase (%) from T1-weighted MRI for Different Brain Regions 
(relative to a homologous region in the contralateral hemisphere) Following Various Stimuli. 
Type of Stimulus Average Signal Increase (%) (using Eq. 6-1)
Cortex  Ventricles   
Mean ± SD ISSDa Mean ± SD ISSDa 
Glutamate Administration (N = 2) 29 ± 3 5 21 ± 6 10 
Saline Control (N = 2) 6 ± 1 4 29 ± 9 20 
Experimental CSD  
     Single KCl Application (N =1) 40 20 40 20 
     Two KCl Applications (N = 4) 60 ± 30* 20 46 ± 3 10 
NaCl Control (N = 2) 20 ± 10 4 50 ± 10 20 
aTo account for intra-animal variability, the inter-slice standard deviation (ISSD) was 
calculated from values for the average signal increase (%) across affected slices. 
*MEMRI signal intensity changes in the ipsilateral cortex were not significantly different 
from the ventricles (P > 0.32, N = 4) in the experimental CSD group receiving two KCl 
applications. 
 
6.4 Discussion 
6.4.1 Celllular Uptake of Manganese 
Mn2+ is paramagnetic and has been used for MRI tissue contrast enhancement by oral or 
intravenous administration of MnCl2 or Mn complexes.  Mn
2+ mimics Ca2+ uptake in 
many biological systems and is known to enter cells through ligand- or voltage-gated 
Ca2+ channels during nerve action potentials (17).  Following experimental induction of 
CSD, membrane depolarization facilitates opening of voltage-gated Ca2+ channels and a 
concomitant influx of Mn2+.  Upon deactivation, channels return to their closed resting 
state, resulting in the entrapment of intracellular Mn2+.  This phenomenon is supported by 
the observation that the specific action of verapimil, a voltage-gated Ca2+ channel 
blocker, inhibits influx of Mn2+ into cells (18). 
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6.4.2 Validation of Method   
In the present work, validation of Mn2+ as an activation-specific contrast agent was done 
through glutamate administration in the presence of a compromised BBB using the 
methodology of Aoki et al. (15).  For simplicity, all surgical procedures and drug 
administration were performed outside the magnet with image acquisition at 1.5 hours 
after the start of MnCl2 infusion.  Fig. 6-6a demonstrates that the infusion of MnCl2 
during glutamate activation causes cortical and ventricular contrast enhancement of 
similar magnitude and regional coverage when compared to previous MEMRI studies 
(14,15).  Aoki et al. (15)  reported a relative signal enhancement of 174% for the right 
hemisphere (excluding the ventricles) and 155% for the ventricles alone following 
glutamate administration.  These results were based on the comparison of the relative 
signal intensities in the ipsilateral cortex measured at baseline (prior to injection of 
mannitol) and following glutamate administration (Fig. 6-8).  If instead a comparison is 
drawn between the relative signal intensities of the ipsilateral cortex and the contralateral 
cortex following glutamate administration, the relative signal enhancement is 
approximately 120%.  This estimated increase (20%) is consistent with the values 
reported in Table 1.  After drawing a similar comparison between the relative signal 
intensities of the ventricles and the contralateral cortex, the relative signal enhancement is 
approximately 135%.  Lin and Koretsky (14) reported a steady-state ventricular signal 
enhancement of 149% following infusion of MnCl2.  These increases (35% and 49%) are 
close to the changes in ventricular signal intensity seen in the experimental groups listed 
in Table 1. 
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Figure 6-8.  Time-course of relative signal intensities in the cortex and ventricle obtained 
from the glutamate administration (filled symbols) and control (open square) groups.  The 
inset indicates typical ROIs.  Timing for MnCl2 infusion, mannitol injection, and glutamate 
injection are indicated by the labeled arrows.  Figure reproduced from reference (15). 
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6.4.3 Derivation of Activation Scheme 
For the experimental CSD group, an activation scheme with a set waiting period was 
devised (Fig. 6-4c) to account for the approximate 3-min refractory period between 
initiation of individual episodes of CSD.  During the first application of 4M KCl, the 
local increase in [K+]o induces depolarization of presynaptic terminals, opening of 
voltage-gated Ca2+ channels, and the intracellular accumulation of Mn2+.  This takes 
place during the negative phase of the DC-potential shift over the course of 1-2 min.  
Upon repolarization, the Ca2+ channels close resulting in the retention of Mn2+ inside the 
cell.  While this repolarization occurs locally, the increase in [K+]o is thought to 
depolarize adjacent neurons, allowing propagation of the CSD wave along the entire 
extent of the cortex.  During the 3-min wait period, restoration of ion gradients occurs 
with normalization of spontaneous electrical activity, after which a second CSD episode 
may be induced.  Although electrophysiological recordings were not performed, previous 
work employing this experimental-CSD model reported induction of a single CSD event 
following one 3-min KCl application (20).  Based on these results, one CSD event is 
expected for the single 3-min KCl application and a minimum of two CSD events are 
expected for the double KCl application.  Each CSD event results in the intracellular 
accumulation of Mn2+.  With multiple CSD events there is an integration effect where the 
total amount of [Mn2+]i accumulated is proportional to the signal intensity in T1-weighted 
MRI.  As MEMRI ‘records’ all cortical regions having undergone CSD-induced 
depolarizations, CSDs appear as a hyperintense streak down the cortex (Fig. 6-6c). 
6.4.4 MEMRI Integration Effect 
Correlation Between MEMRI Enhancement and Degree of Neuronal Activation 
An MEMRI integration effect was first demonstrated following brain activation using 
multiple injections of glutamate (14).  The authors followed the temporal evolution of T1-
weighted MRI signal intensity changes in the cortex from rats undergoing MnCl2 
infusion, mannitol injection, and two injections of glutamate.  They reported an average 
signal enhancement of 123% and 238% for prestimulation and following two glutamate 
injections, respectively.  The time-course diagram from this work (Fig. 6-9), for a single 
representative rat, showed cortical signal intensities of approximately 135%, 200%, and 
250% for prestimulation, following a single injection of glutamate, and following two 
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glutamate injections, respectively.  These signal intensity changes suggest a correlation 
between the number of administered doses of glutamate, or the degree of glutamate-
induced Mn2+ influx, and the MEMRI signal enhancement.   
 
 
 
 
Figure 6-9.  Time course of T1-weighted MRI signal intensity changes in the cortex 
from two individual rats after addition of glutamate or increased CO2 in the presence of 
Mn2+ and a broken BBB.  Filled circles represent the cortical signal intensity taken 
from the rat undergoing mannitol and glutamate (glut) injections, and open squares 
represent signal intensity taken from the rat undergoing mannitol, CO2, and glutamate 
(glut) injections.  The timepoints for MnCl2 infusion, mannitol injection, glutamate 
injection, or high CO2 are indicated by the labeled arrows.  Figure reproduced from 
reference (14). 
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Correlation Between MEMRI Enhancement and CSD-induced Manganese Influx 
In order to investigate the integration effect for CSD, comparisons were made between 
animals receiving a single or double application of 4M KCl.  Results of a single KCl 
application versus two KCl applications for experimental induction of CSDs support this 
relationship between [Mn2+]i accumulation and the signal enhancement in T1-weighted 
MRI.  Fig. 6-7 shows the integration effect of multiple CSD events for representative 
axial images located coincident with and adjacent to the KCl application site.  Following 
a single 3-min application of 4M KCl, the average percentage increase in cortical signal 
intensity was 40% (Fig. 6-7a).  Following two 3-min applications of 4M KCl, the average 
percentage increase in cortical signal intensity was 80% (60% ± 30% for N = 4) (Fig. 6-
7b), double that of the single 4M KCl application.  Both had comparable levels of 
ventricular enhancement, suggesting similar steady-state levels of Mn2+ in the CSF space.  
Although the average percentage increase in cortical signal intensity was 60% ± 9% for N 
= 4 in the double 4M KCl application, the average percentage increase for one of the 
animals was 30%.  That particular animal may in fact have only experienced a single 
CSD episode instead of two CSD episodes, resulting in an average percentage increase 
more comparable with the animal receiving a single 4M KCl application (40%).  Further 
study comparing single versus multiple applications of 4M KCl in conjunction with 
electrophysiological measurements will be required to verify the relationship between the 
number of CSD episodes, [Mn2+]i  accumulation, and MEMRI enhancement.     
6.4.5 Role of Apical Dendrites 
Cortical Structure and Composition 
Previous studies suggest that pyramidal cell dendrites are critical to CSD propagation 
(21), and that cortical layers containing proximal apical dendrites are more susceptible to 
CSD than those containing basilar dendrites or distal apical dendritic branches (22).  The 
cortex itself consists of six layers, diagrammed in Fig. 6-10.  Layer 1, the molecular or 
plexiform layer, contains Cajal-Retzius (CR) neurons which establish synaptic contacts to 
the apical dendritic bouquets of all pyramidal neurons regardless of size, function, 
location, or cortical depth (23).  Layers 2 and 3 contain small, medium, and large 
pyramidal cells characterized by networks of vertically oriented apical dendrites 
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extending into layer 1, as well as basilar dendrites extending into deeper cortical layers.  
Layer 4, the granular layer, contains a large number of small and tightly packed 
pyramidal cells, whereas layer 5 contains a thin layer of small pyramidal cells with large 
pyramidal cells scatter throughout, which extend up into layer 1.  Layers 4 and 5 have 
some nonpyramidal cells as well.  Layer 6, the multiform layer, contains multiform and 
fusiform cells arranged in columns by radial fiber bundles, with a sparse population of 
pyramid-like cells characterized by apical dendrites. 
 
 
 
 
Figure 6-10.  Cortical Layer Structure and Composition.  The individual composition 
of cortical layers 1-6 is diagrammed according to a myelin stain for axons (left), Nissl 
stain for somata (middle), and a Golgi stain for whole neurons (right).  
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Layer Specific Enhancement 
Cortical regions exhibiting MEMRI enhancement following experimental CSD included 
layers 1-5, extending dorsolaterally from RSG (retrosplenial granular cortex) or FR2 
(frontal cortex, area 2) to Pir (piriform cortex) or PRh (perirhinal cortex) depending on 
the location anterior-posterior with respect to bregma.  Layer 6 remained unaffected.  
Restriction of MEMRI enhancement to cortical layers 1-5 is consistent with the 
contention that pyramidal cell (apical) dendrites are necessary for the propagation of 
CSDs through individual layers of the cortex.  Note that the apical dendrites in layers 2-5 
are generally thick, have a dense covering of spines, and consist of pyramid-shaped cell 
bodies extending vertically to the pial surface.  In contrast to these, the limited number of 
apical dendrites in layer 6 comes in two forms.  The first group is thick and spiny like the 
apical dendrites of layer 4, but tends to develop horizontally elongated cell bodies instead 
of pyramid shaped ones whose axons follow curved courses with termination in layer 3 or 
4 (24).  The second group of apical dendrites in layer 6 are thin, moderately covered by 
spines, with branching limited to layer 5 before termination in layer 1 (25).  These 
differences in apical dendritic structure for layers 2-5 versus layer 6, degree of extension 
within these layers and into layer 1, may account for differences in synaptic connectivity, 
and why layer 6 is not expected to have MEMRI enhancement. 
6.4.6 Cortical-Subcortical Neuronal Connectivity 
In addition to the cortical enhancement in the experimental CSD group, there was some 
sub-cortical enhancement visible extending well beyond the ventricular space (Fig. 6-6c, 
open arrows).  This enhancement was different from the non-specific ventricular 
enhancement observed in the control (Fig. 6-6d).  Regions of sub-cortical enhancement 
included CA1-3 (Ammon’s Horn), the subiculum, and the dendate gyrus of the 
hippocampus, in addition to the thalamic nucleus, superior and inferior colliculi, and 
geniculate nucleus (Fig. 6-11a-c).   
Hippocampal regions CA1-3, Subiculum, and Dendate Gyrus 
Harris et al (26) reported on the intrinsic connectivity of the rat subiculum, specifically 
the apical dendritic morphology and patterns of axonal arborization.  Following 
neurobiotin-labelling, the existence of axonal varicosities and extensions found on axons 
provided evidence of projection cells connecting the entorhinal cortex with CA1.  Naber 
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et al. (27) showed the existence of direct and indirect projections from the perirhinal 
cortical regions to areas CA1-3 and subiculum of the hippocampus through electrical 
stimulation and current source density analysis.  The authors noted additional projections 
between the postrhinal cortical region and the dendate gyrus.  These connections may 
explain the MEMRI enhancement in hippocampal regions CA1-3, subiculum, and 
dendate gyrus following experimental CSD. 
Thalamic Nucleus, Superior and Inferior Colliculi, and Geniculate Nucleus 
Additional regions of subcortical enhancement included the thalamic nucleus, superior 
and inferior colliculi, and geniculate nucleus.  Previous studies report connections 
between a high percentage of projection and pyramidal neurons in cortical layers 4 and 
thalamic nuclei (28,29).  Levesque et al. (30) reported corticothalamic projections arising 
from cortical layers 4 and 5 following biocytin-labelling techniques.  Other reports 
describe connections between cortical layer 5 and the superior (31)  and inferior (32)  
colliculi, with neuronal projections extending from the superior collicus to the geniculate 
nucleus (33).  During CSD, signal propagation descending the pial surface along apical 
dendrites into cortical layers 4 and 5, and then through the various connections described, 
may explain the thalamic, superior/inferior collicular, and geniculate nuclear 
enhancement seen in the MEMR images.   
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Figure 6-11a.  MEMRI Subcortical Enhancement.  The T1-weighted image for slice location –3.5 mm 
to –5.5 mm from bregma is shown in the left-hand column. The corresponding anatomical maps for –3 
mm, -4 mm, and –5 mm from bregma are shown in the right-hand column.  Regions of subcortical 
enhancement (outlined in red) include: hippocampal regions CA1-3, subiculum (S), dendate gyrus 
(DG), geniculate nucleus (DLG), and thalamic nucleus (LDVL, LMPR).  Rat atlas images in the right-
hand column were reproduced from the Laboratory of NeuroImaging, UCLA 
<http://www.loni.ucla.edu/Research/Atlases/RatAtlas.html>. 
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Figure 6-11b.  MEMRI Subcortical Enhancement.  The T1-weighted image for slice location -5.5 mm to     
-7.5 mm from bregma is shown in the left-hand column. The corresponding anatomical maps for -6 mm, -7 
mm, and -8 mm from bregma are shown in the right-hand column.  Regions of subcortical enhancement 
(outlined in red) include: hippocampal regions CA1-3, subiculum (PrS, S), dendate gyrus (DG), and 
genicute nucleus (DLG).  Rat atlas images in the right-hand column were reproduced from the Laboratory 
of NeuroImaging, UCLA <http://www.loni.ucla.edu/Research/Atlases/RatAtlas.html>. 
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Figure 6-11c.  MEMRI Subcortical Enhancement.  The T1-weighted image for slice location -7.5 mm to      
-9.5 mm from bregma is shown in the left-hand column. The corresponding anatomical maps for -7 mm,     
-8 mm, and -9 mm from bregma are shown in the right-hand column.  Regions of subcortical enhancement 
(outlined in red) include: subiculum (PrS, S), superior colliculus (SuG, IntG, DpG), and inferior colliculus 
(CIC, DCIC, ECIC).  Rat atlas images in the right-hand column were reproduced from the Laboratory of 
NeuroImaging, UCLA <http://www.loni.ucla.edu/Research/Atlases/RatAtlas.html>. 
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6.4.7 MEMRI or DWI? 
Comparison of MEMRI and DWI of Experimental CSD 
The MEMRI signal enhancement in the cortex, described to contain cortical layers 1-5, 
was 0.6-1.2 mm in thickness and extended radially from the induction site.  Zhu (34) 
reported an average apical dendritic length of 1.2 mm in the neocortex of adult rats.  The 
thickness of MEMRI cortical enhancement is similar to this value and suggests that 
apical dendrites support CSD propagation.  Furthermore, these results are consistent with 
previous studies of CSD using diffusion-weighted MRI (DWI) (Fig. 6-2), in which a 
region of decreased water apparent diffusion coefficient (ADC), approximately 2 mm in 
size, propagated away from the application site to the lower regions of the cortex.  The 
discrepancy in the observed thickness of the affected cortical region reported by MEMRI 
versus DWI may be attributed to volume-averaging effects from differences in image 
spatial resolution (400µm for DWI versus 156µm for MEMRI, in-plane).  Although 
MEMRI and DWI both allow for visualization of CSDs, MEMRI has a clear advantage 
over that of DWI.  Because of the relatively rapid propagation of CSDs and the 
transiently-induced changes in EC space, DWI is limited to real-time imaging.  With 
intracellular retention of Mn2+ and a slow clearance rate, MEMRI may be performed after 
application of the stimulus outside of the magnet.  Consequently, longer experiment times 
allow for data acquisition at higher spatial resolutions with longer signal averaging and 
increased signal-to-noise ratios.  MEMRI may also be used for tracking real-time changes 
in-bore. 
Utility of MEMRI in Monitoring Experimental or Pathological CSD 
In summary, MEMRI is a useful technique for the visualization of experimental CSD 
using paramagnetic Mn2+ as a depolarization-dependent contrast agent in conjunction 
with T1-weighted imaging.  Topical application of 4M KCl in the presence of 
extracellular Mn2+ and a compromised BBB allowed differentiation between CSD-
specific cortical signal enhancement and the non-specific enhancement present in the 
ventricular space.  MEMRI is specific to Ca2+ channel activity and the intracellular 
accumulation of Mn2+.  Consequently, MEMRI may be a more direct method for imaging 
the spatial extent of CSD compared with DWI or T2*-weighted imaging, which are based 
on more macroscopic physiological changes (cell swelling and regional blood flow, 
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respectively).  Since the Mn2+ clearance is relatively slow, MEMRI may be useful for 
imaging CSD and its contribution to the temporal evolution of other neurological 
disorders. 
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Abstract 
The role of peri-infarct depolarizations, or PIDs, in the temporal evolution of cerebral 
ischemia is not fully understood.  When confounded with the time-varying nature of 
individual MR parameters, the ability to accurately characterize the ischemic territory 
becomes difficult.  In order to assess the role of PIDs versus that of terminal anoxic 
depolarizations in tissue progression to infarct with and without therapeutic intervention, 
a multispectral (MS) approach may provide greater power than that of a single parameter 
approach.  For this reason, MEMRI and DWI were performed for preliminary analysis of 
the utility of MEMRI in studying the temporal evolution of cerebral ischemia over that of 
standard DWI.  The method for optimum delivery of Mn2+ into the extracellular space 
following BBB disruption was determined to be the following: 6 ml/kg of 25% (w/v) 
mannitol injected at 0.9 ml/min → 10 min. wait period → 2 ml/kg of 50mM MnCl2 
injected at 0.9 ml/min.  Following optimization of BBB opening, MEMRI was employed 
in the characterization of cerebral ischemia.  Preliminary results show significant 
MEMRI enhancement previous to the development of a diffusion deficit, indicating that 
MEMRI may be useful in identifying tissue presumably at risk.  Since PIDs are one of 
the many aggravating factors in progression of penumbra tissue to infarct, MEMRI may 
be employed for studying methods suppressing the frequency and duration of PIDs. 
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7.1 Introduction 
Peri-infarct depolarizations (PIDs), similar in many respects to experimentally-induced 
cortical spreading depressions (CSDs), are one of the many aggravating factors in 
progression of the ischemic penumbra to infarction.  For this reason, methods suppressing 
the frequency and duration of PIDs should reduce total infarct volume.  This chapter will 
address the development of manganese-enhanced MRI for the visualization of PIDs and 
their role in the temporal evolution of cerebral ischemia.   
7.1.1 Peri-Infarct Depolarizations 
Spreading Depression-Like Depolarizations in Ischemia 
In cerebral ischemia, regions with severely compromised blood flow (~20% of control) 
suffer from energy breakdown and failure of ion homeostasis (1-3).  Unable to maintain 
existing ion gradients, there is a massive K+ shift from the IC to EC space.  This increase 
in extracellular K+ is of sufficient magnitude to induce neuronal depolarization, opening 
voltage-gated Ca2+ channels for Ca2+ influx (4,5).  The resultant intracellular Ca2+ 
overload then triggers the release of excitatory neurotransmitters (i.e., glutamate) into the 
EC space (6,7).  Since both K+ and glutamate elicit spreading depression, a phenomenon 
first described by Leao (8,9) in the 1940s, it makes sense that increased levels of these 
substances in ischemia would cause such depolarizations to occur.  The existence of these 
spreading depression-like depolarizations was first described by Nedergaard and Astrup 
(10) in a rat MCAO model of focal ischemia.  The authors reported the occurrence of 
repetitive DC potential deflections throughout the infarct rim, similar to experimentally-
induced spreading depression from 3M KCl application to the cortical surface.   
Frequency and Duration of Depolarization 
Within the ischemic core, membrane repolarization and restoration of ion gradients is not 
possible.   The lack of necessary energy stores leaves this region in a state of permanent 
depolarization, termed terminal anoxic depolarization.  The anoxic release of K+ and 
excitatory neurotransmitters such as glutamate within the infarct core initiate the spread 
of these depolarizations to the lesion periphery (11).  Within the penumbra, the limited 
flow supplied by collateral vessels cannot adequately meet the metabolic demands of 
repetitive depolarizations.  Successive events tend to be of increasing duration—the 
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upregulated glucose utilization within an already oxygen-deficient environment leads to 
transient tissue hypoxia and a lengthened time required for repolarization (12,13).  The 
necessitation for anaerobic glycolysis further aggravates lactate accumulation as well as 
tissue acidosis (14,15).  These exacerbating effects of repetitive transient depolarizations 
within penumbral tissue, termed peri-infarct depolarizations (PIDs), could potentially 
transition the tissue into a terminal state (12,16,17).        
7.1.2 Role of PIDs in Cerebral Ischemia 
Correlation Between PIDs and Infarct Size 
Nedergaard and Astrup (10) first hypothesized that peri-infarct depolarizations (PIDs) 
were the likely cause for progression of penumbral tissue to infarct.  A subsequent study 
by Mies et al. (18) reported a direct correlation between the number of depolarizations 
and infarct volume, with a 13 mm3 increase in infarct size per depolarization.  The 
authors noted that with each depolarization, there was an increase in both DC shift 
duration and recovery time.         
Mechanisms for Progression to Infarct 
In addition to episodic tissue hypoxia and increasing acidosis from lactate accumulation, 
recent studies have reported that cyclooxygenase-2 (COX-2) is transiently-induced 
following spreading depression (19) and focal ischemia (19,20).  COX-2 is a key enzyme 
in the conversion of arachidonic acid to prostaglandins and thromboxanes—mediators of 
glutamate release and free radical formation (i.e., nitric oxide).  Since all of these 
contribute to neuronal damage, repetitive PIDs within the penumbra region increase the 
likelihood of tissue progression to infarct.   
7.1.3 MRI Identification of PIDs 
DWI Correlation with PIDs and Infarct Size 
Following the study by Mies and coworkers (18), several researchers employed DWI 
methods for the non-invasive investigating of PIDs and their role in the spatiotemporal 
evolution of cerebral ischemia.  Experimental elicitation of CSDs, measured as a region 
of transiently declined ADCs moving radially away from the initiation site with a 
propagation speed of ~3 mm/min, results in larger infarct volumes in instances of focal 
ischemia (21,22).  Serial ADC measurements made by Busch et al. (22) and the 
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corresponding increase in infarct size are diagrammed in Fig. 7-1.  Dijkhuizen et al. (23) 
confirmed this correlation between ischemia-induced PIDs and the development of 
neuronal damage.  The authors reported a good correlation between the degree of ADC 
reduction, total depolarization time, and ischemic lesion volume.  These results indicate 
that the severity of cytotoxic edema, and therefore, the magnitude of the ADC change 
detectable by DWI, increases according to the total duration rather than the frequency of 
depolarization.   
DWI Correlation with PIDs and COX-2 Expression 
Transient reductions in ADC, as described above, can be caused by PIDs in acute 
cerebral ischemia. In light of these findings and those of Miettinen et al (19) and Collaco-
Moraes et al. (20), it is not surprising that these transient reductions in ADC have an 
associated increase in COX-2 mRNA expression.  Following 60 minutes of MCA 
occlusion, Mancuso and coworkers (24) reported the expression of COX-2 mRNA in 
cortical regions that had experienced transient ADC reductions (penumbra), but not in 
regions with persistent ADC reduction (core).  These results are diagrammed in Fig. 7-2.  
Since PID-induced COX-2 expression supports the expansion of infarct, COX-2 
inhibitors and/or methods of PID-suppression could play an important role in preventing 
injury.   
Limitations of Real-Time Imaging 
Although DWI has been used to investigate the role of PIDs in ischemia, these studies 
have limited their spatial resolution and signal-to-noise ratios in order to achieve a 
reasonable temporal resolution for monitoring the transient changes in ADC concomitant 
with PIDs.  In addition, DWI methods are based on macroscopic physiological changes 
(cell swelling from cytotoxic edema), limiting the ability to characterize the spatial extent 
of PIDs in the acute stage of focal ischemia.  An MRI method with a higher signal-to-
noise ratio based on more microscopic physiological changes (i.e., Ca2+ channel activity), 
would be helpful in order to overcome these limitations. 
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Figure 7-1.  Diffusion-weighted imaging of experimentally-induced SD and its role in ischemic 
progression.  Left: Evolution of the ischemia-induced hyperintense area in DWI before, during, 
and after the passage of SD.  Every SD was associated with an expansion of the area of 
increased DWI signal intensity.  Right:  Quantitative evaluation of the cortical lesion areas in 
DWI before and during the first 2 h after MCA occlusion. Arrows indicate timepoints of 0.15M 
KCl intracortical injection. One late spontaneous SD is indicated by the star.  In the untreated 
animal, every SD was associated with an expansion of cortical lesion area. In the MK-801 
treated animal, only the first potassium injection, before MK-801 application, resulted in a SD.  
Figure reproduced from reference (22). 
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Figure 7-2.  ADC Maps for two rats subjected to 60-min MCA occlusion, with corresponding 
COX-2 and c-fos autoradiography.  The ADC lesion (regions with at least 20% reduction relative 
to the non-ischemic hemisphere) is shown in color.  Note the transient reductions in ADC within 
cortical regions for both animals.  COX-2 mRNA and c-fos were expressed in regions having 
experienced transient reductions in ADC.  Figure reproduced from reference (24).   
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7.1.4 Manganese as a Paramagnetic Calcium Analog 
Manganese Action and Intracellular Uptake 
Within the past ten years, manganese ions (Mn2+) have gained widespread use as a 
membrane-depolarization-dependent contrast agent for monitoring functional activation 
(25-28), neuronal architecture (29), and neuronal tract tracing (30-33).  Mn2+, having an 
ionic radius and charge similar to Ca2+, competitively enters cells through Ca2+-influx 
pathways such as voltage-gated or ligand-gated Ca2+ channels (34,35), with further 
accumulation within mitochondria (36).  Recently, Aoki et al. (37) employed Mn2+ as a 
surrogate marker for Ca2+ influx in the study of focal ischemia.  The authors reported a 
hyperintense region on T1-weighted MRI smaller than the area of reduced ADC (Fig. 7-
3).  From these results, Aoki and coworkers hypothesized that the T1-weighted signal 
enhancement was indicative of anoxic depolarization, and therefore, the infarct core.    
Manganese and Peri-infarct Depolarizations 
Although terminal anoxic depolarizations within the core result in Ca2+ influx (4), 
transient depolarizations (PIDs) within the penumbral region yield intracellular 
accumulation of Ca2+ as well (16,38).  Ohta et al. (16) reported the existence of two 
distinct regions following permanent MCAO in cats—the first with persistent 
depolarization (i.e., core) and declined levels of extracellular Ca2+; the second with 
repetitive transient depolarizations along the periphery of the first (i.e., penumbra).  The 
authors noted reductions in extracellular Ca2+ from 1.2 mM to 0.15 mM concomitant with 
each depolarization (Fig. 7-4). Since repetitive PIDs resulted in a progressive breakdown 
of neuronal function and ion homeostasis (i.e., penumbral progression to infarct), Ohta 
and coworkers suggested that PID-induced intracellular Ca2+ accumulation is a 
contributing factor for neuronal injury.  Further understanding of the mechanisms of 
Ca2+-mediated cell injury in cerebral ischemia is necessary, particularly in the exact role 
of PIDs in the progression of penumbral tissue to infarct and the potential for therapeutic 
intervention in the acute stage of ischemia.  Since manganese-enhanced MRI (MEMRI) 
methods have recently been shown to aid in the visualization of experimental CSD in the 
rat brain (39), MEMRI should be useful for investigating the role of PIDs in the temporal 
evolution of cerebral ischemia.  The aim of this feasibility study is to demonstrate the 
utility of MEMRI in the visualization of PIDs following ischemic onset. 
MEMRI OF CEREBRAL ISCHEMIA 205
 
 
 
 
 
Figure 7-3.  Comparison of MEMRI, DWI, T2-weighted MRI, and 
ADC images on the same rat following permanent MCAO.  The high 
intensity area localized within the lateral side of caudate-putamen and 
lateral cortex on MEMRI (a) was smaller than both DWI hyperintensity 
(b) and decreased ADC (d).  Slight hypointensity was visible on T2-
weighted MRI (c).  Figure reproduced from reference (37). 
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Figure 7-4.  Plot of electrophysiological recordings in ectosylvian and suprasylvian 
gyri.  The horizonal axis indicates time (hrs) post-MCAO.  (top) In the ectosylvian 
gyrus, which is proximal to the MCA territory,  persistent depolarization was present 
with permanent negative DC deflection and severely decreased extracellular Ca2+ 
levels.  (bottom)  In the supraslyvian gyrus, which is more distal to the MCA territory, 
transient depolarizations were present (indicated by the dots).  Concomitant with each 
depolarization there was a transient decrease in extracellular Ca2+ from approximately 
1.2 mM to 0.15 mM.  The ‘a’ and ‘b’ labeled arrows indicate the transition into 
persistent depolarization and the deterioration of cerebral circulation, respectively. 
Figure adapted from reference (16).  
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7.2 Methods 
7.2.1 Animal Preparation 
The present study was approved by the Institute Animal Care and Use Committee 
(IACUC) of the University of Massachusetts Medical School (IACUC protocol A-875).  
Male Sprague-Dawley rats (300-360 g; Taconic Farms, Germantown, NY) were divided 
into three groups: Optimization of BBB Opening (N = 10), MCAO control (N = 2), and 
MCAO with MnCl2 administration (N = 2).  Rats were initially anesthetized with an 
intraperitoneal injection of chloral hydrate (400 mg/kg).  A modified PE-50 polyethylene 
catheter with a PE-10 catheter tip (PE-10 & PE-50, Becton Dickinson, San Jose, CA) was 
placed in the right external carotid artery (ECA) for drug administration.  For 
catheterization of the right ECA, a ventral midline incision was made in the neck. The 
omohyoid muscle was separated longitudinally and retracted laterally to isolate and 
expose the right ECA.  Following ligation of the vessel, a small incision was made into 
which the catheter was inserted and secured in place.  Cannulation of the right ECA 
limited drug delivery to the right side of the brain, enabling the left side to serve as a 
control.  The common carotid artery (CCA) was kept intact and open in order to maintain 
blood flow to regions originally supplied by the right ECA (i.e., face and underlying 
muscle).  Rectal temperature was monitored continuously with a rectal probe and 
maintained at 37.0°C using a thermostatically-controlled heating lamp (Model 73ATD, 
YSI Inc., Yellow Spring, OH) during preparation.   
7.2.2 Optimization of BBB Opening  
In order to ascertain the regional coverage and heterogeneity present following blood-
brain-barrier (BBB) opening, a mixture of glutamate and MnCl2 was employed in this 
experimental group (N = 10).   The optimum drug dose-timing schedule was determined 
by assigning animals a set rate (ml/min) and dose (mg/kg) for both D-mannitol and the 
MnCl2/Glu combination, with a waiting period (min) between injections (Table 7-1).  In 
addition, the CCA flow dependence of mannitol delivery was tested by advancing the 
catheter from the ECA into the ICA (BBB-1, BBB-2), keeping the catheter in the ECA 
only (BBB-3 → BBB-10), or by clamping the CCA during mannitol injection (BBB-8).  
Following the initial operation, 25% D-mannitol solution (Sigma, St. Louis, MO) was 
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injected via the right ECA.   Individual animals, five or ten minutes after ECA injection 
of D-mannitol, were administered a mixture of 50 mM MnCl2 (MnCl2•4H2O; Sigma, St. 
Louis, MO) and 15 mg/ml L-glutamic acid solution (Sigma, St. Louis, MO).  All syringes 
were prepared and maintained at 37°C prior to injection using an incubator (Isotemp 500 
Series, Fisher Scientific, Hampton, NH).  Individual drug administration was performed 
using a syringe pump (Model 11; Harvard Apparatus, Holliston, MA).  Heparinized 
saline (0.1-0.2ml, 37°C) was injected pre- and post-mannitol delivery to prevent clot 
formation and mannitol recrystallization within the tubing. 
7.2.3 MCAO Procedure 
For both MCAO groups (N = 4), permanent focal ischemia was induced by the 
intraluminal monofilament MCAO model.  Both the right ECA and right CCA were 
ligated proximally and permanently.  Temporarily, the CCA and internal carotid artery 
(ICA) distal to the ECA were ligated. A 4-0 silicone-coated (Bayer Inc.) suture (Ethilon 
Nylon Suture, ETHICON, Inc.) with a heat-rounded tip was introduced into the stump of 
the CCA.  Next, the suture was advanced into the ICA approximately 16-18 mm beyond 
the carotid bifurcation until lodged in the anterior cerebral artery (ACA), blocking blood 
flow to the middle cerebral artery (MCA).  Rectal temperature was monitored 
continuously with a rectal probe and maintained at 37.0°C using a thermostatically-
controlled heating lamp (Model 73ATD, YSI Inc., Yellow Spring, OH) during MCA 
occlusion.  For the MCAO control group (N = 2), prior to MCA occlusion, a 
polyethylene catheter (PE-50, Becton Dickinson, San Jose, CA) was placed in the left 
femoral vein for Gd injection-based PWI.  For the MCAO with MnCl2 administration 
group (N = 2), in order to investigate the role of Ca2+-mediated activity in the progression 
of cerebral ischemia, animals received MnCl2 prior to MCA occlusion.  A 25% D-
mannitol solution (6 ml/kg, Sigma, St. Louis, MO) was injected via the right ECA.  Ten 
minutes after ECA injection of D-mannitol, 50 mM MnCl2 (2ml/kg, Sigma, St. Louis, 
MO) was administered.  Both D-Mannitol and MnCl2 were injected at a rate of 0.9ml/min 
using a syringe pump (Model 11; Harvard Apparatus, Holliston, MA).  Within five 
minutes after stopping the MnCl2 infusion, the silicon-coated nylon suture was inserted 
from the right CCA for MCA occlusion. 
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Table 7-1.  Experimental Setup for Optimization of Blood-Brain-Barrier (BBB) Opening. 
Animal # 
Mannitol Dose 
(ml/kg) / Rate 
(ml/min) 
MnCl2/Glu Combo 
Dose (ml/kg) /Rate 
(ml/min) 
Time Between 
Injections 
(min) 
Placement of 
PE-50/PE-10 
Combo Tubing 
CCA Status 
During 
Mannitol 
Injection 
BBB-1 5/1.8 2/1.8 10 ECA into ICAa Flow-limitedb 
BBB-2 5/1.8 2/1.8 5 ECA into ICAa Flow-limitedb 
BBB-3 5/1.8 2/1.8 10 ECA Open 
BBB-4 5/0.9 2/0.9 10 ECA Open 
BBB-5 6/0.9 2/1.8 10 ECA Open 
BBB-6; 
BBB-7 
6/0.9 2/0.9 10 ECA Open 
BBB-8 6/0.9 2/0.9 10 ECA Clamped 
BBB-9 6/0.9 2/0.9 5 ECA Open 
BBB-10 7.5/0.9 2/0.9 10 ECA Open 
aAnimals with placement of tubing from the ECA into the ICA had a non-modified PE-50 polyethylene 
catheter.  All other animals had a modified PE-50 polyethylene catheter with a PE-10 catheter tip. 
 
bThe flow from the CCA to the ICA was limited due to placement of the PE-50 tubing from the ECA into 
the ICA. 
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7.2.4 MRI Measurements 
Data Acquisition and Parameter Setup 
MR experiments were performed with a Bruker Biospin 2.0T/45cm imaging spectrometer 
equipped with ±20 G/cm self-shielded gradients (Fig. 3-5). Following acquisition of a 
gradient-echo tripilot, the imaging plane was referenced to the rhinal fissure at the 
boundary of the olfactory bulb.  Image acquisition was performed along the axial plane 
[number of slices = 6, slice thickness = 2 mm].    
Optimization of BBB Opening (N = 10) 
For the optimization of BBB opening group, a T1-weighted SE sequence was used to 
acquire images using a TR/TE = 300.0/11.0 ms, FOV = 4 cm × 4 cm, matrix size = 256 × 
256, and NEX = 4.  Imaging was performed approximately 30-min post drug 
administration, with a total experiment time of 10m24s. 
MCAO Control Group (N = 2) 
For the MCAO control group, a DW, SE-EPI sequence was used to acquire images at six 
b-values (b = 23 → 1471 s mm-2) along the three principal directions (read(x), phase(y), 
slice(z)) with TR/TE = 2000/51 ms, δ = 6 ms, and ∆ = 24.31 ms, resulting in an effective 
diffusion time tdif = 21.31 ms. A PW, SE-EPI sequence was used to acquire images pre- 
and post-contrast Gd-injection with TR/TE = 800/51 ms.  A total of 40 repetitions were 
acquired, with injection of 0.35ml Magnevist (gadopentetate dimeglumine; Berlex, 
Montville, NJ) at the start of the 10th repetition using a syringe pump (PHD 2000; 
Harvard Apparatus, Holliston, MA) and a rate of 17 ml/min.  A T2W, SE-CPMG 
sequence was used to acquire images at ten echo times (TE = 10 → 150 ms) with TR = 
2000 ms. For DWI, PWI, and T2WI, images were acquired at 30-, 60-, 90-, 120-, and 
180-min post-MCAO using matrix size = 64 × 64, FOV = 2.56 cm × 2.56 cm, with NEX 
= 8 for DWI and NEX = 2 for T2WI.  The total experiment times for DWI, PWI, and 
T2WI were 4m48s (1m36s per direction), 36s, and 4m34s, resulting in an approximate 
10-minute temporal resolution.   
MCAO with MnCl2 Administration (N = 2) 
For the MCAO with MnCl2 administration group, DWI was performed in the same 
manner as that of the MCAO control group.  A T1-weighted SE sequence was used to 
acquire images using a TR/TE = 300.0/7.0 ms, FOV = 2.56 cm × 2.56 cm, matrix size = 
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64 × 64, and NEX = 4.  The total experiment times for DWI and T1WI were 4m48s 
(1m36s per direction) and 1m17s, resulting in an approximate 6-minute temporal 
resolution.     
Imaging Setup and Physiological Monitoring 
During imaging, animals were placed supine in a home-built animal holder (Fig. 6-5a).  
The head of the animal was fixed inside a 2.0 cm x 3.5 cm rectangular 1H surface coil 
shaped to conform to the curvature of the skull (Fig. 6-5b).  Animals were anesthetized 
with 1.2% isoflurane delivered at 1.0 L/min in breathing-quality air (Fig. 6-5c).  Body 
temperature was maintained at 37.0 ± 1.0°C by circulated warm air using a T-type 
thermocouple and a double-point feedback control system (Fig. 6-5d).  
7.2.5 Data Analysis 
Optimization of BBB Opening (N = 10) 
Image reconstruction was performed using Paravision’s Image Processing and Display 
Software (Xtip).  ROIs were user-defined to delineate between MEMRI-enhanced 
regions and normal tissue using ImageJ (Version 1.33; NIH, Bethesda, MD).  Additional 
ROIs were drawn for hemispheric and total brain volume calculations.  Percent 
hemispheric enhancement was calculated through comparison of the ipsilateral and 
contralateral hemispheres on a slice-by-slice basis: 
 100
SI
SISI
(%)t Enhancemen cHemispheri
CH
CHIH ×−=  (7-1) 
where SIIH is the signal intensity for the ipsilateral hemisphere (side with BBB disruption) 
and SICH is the signal intensity in the contralateral hemisphere (side with intact BBB).  
Percent hemispheric coverage was calculated through a volumetric comparison of the 
MEMRI-enhanced regions and the ipsilateral hemisphere on a slice-by-slice basis:  
 100
V
V(%) Coverage cHemispheri
IH
E ×=  (7-2) 
where VE is the volume of the MEMRI-enhanced region and VIH is the volume of the 
ipsilateral hemisphere.  Percent regional enhancement was calculated through a 
comparison of the MEMRI-enhanced region and the contralateral hemisphere: 
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Data are presented as mean ± inter-slice signal variability (IS-SD).  Additional variance 
calculations were performed for MEMRI-enhanced regions on an animal-by-animal 
basis. 
MCAO Control (N = 2)  
Image reconstruction was performed using Paravision’s Image Processing and Display 
Software (Xtip).  Image analysis and parameter map production was performed using 
routines written in IDL (Research Systems Inc., Boulder, CO).  ADC and T2 parameter-
map production was performed on a pixel-by-pixel basis based on the relationship 
between the log of the signal intensity and b-value (Eq. 7-4) or signal intensity and echo 
time (Eq. 7-5), respectively, using a linear fitting procedure based on the minimization of 
the chi-square statistic: 
 bD0eMM(t)
−=  (7-4) 
 2TE/T0eMM(t)
−=  (7-5) 
where M/M0 is the signal intensity at a particular b-value or TE value; D is the diffusion 
along a single direction, and T2 is the spin-spin or transverse relaxation time.  Following 
ADC parameter map production for the three principal directions (x, y, and z), spatial 
maps of the mean diffusivity (i.e., ADCavg) were constructed for a scalar measure of 
isotropic diffusion: 
 
3
DDDD 321 ++=  (7-6) 
CBF parameter-map production was performed on a pixel-by-pixel basis based on the 
change in the relaxation rate ∆R2 as a function of time pre- versus post-contrast injection:  
 

×−=∆
0
2 M
)t(Mln
TE
1)t(R  (7-7) 
where M(t) is the signal intensity at a time t during bolus passage of the contrast agent 
(repetitions 11-40), M0 is the signal intensity value at baseline pre-contrast (average of 
repetitions 1-10), and TE is the echo time.  First, a mean filter (3×3) was applied to the 
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data to lower the noise level.  Second, the ∆R2 values calculated using Eq. 7-7 were fit to 
the following gamma-variate function using non-linear regression (40,41): 
 )b/t(r2 etQ)t(R =∆  (7-8) 
where t is the time and Q, r, and b are the three unknown parameters.  Third, estimates of 
relative cerebral blood volume (rCBV) and vascular transit time (VTT) were obtained by 
calculating the area (Eq. 7-9) and the first moment (Eq. 7-10) of the ∆R2 (t) versus time 
curve, respectively: 
  ∫∞ + +Γ=∆=
0
1r
2 )1r(Qbdt)t(RrCBV  (7-9) 
 ∫∞ +=∆=
0
2 )1r(bdt)t(RtVTT  (7-10) 
where t is the time, Q, r, and b are the three parameters determined from non-linear 
regression, and Γ(r+1) is the gamma function from Eq. 7-8 evaluated at time t = r+1.  
Finally, the CBF index (CBFi) was calculated on a pixel-by-pixel basis by taking the ratio 
of Eqs. 7-9 and 7-10.   
MCAO with MnCl2 Administration (N = 2) 
Image reconstruction was performed using Paravision’s Image Processing and Display 
Software (Xtip).  Image analysis and parameter map production was performed using 
routines written in IDL (Research Systems Inc., Boulder, CO).  ADC parameter-map 
production was performed per previous description according to Eq. 7-4. 
7.2.6 Tissue Characterization 
Tissue characterization using multispectral (MS) analysis and the k-means (KM) 
clustering algorithm (42) was employed for subdivision of tissue into normal and 
abnormal (penumbra, core) populations based on methodology developed by Carano and 
coworkers (43,44).   
MCAO Control (N = 2) 
A 3D feature vector, containing the ADC, CBF, and T2 parameter maps, was generated.  
KM clustering was performed on a pixel-by-pixel basis using the Euclidean distance 
measure (42): 
 ( ) ( )iti µxµxD −−=    (7-10) 
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where x ε R3 is the feature vector and µi is the cluster mean, both determined from all of 
the data (N = 2 datasets, 5 timepoints per dataset).  Incorporation of the inverse 
covariance matrix accounts for variability across features, allowing data classification via 
hyperplane decision boundaries without an orthogonality requirement.  Prior to KM 
clustering, the background was removed based on the delineation between the brain and 
surrounding tissue using the M0 maps from the T2-fitting procedure and ImageJ (Version 
1.33; NIH, Bethesda, MD).  Feature normalization (µ = 0, s = 1) was then performed for 
removal of potential scaling differences.  Following background removal and 
normalization steps, KM (k = 3) was applied to segment the data into three regions, one 
each for normal and abnormal tissue, and one for cerebrospinal fluid (CSF).  Following 
segmentation, the abnormal tissue region was then subdivided into penumbra and core. 
MCAO with MnCl2 Administration (N = 2) 
ADC lesion area was determined by pixels exhibiting values of 0.53 × 10-5 cm2s-1 or less, 
based on a previously derived percent-reduction threshold (~33%) for estimating lesion 
volume (45).  MEMRI lesion area was determined by pixels with signal intensities 
greater than the mean + 2 standard deviations (SDs) in the contralateral hemisphere.  The 
correspondence between ADC and MEMRI was determined through generation of a 
parameter map with separate color designations for the following:  ADC lesion and 
MEMRI lesion, ADC lesion and normal MEMRI, MEMRI lesion and normal ADC, and 
normal MEMRI and normal ADC.  Data are presented as mean ± SD. 
 
7.3 Results 
7.3.1 Optimization of BBB Opening (N = 10) 
Fig. 7-5 shows the regional coverage and relative MEMRI enhancement for the BBB 
optimization group at a single time-point 30 minutes post drug administration (Fig.7-5a-j 
correspond to BBB-1-10 in Table 7-1).  A quantitative summary for percent average 
hemispheric enhancement, percent average hemisphere coverage, and percent average 
regional enhancement are provided in Table 7-2. 
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Figure 7-5.  T1-weighted MEMRI following MnCl2/Glu combo administration for the BBB 
opening optimization group.  a) → j) correspond to BBB-1 → BBB-10 in Table 7-1.  A single 
axial image is shown for each animal.  Individual images were contrast-enhanced for optimum 
viewing. Slice thickness = 2mm.  
 
Effect of Timing of Drug Administration on BBB Opening 
Although results for a wait period of 5-min versus 10-min for BBB-1 (Fig.7.5a) versus 
BBB-2 (Fig.7b) at injection rates of 1.8ml/min were not significantly different, two of the 
six imaging slices for the 5-min wait period exhibited no enhancement at all in 
comparison to coverage across all six slices for the 10-min wait period.  Comparison of a 
wait period of 5-min versus 10-min for BBB-9 (Fig.7.5i) versus BBB-6 (Fig.7.5f) at 
injection rates of 0.9ml/min showed significantly greater hemispheric enhancement (i.e., 
more effective BBB opening) as well as increased regional enhancement (i.e., greater 
Mn2+ uptake in regions of BBB opening) for the 10-min waiting period (p < 0.01, two-
tailed t-test assuming unequal variance).   
Effect of Rate of Drug Administration on BBB Opening 
Comparison of rates of 1.8ml/min (BBB-3, Fig.7.5c) and 0.9ml/min (BBB-4, Fig.7-5d) 
for drug administration showed significantly better hemispheric coverage, greater than a 
factor two difference (p < 0.001) between them. 
Effect of Mannitol Dose on BBB Opening 
Three doses of 25% (w/v) mannitol were compared, that being 5ml/kg (BBB-4, Fig.7-
5d), 6ml/kg (BBB-6, Fig.7-5f), and 7.5ml/kg (BBB-10, Fig.7-5j) at injection rates of 
0.9ml/min and a waiting period of 10-min between mannitol injection and delivery of the 
MnCl2/Glu combination.  The 6ml/kg dose resulted in significantly greater hemispheric 
coverage than that of the 5ml/kg or 7.5ml/kg doses (p < 0.01).  Although there was no  
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Table 7-2.  Quantitative Summary of Percent Hemispheric Enhancement, Hemispheric 
Coverage, and Regional Enhancement for the Optimization of BBB Opening Group (N = 10). 
Animal # 
% Hemispheric 
Enhancement 
(using Eq. 7-1) 
% Hemispheric 
Coverage (using 
Eq. 7-2) 
% Regional 
Enhancement 
(using Eq. 7-3) 
 Mean ISSD Mean ISSD Mean ISSD 
BBB-1 145 20 77 14 180 15 
BBB-2 87 61 47 42 154 54 
BBB-3 64 19 50 22 113 15 
BBB-4 101 36 110 9 112 30 
BBB-5 106 27 90 8 116 24 
BBB-6; 
BBB-7 
130; 
118 
35;     
31 
115;   
64 
10;      
23 
123; 
185 
31;     
41 
BBB-8 55 30 44 43 73 66 
BBB-9 66 18 109 10 14 31 
BBB-10 90 12 92 13 99 18 
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significant difference between the levels of hemispheric enhancement between the three, 
the animal receiving the 6ml/kg dose had a mean hemispheric enhancement of 130% that 
was slightly higher than the remaining two (101% and 90% for the 5ml/kg and 7.5ml/kg 
doses, respectively). 
Effect of MnCl2/Glu Injection Rate on BBB Opening 
Comparison of two different rates of MnCl2/Glu injection, 1.8ml/min (BBB-5, Fig.7-5e) 
and 0.9ml/min (BBB-6, Fig.7-5f), yielded significantly better hemispheric coverage on 
the part of the 0.9ml/min injection rate (p < 0.001).  Although there was no significant 
difference in hemispheric enhancement or regional MEMRI enhancement between the 
two, since the MnCl2/Glu dose and the Mannitol dose/rate were identical, this was not 
surprising. 
Effect of CCA Flow on BBB Opening 
Three experimental setups were tested in order to ascertain the effect of the CCA flow on 
the heterogeneity of BBB opening.  Three separate animals received the following:  
BBB-1 (Fig.7-5a) had the catheter placed in the ECA, which was then advanced into the 
ICA, limiting the CCA flow; BBB-6 (Fig.7-5f) had the catheter in the ECA only, 
permitting CCA flow; and BBB-8 (Fig.7-5h) had the catheter in the ECA only, but the 
CCA was clamped to stop CCA flow during mannitol injection.  BBB-6 exhibited 
significantly greater levels of both hemispheric enhancement and coverage than that of 
BBB-1 or BBB-8 (p < 0.01).  
Effect of Animal Variability on BBB Opening 
BBB-6 (Fig.7-5e) and BBB-7 (Fig.7-5f) received the same protocol, but BBB-6 had 
significantly higher values of regional MEMRI enhancement (p = 0.01) and greater 
hemispheric coverage (p < 0.01) than BBB-7.   
7.3.2 Temporal Evolution of Ischemia 
Temporal Evolution of Lesion Volume  
Fig. 7-6 shows the temporal evolution of the ischemic territory between 30-min and 3h 
post MCA-occlusion.  For the 30-min timepoint post MCA occlusion, the abnormal 
population was subdivided into core and penumbra.  The multislice parameter maps for 
<D>, CBFi, and T2 are diagrammed in the left three columns.  In the fourth column of 
Fig.7-6, the KM segmentation map is shown, with subdivision of the brain into normal 
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tissue, CSF, and two populations of abnormal tissue (i.e., core and penumbra).  The 
penumbral region represents the tissue that is ‘at risk’ for progression to infarction and 
permanent neuronal injury.  For the 3h timepoint post MCA occlusion, the <D> and KM 
maps (5th and 6th columns of Fig.7-6) are shown, with the corresponding TTC-stained 
sections at 24h (images taken for both the front and back of the stained slices, designated 
‘f’ and ‘b’).  These results indicate a progression of the penumbral region to infarct by the 
3h-timepoint.    
Temporal Evolution of Individual MR Parameters 
Fig. 7-7 diagrams the evolution of <D> (Fig.7-7a), CBFi (Fig.7-7b), and T2 (Fig.7-7c) as 
a function of time post MCA-occlusion.  Mean values for individual tissue populations 
were calculated based on a pixel-by-pixel comparison between the KM segmentation 
map and individual MR parameters.  Fig.7-7a shows a trend of decreased <D> with the 
passage of time for the abnormal tissue population.  Note that the mean <D> values for 
the core at 30-min and 60-min are very close to the values of the total abnormal region 
from 90-min on.  This is expected because the core denotes permanently damaged tissue.  
Beyond 1hr post MCA-occlusion, tissue assigned to the abnormal population is expected 
to be core with no salvageable tissue remaining (i.e., no penumbra).   Fig.7-7b shows a 
slight trend of decreased CBFi for the abnormal population concomitant with an increase 
in CBFi for the normal population.   Increased CBFi for normal tissue is likely from 
hyperperfusion in an attempt to compensate for the existing perfusion deficit.  Fig. 7-7c 
shows relatively invariant T2 values for all tissue regions.  Pathologically induced 
changes in T2 (i.e., edema) generally do not present until later timepoints, such as at 12h 
or 24h.   
KM Correspondence with Histological Estimates 
Fig. 7-8 shows the slice-by-slice correlation between KM percent hemispheric lesion 
volume at 3hr (%TBV) and TTC volume at 24hr (%TBV) for a representative animal.  
KM and TTC volumes were both found to be 28% of TBV, with good slice-by-slice 
correspondence (highly correlated, r = 0.89).   
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Figure 7-6.  k-means (KM) segmentation of the ischemic rat brain into normal, abnormal (core, 
penumbra), and CSF at 30-min post MCA-occlusion.  Multislice parameter maps are shown for 
<D>, CBFi, and T2 in the first three columns, respectively.  In the fourth column, the KM 
segmentation map is diagrammed with red = normal, brown = CBF, white = core, and peach = 
penumbra.  The penumbra represents tissue at risk, i.e., potentially salvageable with therapeutic 
intervention.  In the fifth and sixth columns, <D> and KM are shown for the 3h timepoint.  Since 
this is a permanent MCAO model, the penumbra progresses to infarct.  This is visible by comparison 
of the KM maps at 30-min and 3h.  In the last two columns, the front (f) and back (b) of the TTC-
stained sections are shown, demonstrating a good correspondence on a slice-by-slice basis with the 
3h-KM map. 
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Figure 7-7a.  Temporal evolution of <D> post MCA-occlusion. Mean values 
were determined from individual tissue populations based on KM segmentation.   
 
 
Figure 7-7b.  Temporal evolution of CBFi post MCA-occlusion. Mean values 
were determined from individual tissue populations based on KM segmentation.   
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Figure 7-7c.  Temporal evolution of T2 post MCA-occlusion. Mean values were 
determined from individual tissue populations based on KM segmentation.   
 
Figure 7-8.  Scatter plot of KM-derived lesion volume (at 3hr) versus TTC-
derived lesion volume (at 24hr) on a slice-by-slice basis for a representative 
animal.  Values were highly correlated (r = 0.89). 
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7.3.3 MEMRI and Ischemia 
Temporal Evolution of Lesion Volume  
Fig. 7-9 shows the temporal evolution of the ischemic territory between 30-min and 60-
min post MCA-occlusion.  For both timepoints, the brain was divided into four regions 
based on the correspondence between the <D> lesion estimate and the MEMRI lesion 
estimate.  The multislice parameter maps for <D> and the corresponding T1W images are 
diagrammed in the 1st and 2nd columns for 30-min and the 4th and 5th columns for 60-min.  
The 3rd and 6th columns show the color-coded maps, with blue = normal, red = <D>/T1W 
lesion, yellow = T1W lesion, and orange = <D> lesion. For the 30-min timepoint, there is 
a large lesion on T1W, but nothing on <D> (Fig.7-9, 3rd column, yellow).  By 60-min, a 
central core region (Fig.7-9, 6th column, red) with abnormal <D> and MEMRI 
enhancement is evident, surrounded by a peripheral region (Fig.7-9, 6th column, yellow) 
with significant MEMRI enhancement but <D> values around 0.60 to 0.65 x 10-5 cm2s-1.   
Quantitative Summary of Individual Tissue Regions 
Table 7-3 provides a quantitative summary of <D> and T1W values for individual tissue 
regions. Values are presented as mean ± SD.  For the 30-min timepoint, since no pixels 
were assigned to the <D> lesion (orange), there are no values for <D> or T1W percentage 
increase.  For the central core region (Fig.7-9, red), characterized by severely reduced 
<D> and significant hyperintensity on T1W, there seems to be no appreciable change in 
<D> or T1W percentage signal increase between 30-min and 60-min.  For the peripheral 
region (Fig.7-9, yellow), characterized by significant hyperintensity on T1W with close to 
normal values for <D>, there is an additional 20% increase in signal intensity on T1W 
between 30-min and 60-min, accompanied by an approximate 10% decline in <D>.  
There were no appreciable changes for normal brain (Fig.7-9, blue). 
 
MEMRI OF CEREBRAL ISCHEMIA 223
 
Figure 7-9. Segmentation of the ischemic rat brain into normal and abnormal regions at 30-
min and 60-min post MCA-occlusion.  Multislice parameter maps are shown for <D> (1st and 
4th columns), with the corresponding T1-weighted MEMRI images (2nd and 5th columns).  In 
the 3rd and 6th columns, color-coded maps were generated based on the correspondence 
between regions exhibiting lesion on <D> (values less than or equal to 0.52 x 10-5 cm2s-1) and 
lesion on the T1-weighted MEMRI (values greater than mean + 2 SD of the contralateral 
hemisphere).  Color designations are as follows:  blue = normal <D> and normal T1W,  
yellow = abnormal T1W, orange = abnormal <D>, and red = abnormal <D> and abnormal 
T1W.  The color maps demonstrate that MEMRI enhancement precedes the development of 
an ADC lesion (yellow region, 30-min), making it a potential marker for tissue ‘at risk’.  For 
the 60-min timepoint, regions that are lesion on both <D> and MEMRI (red) likely represent 
the infarct core, whereas regions that are lesion only on MEMRI (yellow) may indicate tissue 
at risk (i.e., peri-infarct depolarization).   
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Table 7-3.  Quantitative Summary of <D> and MEMRI enhancement for individual tissue populations 
based on a threshold of 0.52 x 10-5 cm2s-1 for <D> and a threshold of the mean + 2 SD (based on the 
contralateral hemisphere).   
Tissue Region 
30-min post MCA-
occlusion 
60-min post MCA-
occlusion 
 
<D>        
(10-5 cm2s-1) 
T1W Increase 
(%) 
<D>        
(10-5 cm2s-1) 
T1W Increase 
(%)  
Normal  0.8 ± 0.1 40 ± 50  0.8 ± 0.1 40 ± 50 
<D> and T1W lesion  0.46 ± 0.05 170 ± 60 0.47 ± 0.07 180 ± 80 
T1W lesion  0.7 ± 0.1 180 ± 80 0.6 ± 0.1 200 ± 100 
<D> lesion n/a* a/a* 0.47 ± 0.03 60 ± 40 
 
*There were no pixels below the <D> threshold at 30-min post MCA-occlusion, therefore, there are 
no mean ± SD values for <D> or T1W percentage increase.   
 
7.4 Discussion 
7.4.1 Cellular Uptake of Manganese 
Mechanisms of Manganese Uptake During Ischemia 
Two types of depolarization occur during the temporal evolution of cerebral ischemia: 
terminal anoxic depolarizations (present in the infarct core) and transient depolarizations 
(present at the core periphery, i.e., the penumbra).  In the case of terminal anoxic 
depolarization, both ligand-gated (ex. NMDA-receptor mediated) and voltage-gated Ca2+ 
channels are activated, permitting Ca2+ influx.  Buildup of [Ca2+]i triggers the release of 
excitatory neurotransmitters, such as glutamate, as well as an increase in [K+]o. Both of 
these, glutamate and K+, have been shown to induce cellular depolarization; therefore, 
their spread to the edge of the core likely induce PIDs.  Individual PIDs yield transient 
activation of voltage-gated Ca2+ channels, permitting Ca2+ influx until which time cellular 
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repolarization and channel closing occurs.  Mn2+, a paramagnetic Ca2+ analog shown to 
enters cells via Ca2+-mediated pathways (34,35), has recently been employed in the 
visualization of experimental CSD (39) and for the characterization of cerebral ischemia 
(37).  Since MEMRI is able to identify experimentally-induced CSDs, it should be able to 
identify pathologically-induced depolarizations—both anoxic and peri-infarct.  Although 
Aoki’s study of focal ischemia (37) was able to identify the ischemic territory using 
MEMRI, there was a temporal discrepancy between T1-weighted MRI and DWI data 
acquisition of approximately one hour.  As there is considerable lesion progression within 
the first 1-2 hours following permanent MCA occlusion, this time may account for the 
smaller manganese-enhanced area seen on T1-weighted MRI versus that of DWI.  Since 
both anoxic and peri-infarct depolarizations induce Ca2+ influx, the volume of MEMRI 
enhancement should be larger than the DWI lesion at acute timepoints, with temporal 
progression of the diffusion deficit to match the initial MEMRI-enhanced region.  In 
order to assess the MEMRI-DWI ‘mismatch’, increased temporal resolution is necessary. 
7.4.2 Heterogeneity of BBB Opening 
Manganese as an Intracellular Marker 
Since accumulated [Mn2+]i is retained following a specific stimulus (i.e., functional 
activation, experimentally-induced CSD, or cerebral ischemia), and since there is 
negligible MEMRI enhancement when Mn2+ is restricted to the interstitial space, any 
resultant MEMRI enhancement is likely from an increase in [Mn2+]i.  Mn2+ has several 
coordination sites for water binding, and when inside the cell it tends to be complexed 
with macromolecules such as proteins.  This makes for longer τc correlation times, 
increasing the relaxivity and significantly shortening T1.  While outside the cell, Mn2+ is 
in a free state, and with relatively fast exchange rates, it has a relatively minimal effect on 
relaxivity and T1 values.  It is for these reasons that Mn2+ may serve as a powerful 
intracellular marker.         
Dependence of Manganese Accumulation on BBB Disruption 
Although this is the case, the intracellular accumulation of Mn2+ requires the presence of 
Mn2+ in the interstitium at the time of stimulus.  In order to get Mn2+ into the interstitial 
space, the BBB is osmotically disrupted using a hypertonic mannitol solution.  Since 
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BBB opening via mannitol is reversible, over the time course at which the BBB is 
disrupted there exists a window of opportunity for drug delivery.  This is based on 
maximum osmotic shrinkage of the endothelial cells and widening of intercellular tight 
junctions.  Previous reports have indicated the onset of optimal BBB opening to be up to 
15-min post mannitol administration (46,47), with dependence on mannitol 
concentration, dose, and rate of injection.  Additional factors affecting BBB opening via 
mannitol include temperature and blood pressure.  In order to ascertain the optimum 
BBB-opening methodology, various drug dose, timing, and rates of administration were 
tested (Table 7-1).  Based on the results for the optimization of BBB-opening group 
(Fig.7-5 and Table 7-2), it was determined that 6ml/kg of 25% (w/v) mannitol delivered 
at a rate of 0.9ml/min, followed by a 10-min waiting period, provided the best overall 
hemispheric enhancement and coverage (BBB-6, Fig.7-5f).  Following optimization of 
mannitol administration, the rate of MnCl2 administration was tested.  A rate of 
0.9ml/min (BBB-6, Fig.7-5f) resulted in significantly better hemispheric coverage (p < 
0.001) than a rate of 1.8ml/min (BBB-5, Fig.7-5e).  Although there was no significant 
differences in regional enhancement (i.e., degree of enhancement in regions of BBB 
opening), because the dose of MnCl2 was kept constant, the amount of accumulated 
[Mn2+]i could potentially be the same for the two. 
CCA Flow Dependence on BBB Opening 
Limitations imposed on CCA flow (i.e., partial blockage from catheter placement or 
clamping of the vessel) during mannitol delivery resulted in poor hemispheric coverage 
and enhancement (flow-limited = BBB-1 and BBB-2, Fig.7-5a and Fig.7-5b; no flow = 
BBB-8, Fig.7-5h).  These results indicate that maintenance of CCA flow is extremely 
important for effective BBB disruption and a homogeneous distribution of Mn2+ in the 
interstitial space prior to application of the desired stimulus.  Placement of the catheter in 
the ICA or CCA clamping reduces the flow, resulting in inefficient delivery of mannitol 
to the hemisphere-of-interest.  This results in patchy enhancement or no enhancement at 
all.  Since flow is affected by physiological variables such as body temperature and blood 
pressure, it is extremely important to keep the animals warm while also maintaining a 
constant level of anesthesia.   
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Issue of Intra-animal Variability 
Even with optimization of the MEMRI protocol, it is important to keep in mind that intra-
animal variability in terms of vessel architecture, brain volume, age, and weight may also 
affect BBB opening.  In a recent report by Aoki and coworkers (48), several 
methodological issues with MEMRI were identified, such as potential brain swelling 
from mannitol injection, anesthetic level effect on enhancement, as well as the 
contribution of intra-animal variability to heterogeneous BBB opening.  The effect of 
inter-animal variability is evident in the comparison of two animals having receiving the 
optimized protocol described above.  Both BBB-6 (Fig.7-5f) and BBB-7 (Fig.7-5g) 
received the same protocol, but differed significantly in regional MEMRI enhancement (p 
= 0.01) and hemispheric coverage (p < 0.01).   
7.4.3 Temporal Evolution of Ischemia  
KM segmentation provides a time-invariant method of tissue segmentation requiring 
minimal user intervention for subdivision of the brain into normal tissue, abnormal tissue 
(with subdivision into core and penumbra at early timepoints [30-min, 60-min] post 
MCAO), and CSF (Fig.7-6).  Delineation between the infarct core, regions exhibiting 
severely reduced <D> and CBFi values, and the penumbra, regions with decreased CBFi 
and slightly reduced <D>, permits identification of tissue at risk.  Since this is a 
permanent MCAO model, all tissue identified as penumbra (Fig.7-6, 4th column, peach) 
progresses to infarct by 3hr (Fig.7-6, 6th column, white).  KM may provide a method for 
severity assessment and potential therapeutic intervention.  Additional studies employing 
permanent and transient MCAO with and without therapeutic intervention, and the 
tracking of the penumbral region (i.e., prediction of tissue fate), would be required in 
order to ascertain the overall utility and clinical relevance.   
7.4.4 MEMRI and Ischemia 
The goal of this study was to demonstrate the utility of MEMRI for characterizing the 
ischemic territory.  Based on the correspondence between the MEMRI-defined lesion and 
the <D>-defined lesion, four tissue regions were identified and color-coded (Fig.7-9).  
The first region was characterized by severely reduced <D> and significant MEMRI 
enhancement (Fig.7-9, 6th column, red).  This region is presumably core because the 
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severely reduced <D> values are reflective of cytotoxic edema and the hyperintensity on 
T1W is most likely from terminal anoxic depolarization and massive influx of Mn2+.  
Coverage included sub-cortical regions such as the caudate-putamen and globus pallidus 
of the basal ganglia, which tends to be infarcted in both animal models of ischemia as 
well as in the clinical setting.  The second region was characterized by normal to slightly 
reduced <D> values and significant MEMRI enhancement (Fig.7-9, 6th column, yellow). 
Coverage was generally along the periphery of the core.  This region, presumably 
salvageable tissue, most likely represents a region experiencing transient PIDs.    This is 
supported by the additional 20% signal intensity increase on MEMRI with a concomitant 
10% decrease in <D> between the 30-min and 60-min timepoints.  These results indicate 
that repetitive PIDs yield further Mn2+ influx and depletion of energy metabolism to 
restore membrane-ion gradients.  Since the area exhibiting significant MEMRI 
enhancement (Fig.7-9, 3rd column, yellow) preceded the development of <D> lesion, 
MEMRI may provide an additional technique for identifying tissue at risk for infarction 
at acute timepoints post-ischemic onset.   
7.4.4 Utility of MEMRI for PID Identification 
In order to determine MEMRI visualization of PIDs versus that of anoxic depolarization, 
a multispectral (MS) approach investigating the temporal evolution of <D>, CBFi, T2, 
and MEMRI needs to be performed with histological validation.  MS analysis provides an 
improved estimate of ischemic lesion volume over that obtained from <D> alone 
(43,44,49).  Jacobs and coworkers (50,51)  demonstrated that MS analysis using the 
ISODATA technique (similar to KM, but doesn’t require a priori knowledge of the 
number of clusters) performed equally well to single parameter methods (DWI, PWI, and 
T2WI).  MS analysis, in addition to being as robust as standard methodology, permits 
subdivision of the ischemic territory into infarct core and a penumbral region that is 
potentially salvageable, opening the window for therapeutic assessment.    Although T1-
weighted MEMRI has been employed for the visualization of experimentally-induced 
CSDs and in the characterization of cerebral ischemia, it only provides a relative measure 
of [Mn2+]i accumulation based on changes in signal intensity. Acquisition of a T1-dataset 
would provided a more quantitative assessment of [Mn2+]i .  Preliminary results shown 
here indicate that MEMRI is a potentially useful method for identifying tissue at risk for 
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infarction, and may provide a way for visualizing PIDs and their role in the temporal 
evolution of cerebral ischemia with and without pharmacological intervention (such as 
MK-801, a NMDA-receptor antagonist).       
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The research presented within this dissertation focused on two major areas of research: 
monitoring the response to single-dose radiotherapy in a RIF-1 tumor model and the role 
of cortical spreading depression in the evolution of ischemic stroke.  In Chapters 3 and 4, 
the apparent diffusion coefficient (ADC), spin-spin relaxation time (T2), and proton 
density (M0) were employed for the characterization of the radiotherapeutic response in a 
radiation-induced fibrosarcoma (RIF-1) tumor model.  Chapter 3 described application of 
multispectral (MS) analysis using the k-means (KM) clustering algorithm for tumor 
tissue characterization, with histological validation via hematoxylin-eosin (H&E) staining 
and hypoxic-inducible factor-1alpha (HIF-1α) immunohistochemistry. Following 
optimization, Chapter 4 described the application of the methodology in Chapter 3 in 
monitoring the radiotherapeutic response (i.e., the temporal evolution of the apparent 
diffusion coefficient (ADC)).  In Chapters 6 and 7, manganese-enhanced MRI (MEMRI) 
was employed for the characterization of both experimental and pathological cortical 
spreading depression (CSD).  Chapter 6 described the utility of MEMRI in the 
visualization of experimental CSD.  Chapter 7 then employed similar methodology to 
monitor the temporal evolution of ischemia, specifically the role of peri-infarct 
depolarizations (PIDs) in the evolution of penumbral tissue to infarction.  A brief 
description for the two major areas of research presented within this dissertation is 
provided on the following pages. 
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Part 1: Monitoring Response to Single-Dose Radiotherapy in a RIF-1 Tumor 
Model 
Assessment of therapeutic efficacy is confounded by intra-tumor and inter-tumor 
heterogeneity.  Variable pre-treatment tissue composition, tumor size, and growth 
kinetics, as well as post-treatment cell kill and tumor regrowth complicate dose-
optimization and the comparison of treatment regimens in animal oncological studies.  In 
addition, the roles of various processes (vasogenic edema, reduced cell density, formation 
of necrosis, and tumor regrowth) with potential contribution to the temporal evolution of 
the total apparent diffusion coefficient (ADC) are not fully understood.   
In order to address these issues, two major goals were developed: first, to gain insight 
into the various processes whose combination yield the total ADC response over time; 
second, to identify the contribution of tissue heterogeneity (viable, necrotic) to the 
treatment response and changes in tumor growth kinetics and cell kill.  To this end, a 
multi-spectral (MS) approach, combining ADC and T2 parameter maps with k-means 
(KM) clustering, was employed for estimation of multiple compartments within both 
viable tumor tissue and necrosis following single-dose (1000 cGy) radiotherapy in a 
radiation-induced fibrosarcoma (RIF-1) tumor model.  Results were compared with 
conventional histology via the hematoxylin-eosin (H&E) staining procedure (for 
identification of regions of viable tumor versus necrosis), as well as via hypoxic-
inducible factor-1alpha (HIF-1α) immunohistochemistry (for identification of regions of 
hypoxia versus well-oxygenated tissue).   
The results of this study demonstrate that the MS analysis provides: (1) an improved 
tissue segmentation method over results obtained from conventional single-parameter 
approaches, (2) subdivision based on the degree of necrosis, as well as delineation 
between well-oxygenated and hypoxic viable tissue, (3) good correlation with both H&E 
staining and HIF-1α immunohistochemistry, and (4) a method for monitoring the range 
of tissue viability as a function of time post-treatment, with the potential for predicting 
therapeutic efficacy.  
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Part 2: Role of Spreading Depression in Ischemic Stroke 
At present, the mechanisms by which focal ischemia evolves into infarction remain 
poorly understood.  Past studies suggest a causative role of spreading depression (SD) in 
the evolution of focal brain ischemia.  Recent studies have reported the use of manganese 
ions (Mn2+) as a depolarization-dependent contrast agent in monitoring brain activation 
through the application of glutamate, as well as in the study of focal ischemia.  Since SD 
or SD-like depolarizations induce calcium (Ca2+) influx following loss of ion 
homeostasis, and knowing that Mn2+, having an ionic radius similar to that of Ca2+, is 
handled in a similar manner to Ca2+, these studies suggest the possible use of Mn2+ in 
tracking SD or SD-like depolarizations in the evolution of focal brain ischemia. 
In order to determine the utility of Mn2+ as a marker for SD, experimental SD was 
elicited by chemical stimulation (KCl application to exposed rat cortex) and compared 
with control conditions.  This study demonstrated that (1) Mn2+ is a more accurate marker 
for SD than DWI or T2* methods, (2) cortical restriction of MEMRI enhancement 
supports the contention that apical dendrites are necessary for SD propagation.  (3) 
subcortical enhancement was a result of cortical-subcortical neuronal connectivity.  
Based on these results, preliminary experiments involving the study of SD in ischemia 
using Mn2+ were performed.  Initial results indicate: (1) MEMRI may provide a method 
for estimating the likelihood of progression to infarction at acute timepoints post onset of 
stroke.  These studies provide a foundation for further investigation into the role of SD in 
stroke, and the application of Mn2+ towards the design of therapeutic strategies targeting 
SD inhibition. 
 
Conclusions and Medical Significance 
The research within this dissertation employed magnetic resonance imaging techniques 
for monitoring the temporal evolution of pathological disease states such as focal 
ischemia and cancer, with and without therapeutic intervention.  Optimization of these 
techniques in experimental models will open the possibility for future application in a 
clinical setting.  Clinical availability of these non-invasive methods, with the ability to 
detect an early therapeutic response or to provide staging and prediction of tissue fate, 
would greatly aid in patient management of both cancer and stroke. 
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Visualization of Cortical Spreading Depression Using
Manganese-Enhanced Magnetic Resonance Imaging
Erica C. Henning,1 Xiangjun Meng,3 Marc Fisher,3,4 and Christopher H. Sotak1,2,4*
Cortical spreading depression (CSD) was visualized using man-
ganese-enhanced MRI (MEMRI) following topical application of
KCl to the exposed rat cortex. MEMRI signal increase in the
ipsilateral cortex relative to the contralateral control region was
60  30% following two KCl applications. MEMRI signal in-
crease for a single (40%) versus double (80%) KCl application
suggests an integration effect over successive CSD episodes.
CSD-induced MEMRI enhancement involved cortical layers
containing dense regions of apical dendrites, supporting the
contention that these neuronal structures are necessary for
propagation of CSDs. Subcortical enhancement was present in
hippocampal and thalamic regions, most likely a result of neu-
ronal connections with cortical layers 4 and 5. These results are
consistent with previous studies of CSD using diffusion-
weighted MRI and T2
*-weighted MRI and should be useful for
investigating CSD itself and its role in other neurologic
disorders. Magn Reson Med 53:851–857, 2005. © 2005 Wiley-
Liss, Inc.
Key words: manganese-enhanced MRI; cortical spreading de-
pression; rat brain; glutamate; calcium channels
Cortical spreading depression (CSD), a pathophysiological
phenomenon of the central nervous system ﬁrst described
by Leao (1,2), is characterized by a spontaneous and re-
versible depression of electrical activity that spreads from
the site of onset as a radial wave across the cortex with a
speed of 2 to 5 mm/min. Experimental induction of CSD
relies on methods that increase the extracellular K con-
centration ([K]0), leading to depolarization of adjacent
presynaptic terminals, neurotransmitter release, and local
failure of ion homeostasis (3). The radial wave of de-
pressed cortical electrical activity leads to depolarization
of the cellular membrane, causing an abrupt negative shift
in direct-current (DC) potential on the order of 5 to
15 mV, followed immediately by a smaller but more
prolonged positive phase (4). For the duration of the neg-
ative potential shift (approximately 1 min), a large increase
in [K]0 is accompanied by a drop in [Cl
]0, [Na
]0, and
[Ca2]0, suggesting that K
 leaving cells is exchanged
against Na and Ca2 that are entering (5). The increase in
[K]0 to levels of 10 to 60 mmol/L is sufﬁcient to depolar-
ize adjacent neurons in the path of the CSD wave, permit-
ting its continued propagation. Concomitant with the
movement of Na and Cl into the cell, there is an inﬂux
of water, subsequent cellular swelling, and a reduction in
extracellular space by 50% (6,7). These transient cellular
changes are accompanied by increased cortical perfusion
and decreased tissue pO2, accounting for the local increase
in oxygen consumption required to restore membrane ion
gradients (8). Upon passage of the CSD wave, cortical
electrical activity renormalizes over the course of several
minutes, permitting additional episodes of CSD following
an approximate 3-min refractory period.
CSD is of interest because of its contribution to the
pathophysiology of stroke, head trauma, epilepsy, hypo-
glycemia, and subarachnoid hemorrhage (3). Unfortu-
nately, a comprehensive evaluation of CSD in human sub-
jects has not been performed, largely in consideration of
the challenges involved and the lack of appropriate mea-
suring techniques. The majority of studies investigating
the role of CSDs under these conditions have been in
animal models, speciﬁcally lissencephalic species (mouse,
rat, rabbit), versus gyroencephalic species (cat, monkey)
(5). CSD, which can be elicited by direct chemical, me-
chanical, or electrical stimulation to the cortex, is pro-
duced more readily in lissencephalic species, and, al-
though gyroencephalic species are relatively resistant to
CSD propagation, they are by no means immune. Further
investigation of the dynamic physiologic changes of CSD
could aid in understanding the underlying mechanisms of
the aforementioned conditions.
Past studies have used MRI as a noninvasive tool for the
characterization of CSD. Gardner-Medwin et al. (9) dem-
onstrated the identiﬁcation of experimentally induced
CSD in a rat model using T2
*-weighted MRI. The authors
suggested that the observed increase in signal intensity
(10%) was a result of sensitivity to alterations in the
oxygenation state of hemoglobin within the local cerebral
vasculature (10). CSD causes a local increase in cerebral
blood ﬂow and tissue oxygenation, yielding increased sig-
nal in gradient-echo images. Other studies present obser-
vations of a similar phenomenon in which experimentally
induced CSD is characterized by a transient decline in the
apparent diffusion coefﬁcient (ADC) of water (11–13). La-
tour et al. (11) characterized the temporal evolution of CSD
using diffusion-weighted MRI (DWI). The authors ob-
served a region of declined ADC (35%) moving across
the cortex with a uniform velocity of approximately 3 mm/
min. The authors hypothesized that the induced depolar-
izations of the cellular membrane, resulting in cellular
swelling and a decrease in the extracellular volume frac-
tion, account for the transient decrease in ADC. In line
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with this study, Busch et al. (12) demonstrated the simul-
taneous recording of EEG, DC potential, and the temporal
evolution of CSD using DWI. Their results coincide with
those of Latour et al. (11), but allow a method of obtaining
electrophysiological recordings in the magnet during CSD
imaging. For a better understanding of the temporal rela-
tion between cell membrane depolarizations and the ac-
companying hemodynamic response, de Crespigny et al.
(13) assessed both during CSD using T2
*-weighted MRI
and DWI. The authors found that the transient regional
hyperperfusion following the ADC decrease was delayed,
suggesting that the perfusion increase is a consequence of
elevated ATP requirements for cellular repolarization.
Although T2
*-weighted MRI and DWI have been used to
investigate CSD, these studies have limited their spatial
resolution and signal-to-noise ratios in order to achieve a
reasonable temporal resolution for monitoring the tran-
sient changes in ADC and T2
* concomitant with CSD prop-
agation. T2
*-weighted MRI also suffers from susceptibility-
induced artifacts from the interface between tissue bound-
aries, degrading image quality. Since DWI and T2
*
methods are based on macroscopic physiologic changes
(cell swelling and regional blood ﬂow, respectively), they
are limited in their ability to characterize the spatial extent
of CSD. An MRI method with a higher signal-to-noise ratio
for whole-brain imaging of CSD, based on more micro-
scopic physiologic changes, would be helpful in order to
overcome these limitations.
Recent studies have reported the use of manganese ions
(Mn2) as a membrane-depolarization-dependent contrast
agent for monitoring neuronal activation following the
application of glutamate (14,15), as well as in the study of
focal ischemia (16). Mn2 competitively enters cells
through Ca2-inﬂux pathways such as voltage-gated Ca2
channels (17,18). Lin and Koretsky (14) ﬁrst demonstrated
the utility of paramagnetic Mn2 in monitoring regional
brain function using T1-weighted MRI. The presence of
extracellular Mn2 during neuronal depolarization elicits
Mn2 inﬂux through Ca2 channels. Upon repolarization,
Ca2 channels close resulting in the “permanent” intracel-
lular uptake of Mn2. Since Mn2 remains sequestered in
previously activated regions, it allows for “snapshot” im-
aging of brain activation patterns in functional task para-
digms performed outside the magnet (14).
Extracellular accumulation of K, like glutamate, is be-
lieved to play a central role in the propagation of CSDs.
Whether pathophysiologically or experimentally induced,
local increases in [K]0 lead to the depolarization of pre-
synaptic terminals and the opening of Ca2 channels. Mir-
roring the rise in [K]0, [Ca
2]0 declines from its normal
level of 1.2–1.5 mM to less than 0.3 mM, indicating a Ca2
shift to the intracellular compartment during CSD. Since
Mn2 is transported into the cell in a manner similar to
Ca2, it should be possible to use Mn2 to track the spatial
distribution of CSD using manganese-enhanced MRI
(MEMRI). The purpose of this feasibility study is to dem-
onstrate the utility of Mn2 as a paramagnetic Ca2 analog
in the visualization of CSD in the rat brain. MEMRI should
be useful for investigating CSD itself as well as its role in
the pathophysiology of other neurologic disorders.
METHODS
Animal Preparation
The present study was approved by the Institute Animal
Care and Use Committee (IACUC) of the University of
Massachusetts Medical School (IACUC Protocol A-875).
Male Sprague–Dawley rats (300–360 g; Taconic Farms,
Germantown, NY) were divided into three groups: saline
control (N  4), glutamate (N  2), and experimental CSD
(N  5). Rats were initially anesthetized with an intraperi-
toneal injection of chloral hydrate (400 mg/kg). Polyethyl-
ene catheters (PE-50, Becton–Dickinson, San Jose, CA)
were placed in the left femoral vein (i.v.) and the right
external carotid artery (ECA) for drug administration. For
catheterization of the right ECA, a ventral midline incision
was made in the neck. The omohyoid muscle was sepa-
rated longitudinally and retracted laterally to isolate and
expose the right ECA. Following ligation of the vessel, a
small incision was made into which the catheter was in-
serted and secured in place. Cannulation of the right ECA
limited drug delivery to the right side of the brain, en-
abling the left side to serve as a control. The common
carotid artery was kept intact and open in order to main-
tain blood ﬂow to regions originally supplied by the right
ECA (i.e., face and underlying muscle). Rectal temperature
was monitored continuously with a rectal probe and main-
tained at 37.0°C using a thermostatically controlled heat-
ing lamp (Model 73ATD, YSI, Inc., Yellow Spring, OH)
during preparation.
MnCl2 Administration
Physiologically buffered saline containing 74.5 mM man-
ganese chloride (MnCl2  4H2O; Sigma, St. Louis, MO) was
infused through the left femoral vein at a rate of 3.97 mol/
min (3.2 mL/hr) using a syringe pump (Model 11; Harvard
Apparatus, Holliston, MA) for 32 min. The total volume of
infused MnCl2 solution was 1.71 mL (127 mol). To open
the blood–brain barrier (BBB), 25% D-mannitol solution
(5 mg/kg; Sigma) was bolus-injected via the right ECA
10 min after the start of the MnCl2 infusion.
Glutamate Administration
A glutamate administration group (N 2) was evaluated to
validate our use of the MEMRI method previously devel-
oped by Aoki et al. (15), a modiﬁcation of the original by
Lin and Koretsky (14). A solution of L-glutamic acid
(0.2 mL of 10 mg/mL; Sigma) was bolus-injected via the
right ECA 22 min after the start of the MnCl2 infusion (Fig.
1a). For the corresponding controls (N  2), physiologi-
cally buffered saline (0.2 mL) was injected through the
right ECA in place of the glutamate.
Experimental Cortical Spreading Depression
For the experimental CSD group (N  5), rats were
mounted prone on a homemade stereotaxic surgical board
with a head holder and tooth bar. The frontoparietal cra-
nium was exposed by a midsagittal incision, and a burr
hole, 2.0 mm in diameter, was made in the right parietooc-
cipital cortex, 1 mm posterior and 1.5 mm lateral of
bregma. Following careful excision of the dura using a
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23-gauge needle, two syringes were prepared for cortical
application of 4M KCl or 0.9% (w/v) NaCl, respectively.
In order to evaluate the effects of single versus multiple
applications of KCl on CSD-induced MEMRI enhance-
ment, animals were subdivided into two groups: a single
4 M KCl application (N  1) and two 4 M KCl applications
(N  4). For the single 4 M KCl application, 22 min after
the start of MnCl2 infusion, a 20-L volume of KCl solu-
tion was administered over the course of 3 min followed
by a saline wash (Fig. 1b). For two 4 M KCl applications, a
40-L volume of KCl solution was administered in the
following manner, 22 min after the start of MnCl2 infusion:
3-min 4 M KCl exposure, saline wash 3 3-min waiting
period 3 3-min 4 M KCl exposure, saline wash (Fig. 1c).
For the corresponding controls (N  2), 40 L of 0.9%
(w/v) NaCl was applied to the exposed cortex in place of
the 4 M KCl.
MRI Measurements
MR experiments were performed with a Bruker Biospin
2.0 T/45 cm imaging spectrometer equipped with
20 G/cm self-shielded gradients. T1-weighted imaging
was performed using the following acquisition parameters:
TR/TE  300.0/12.0 ms, FOV  4  4 cm, matrix size 
256  256. The imaging plane was referenced to the rhinal
ﬁssure at the boundary of the olfactory bulb. For the glu-
tamate administration group and controls, six 3-mm slices
were acquired with NEX  2. For the experimental CSD
group and controls, eight 2-mm slices were acquired with
NEX  4. The total experiment times were 2.6 and 5.2 min
for the glutamate and experimental CSD experiments, re-
spectively. During imaging, animals were placed supine in
a homebuilt animal holder. The head of the animal was
ﬁxed inside a 2.0  3.5 cm rectangular 1H surface coil
shaped to conform to the curvature of the skull. Animals
were anesthetized with 1.2% isoﬂurane delivered at
1.0 L/min in breathing-quality air. Body temperature was
maintained at 37.0  1.0°C by circulated warm air using a
T-type thermocouple and a double-point feedback control
system.
Data Analysis
Image analysis, image reconstruction, and region of inter-
est (ROI) calculations were performed using Paravision’s
Image Processing and Display Software (Xtip). The spatial
extent of MEMRI-enhanced regions (cortical, subcortical)
was determined by correlation to a standard rat brain atlas
(19) based on the slice location in terms of distance from
bregma. ROIs were user-deﬁned to delineate between
MEMRI-enhanced cortical regions and normal tissue. Per-
centage signal increase was calculated through compari-
son of the ipsilateral cortex to the equivalent contralateral
control region on a slice-by-slice basis,
Signal increase (%) 
SIIC  SICC
SICC
 100, [1]
where SIIC is the signal intensity for the ROI in the ipsi-
lateral cortex and SICC is the signal intensity for the ROI in
the contralateral cortex. Data are means  standard devi-
ation (SD), with a separate term for the interslice signal
variability (IS-SD).
RESULTS
Figure 2 shows the multislice T1-weighted MEMRI for the
glutamate group, experimental CSD group, and the corre-
sponding controls at a single time point 1.5 hr after the
start of MnCl2 infusion. Figure 2a shows the signal en-
hancement from T1-weighted MEMRI following neuronal
activation via glutamate administration. The average per-
centage increase in cortical signal intensity was 29  3%,
with a similar increase seen in the ventricles. Cortical
enhancement was visible across ﬁve of the six imaging
slices, resulting in approximately 15 mm of coverage
(4.5 mm anterior to 10.5 mm posterior of bregma). Figure
2c shows the signal enhancement from T1-weighted
MEMRI of experimental CSD following two applications of
4 M KCl. The region of MEMRI enhancement was conﬁned
to a 0.6- to 1.2-mm-thick cortical layer, appearing as a
hyperintense streak extending radially from the CSD in-
duction site (solid arrows). The average percentage in-
crease in cortical signal intensity was 60  30%. Cortical
enhancement was visible across six of the eight imaging
slices, resulting in approximately 12 mm of coverage
(2.5 mm anterior to 9.5 mm posterior of bregma). In a few
of the slices (Fig. 2b, open arrows), subcortical enhance-
ment was present that did not match with the regional
ventricular enhancement of the NaCl control (3.5 to
FIG. 1. Timing of drug administration (in minutes) for glutamate (a),
experimental CSD with one KCl application (b), and experimental
CSD with two KCl applications (c). The time points for starting the
MnCl2 infusion, mannitol injection, glutamate injection, KCl applica-
tions, and saline washes are indicated by the labeled arrows. For the
corresponding controls, physiologically buffered saline (NaCl) was
applied in place of the glutamate or KCl.
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9.5 mm posterior of bregma). Areas of subcortical enhance-
ment included hippocampal regions CA1–3, subiculum,
and dentate gyrus, as well as the thalamic nucleus, supe-
rior and inferior colliculi, and geniculate nucleus. No sig-
niﬁcant changes in cortical signal intensity were detected
for the saline controls (Fig. 2b and d), but the same degree
of ventricular enhancement was present.
Figure 3 illustrates the effect of single versus multiple
applications of KCl on CSD-induced MEMRI enhance-
ment. Three representative axial images are shown for
each animal (solid arrows indicate the image located co-
incident with the KCl application site). Figure 3a shows
the signal enhancement from T1-weighted MEMRI follow-
ing a single application of 4 M KCl. The average percentage
increase in cortical signal intensity was 40% for this par-
ticular animal. Figure 3b shows the signal enhancement
from T1-weighted MEMRI following two applications of
4 M KCl. The average percentage increase in cortical signal
intensity was 80% for this particular animal (60 30% for
N  4), double that of the single 4 M KCl application. Both
animals had similar levels of ventricular enhancement.
Table 1 summarizes the average percentage signal inten-
sity increase for different brain regions for the glutamate
administration group, experimental CSD group, and the
corresponding controls. In the glutamate administration
group, changes in signal intensity in the ipsilateral cortex
were comparable to that of the ventricles. Animals in the
experimental CSD group that received two applications of
4 M KCl exhibited no signiﬁcant difference in percentage
signal increase between the ipsilateral cortex and the ven-
FIG. 2. T1-weighted MEMRI following glutamate administration and experimental CSD. (a) Neuronal activation following glutamate
administration. Glutamate administration results in heterogeneous cortical enhancement (29  3% signal increase) in ﬁve of six images
(solid arrows). Slice thickness  3 mm. (b) Saline control for glutamate experiments. (c) Cortical signal enhancement following two 4 M KCl
applications. Two 4 M KCl applications result in a thin layer of cortical enhancement (60  30% signal increase) in six of eight images (solid
arrows). Slice thickness  2 mm. Only images exhibiting enhancement are shown. Signal enhancement following CSD in the presence of
Mn2 is clearly visible in the right cortex. Regions of CSD-induced MEMRI enhancement appear as a hyperintense streak extending
dorsolaterally from retrosplenial granular cortex or frontal cortex, area 2, to piriform cortex or perirhinal cortex depending on the location
anterior–posterior with respect to bregma. Regions of subcortical enhancement (open arrows) include CA1–3 (Ammon’s horn), the
subiculum, and the dentate gyrus of the hippocampus, in addition to the thalamic nucleus, superior and inferior colliculi, and geniculate
nucleus. Subcortical enhancement is thought to be due to neuronal connections between these particular regions and the cortex. (d) NaCl
control for experimental CSD.
FIG. 3. Effect of single versus double KCl applica-
tions on MEMRI appearance. (a) MEMRI enhance-
ment following a single application of 4 M KCl. One
KCl application results in a thin layer of cortical en-
hancement (40% signal increase for this particular
animal). (b) MEMRI enhancement following two ap-
plications of 4 M KCl. Two applications of KCl in-
duce multiple episodes of CSD, resulting in an inte-
gration of MEMRI cortical signal intensity (80% sig-
nal increase for this particular animal; 60  30% for
N  4). MEMRI enhancement was visible across six
of eight images for both the single and the double
KCl application. Representative axial images coinci-
dent with and adjacent to the KCl application site are
shown. Solid arrows indicate the location of the KCl
application site.
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tricles (P  0.32, N  4). A similar trend was seen for the
single application of 4 M KCl. For both sets of controls,
changes in cortical and ventricular signal intensity were
comparable, indicating experimental reproducibility.
DISCUSSION
Mn2 is paramagnetic and has been used for MRI tissue
contrast enhancement by oral or i.v. administration of
MnCl2 or Mn complexes. Mn
2 mimics Ca2 uptake in
many biologic systems and is known to enter cells through
ligand- or voltage-gated Ca2 channels during nerve action
potentials (17). Following experimental induction of CSD,
membrane depolarization facilitates opening of voltage-
gated Ca2 channels and a concomitant inﬂux of Mn2.
Upon deactivation, channels return to their closed resting
state, resulting in the entrapment of intracellular Mn2.
This phenomenon is supported by the observation that the
speciﬁc action of verapamil, a voltage-gated Ca2 channel
blocker, inhibits inﬂux of Mn2 into cells (18).
In the present work, validation of Mn2 as an activation-
speciﬁc contrast agent was done through glutamate admin-
istration in the presence of a compromised BBB using the
methodology of Aoki et al. (15). For simplicity, all surgical
procedures and drug administration were performed out-
side the magnet with image acquisition at 1.5 hr after the
start of MnCl2 infusion. Figure 2a demonstrates that the
infusion of MnCl2 during glutamate activation causes cor-
tical and ventricular contrast enhancement of similar mag-
nitude and regional coverage when compared to previous
MEMRI studies (14,15). Aoki et al. (15) reported a relative
signal enhancement of 174% for the right hemisphere
(excluding the ventricles) and 155% for the ventricles
alone following glutamate administration. These results
were based on the comparison of the relative signal inten-
sities in the ipsilateral cortex measured at baseline (prior
to injection of mannitol) and following glutamate admin-
istration. If instead a comparison is drawn between the
relative signal intensities of the ipsilateral cortex and the
contralateral cortex following glutamate administration,
the relative signal enhancement is approximately 120%.
This estimated increase (20%) is consistent with the val-
ues reported in Table 1. After a similar comparison is
drawn between the relative signal intensities of the ven-
tricles and the contralateral cortex, the relative signal en-
hancement is approximately 135%. Lin and Koretsky (14)
reported a steady-state ventricular signal enhancement of
149% following infusion of MnCl2. These increases (35
and 49%) are close to the changes in ventricular signal
intensity seen in the experimental groups listed in Table 1.
For the experimental CSD group, an activation scheme
with a set waiting period was devised (Fig. 1c) to account
for the approximate 3-min refractory period between ini-
tiation of individual episodes of CSD. During the ﬁrst
application of 4 M KCl, the local increase in [K]0 induces
depolarization of presynaptic terminals, opening of volt-
age-gated Ca2 channels, and the intracellular accumula-
tion of Mn2. This takes place during the negative phase of
the DC-potential shift over the course of 1–2 min. Upon
repolarization, the Ca2 channels close resulting in the
retention of Mn2 inside the cell. While this repolarization
occurs locally, the increase in [K]0 is thought to depolar-
ize adjacent neurons, allowing propagation of the CSD
wave along the entire extent of the cortex. During the
3-min wait period, restoration of ion gradients occurs with
normalization of spontaneous electrical activity, after
which a second CSD episode may be induced. Although
electrophysiological recordings were not performed, pre-
vious work employing this experimental-CSD model re-
ported induction of a single CSD event following one
3-min KCl application (20). Based on these results, one
CSD event is expected for the single 3-min KCl application
and a minimum of two CSD events are expected for the
double KCl application. Each CSD event results in the
intracellular accumulation of Mn2. With multiple CSD
events there is an integration effect where the total [Mn2]i
accumulated is proportional to the signal intensity in T1-
weighted MRI. As MEMRI “records” all cortical regions
having undergone CSD-induced depolarizations, CSDs ap-
pear as a hyperintense streak down the cortex (Fig. 2c).
A MEMRI integration effect was ﬁrst demonstrated fol-
lowing brain activation using multiple injections of gluta-
mate (14). The authors followed the temporal evolution of
T1-weighted MRI signal intensity changes in the cortex
from rats undergoing MnCl2 infusion, mannitol injection,
and two injections of glutamate. They reported an average
signal enhancement of 123 and 238% for prestimulation
and following two glutamate injections, respectively. The
Table 1
Average Signal Increase (%) from T1-Weighted MRI for Different Brain Regions (Relative to a Homologous Region in the Contralateral
Hemisphere) Following Various Stimuli
Type of stimulus
Average signal increase (%) (using Eq. [1])
Cortex Ventricles
Mean  SD ISSDa Mean  SD ISSDa
Glutamate administration (N  2) 29  3 5 21  6 10
Saline control (N  2) 6  1 4 29  9 20
Experimental CSD
Single KCl application (N  1) 40 20 40 20
Two KCl applications (N  4) 60  30* 20 46  3 10
NaCl control (N  2) 20  10 4 50  10 20
aTo account for intra-animal variability, the inter slice standard deviation (IS-SD) was calculated from values for the average signal increase
(%) across affected slices.
*MEMRI signal intensity changes in the ipsilateral cortex were not signiﬁcantly different from the ventricles (P  0.32, N  4) in the
experimental CSD group receiving two KCl applications.
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time-course diagram from this work, for a single represen-
tative rat, showed cortical signal intensities of approxi-
mately 135, 200, and 250% for prestimulation, following a
single injection of glutamate, and following two glutamate
injections, respectively. These signal intensity changes
suggest a correlation between the number of administered
doses of glutamate, or the degree of glutamate-induced
Mn2 inﬂux, and the MEMRI signal enhancement.
In order to investigate the integration effect for CSD,
comparisons were made between animals receiving a sin-
gle or double application of 4 M KCl. Results of a single
KCl application versus two KCl applications for experi-
mental induction of CSDs support this relationship be-
tween [Mn2]i accumulation and the signal enhancement
in T1-weighted MRI. Figure 3 shows the integration effect
of multiple CSD events for representative axial images
located coincident with and adjacent to the KCl applica-
tion site. Following a single 3-min application of 4 M KCl,
the average percentage increase in cortical signal intensity
was 40% (Fig. 3a). Following two 3-min applications of
4 M KCl, the average percentage increase in cortical signal
intensity was 80% (60  30% for N  4) (Fig. 3b), double
that of the single 4 M KCl application. Both had compara-
ble levels of ventricular enhancement, suggesting similar
steady-state levels of Mn2 in the CSF space. Although the
average percentage increase in cortical signal intensity was
60  9% for N  4 in the double 4 M KCl application, the
average percentage increase for one of the animals was
30%. That particular animal may in fact have only expe-
rienced a single CSD episode instead of two CSD episodes,
resulting in an average percentage increase more compa-
rable with the animal receiving a single 4 M KCl applica-
tion (40%). Further study comparing single versus multi-
ple applications of 4 M KCl in conjunction with electro-
physiological measurements will be required to verify the
relationship among the number of CSD episodes, [Mn2]i
accumulation, and MEMRI enhancement.
Previous studies suggest that pyramidal cell dendrites are
critical to CSD propagation (21) and that cortical layers con-
taining proximal apical dendrites are more susceptible to
CSD than those containing basilar dendrites or distal apical
dendritic branches (22). Cortical regions exhibiting MEMRI
enhancement following experimental CSD, expected to en-
compass layers containing these neuronal structures, ex-
tended dorsolaterally from retrosplenial granular cortex or
frontal cortex, area 2, to piriform cortex or perirhinal cortex
depending on the location anterior–posterior with respect to
bregma. Cortical restriction of MEMRI enhancement is con-
sistent with the contention that pyramidal cell (apical) den-
drites are necessary for the propagation of CSDs through
individual layers of the cortex.
In addition to the cortical enhancement in the experimen-
tal CSD group, there was some visible subcortical enhance-
ment extending well beyond the ventricular space (Fig. 2c,
open arrows). This enhancement was different from the non-
speciﬁc ventricular enhancement observed in the control
(Fig. 2d). Regions of subcortical enhancement included
CA1–3 (Ammon’s horn), the subiculum, and the dentate
gyrus of the hippocampus, in addition to the thalamic nu-
cleus, superior and inferior colliculi, and geniculate nucleus.
Previous studies report on the intrinsic connectivity between
hippocampal regions and the entorhinal, perirhinal, and pos-
trhinal cortices (23,24), as well as corticothalamic projections
arising from cortical layers 4 and 5 (25–27). Other reports
describe connections between cortical layer 5 and the supe-
rior (28) and inferior (29) colliculi, with neuronal projections
extending from the superior colliculus to the geniculate nu-
cleus (30). During CSD, signal propagation descending the
pial surface along apical dendrites into individual layers of
the cortex, and then through the various connections de-
scribed, may explain the subcortical enhancement seen in
the MEMR images.
The MEMRI signal enhancement in the cortex was 0.6–
1.2 mm in thickness and extended radially from the in-
duction site. Zhu (31) reported an average apical dendritic
length of 1.2 mm in the neocortex of adult rats. The thick-
FIG. 4. Water apparent diffusion coefﬁcient (ADC) maps of a single
MRI slice though the rat brain exposed to physiologic saline (NaCl)
(left) or 3 M KCl (right). The grayscale intensity is proportional to the
water ADC and a nonlinear mapping, such that ADC values below
0.55  105 cm2 s1 appear nearly black, was used to exaggerate
the affected region. The ADC maps acquired after NaCl application
are unchanged, indicative of normal rat brain. After application of
3 M KCl, a region of decreased water ADC, approximately 2 mm in
size, is clearly visible moving away from the application site to the
lower cortex. [Reprinted from Latour LL, Hasegawa Y, Formato JE,
Fisher M, Sotak CH. Spreading waves of decreased diffusion coef-
ﬁcient after cortical stimulation in the rat brain. Magn Reson Med
1994;32:189–198. Copyright ©1994. Reprinted with permission of
Wiley–Liss, Inc., a subsidiary of John Wiley and Sons, Inc.] (11)
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ness of MEMRI cortical enhancement is similar to this
value and suggests that apical dendrites support CSD
propagation. Furthermore, these results are consistent
with previous studies of CSD using DWI (Fig. 4), in which
a region of decreased water ADC, approximately 2 mm in
size, propagated away from the application site to the
lower regions of the cortex. The discrepancy in the ob-
served thickness of the affected cortical region reported by
MEMRI versus DWI may be attributed to volume-averaging
effects from differences in image spatial resolution
(400 m for DWI versus 156 m for MEMRI, in-plane).
Although MEMRI and DWI both allow for visualization of
CSDs, MEMRI has a clear advantage over that of DWI.
Because of the relatively rapid propagation of CSDs and
the transiently induced changes in EC space, DWI is lim-
ited to real-time imaging. With intracellular retention of
Mn2 and a slow clearance rate, MEMRI may be performed
after application of the stimulus outside of the magnet.
Consequently, longer experiment times allow for data ac-
quisition at higher spatial resolutions with longer signal
averaging and increased signal-to-noise ratios. MEMRI
may also be used for tracking real-time changes in-bore.
In summary, MEMRI is a useful technique for the visu-
alization of experimental CSD using paramagnetic Mn2
as a depolarization-dependent contrast agent in conjunc-
tion with T1-weighted imaging. Topical application of 4 M
KCl in the presence of extracellular Mn2 and a compro-
mised BBB allowed differentiation between CSD-speciﬁc
cortical signal enhancement and the nonspeciﬁc enhance-
ment present in the ventricular space. MEMRI is speciﬁc to
Ca2 channel activity and the intracellular accumulation
of Mn2. Consequently, MEMRI may be a more direct
method for imaging the spatial extent of CSD compared
with DWI or T2
*-weighted imaging, which are based on
more macroscopic physiologic changes (cell swelling and
regional blood ﬂow, respectively). Since the Mn2 clear-
ance is relatively slow, MEMRI may be useful for imaging
CSD and its contribution to the temporal evolution of other
neurologic disorders.
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Introduction 
 The development of MRI endpoints to detect an early tumor therapeutic response would aid greatly in patient management, opening the possibility 
for both rapid radio- and chemotherapeutic dose optimization and replacement of ineffective therapies with alternative treatment.  Unfortunately, 
inter- and intra-tumor heterogeneity complicate the quantification of treatment response using MRI.  A multi-spectral (MS) analysis approach in 
combination with ADC and T2 maps has been shown to aid in the identification of multiple compartments within necrotic tissue.1  Here we report on 
a single-dose radiotherapy study using RIF-1 tumors in which MS analysis, using k-means (KM) clustering, was used to identify multiple 
compartments in both viable and necrotic tissue.  The goal is to identify sub-populations in each tissue type to better characterize tissue that includes 
heterogeneity.   
Methods 
 Twenty-nine 6-8 week-old female C3H mice weighing 20-25g were anesthetized with an intraperitoneal injection of ketamine/zylazine 
(100mg/kg:10mg/kg).  All mice were inoculated with 1×106 RIF-1 cells (0.15ml), delivered through a subcutaneous injection into the right hind leg.  
Tumors were allowed to develop for 3-4wks, yielding an approximate 1.0cc starting volume.  
 Data for both control (n=16) and treatment (n=13) groups were acquired with a Bruker Biospin 2.0T/45 cm imaging spectrometer operating at 
85.56 MHz for 1H and equipped with ±20G/cm self-shielded gradients.  The experiments involved multi-slice image acquisition along the coronal 
plane [128×128, FOV=3cm, slices=8, slice thickness=1mm].  A diffusion-weighted, spin-echo (SE) sequence was used to acquire the images at six b-
values (b=50, 110, 210, 500, 690, 910 mm2 s-1) with diffusion sensitization applied along the read direction.  Other acquisition parameters were: 
TR/TE=2000.0/53.0 msec, diffusion gradient duration δ=4.0msec, diffusion gradient separation ∆=35msec, resulting in an effective diffusion time 
tdif=33.75msec.  A T2-weighted, SE sequence was used to acquire images at six echo times (TE = 12.2, 20, 35, 50, 65, 90 msec) with TR=2000msec.  
For the control group, tumors of varying volumes were imaged at a single time point and then extracted for histological examination.  For the 
treatment group, tumors were irradiated with 1000cGy at a rate of 300cGy/min (Siemens Mevatron 77, 6 MeV electrons).  Imaging was performed 
1d pre-treatment, 5-hr, 1d-, 2d- post-treatment, and every 2d thereafter until tumor doubling (maximum 14d post-treatment). 
 Image reconstruction and ADC and T2 parameter-map generation was performed using routines written in IDL® (RSI, Boulder, CO). Tissue 
classification was performed using the k-means (KM) clustering algorithm in a hierarchical manner.  In the first step of the classification algorithm, it 
was applied to separate the data into two clusters (k = 2) of tumor tissue and background noise.  All voxels classified as noise were set to zero and 
removed from further processing.  In the second step, KM (k = 4) was applied to the remaining tissue voxels to segment the data into regions of 
viable tumor and necrosis.  Average ADC and T2 values were calculated for each cluster over all time points. 
 Results and Discussion 
Fig. 1 shows the cluster assignments for a representative RIF-1 tumor.  A 
central necrotic region is visible and is characterized by a small area of high ADC 
and high T2-values surrounded by an area of somewhat lower ADC and T2 values 
also associated with necrotic tissue.  The viable tissue regions have similar T2 
values, but differing ADCs.  The cluster with the higher ADC is adjacent to the 
necrotic clusters; the cluster with the lower ADC is located at the tumor 
periphery.  The mean MR parameter values for each cluster in Fig. 1 are given in 
Table 1.  Fig. 2 shows the temporal changes in individual cluster volume fractions 
(percent of total volume) pre- and post-irradiation for the treatment group.  The 
total viable fraction decreased out to Day 4, with a concomitant increase in the 
total necrotic fraction.  This decrease in viable fraction mirrors that of the initial 
decrease in tumor volume post-irradiation. Tumor volumes began to increase again 
after Day 4.  Tumors that had not yet doubled in size by Day 10 were slower 
growing and had relatively smaller necrotic fractions.  This accounts for 
suppression of the expected increase in necrotic fraction as the tumor regrows.  In 
conclusion, this method allows the characterization of tissue heterogeneity within 
the broad categories of viable and necrotic tissue and may be used for tracking 
changes in tissue viability post-therapeutic intervention.  
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Fig. 2: Plot of the temporal evolution of individual cluster 
volumes for the treatment group. 
Table 1: Mean parameters 
for the multispectral (MS) 
tissue classes of the RIF-1 
tumor shown in Fig. 1. 
The measured parameters, 
ADC and T2, are given as 
the mean ± standard 
deviation. 
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Fig. 1: A multispectral (MS) 
image of a representative RIF-1 
tumor. (A) T2 parameter map. 
(B) ADC parameter map.  (C)
KM map.  The map derived by 
k-means (C) depicts the 
segmentation of the tumor into 
two regions of viable tumor and 
two regions of necrosis.  Color 
assignments are:  Viable 1 = 
Orange; Viable 2 = Red, 
Necrosis 1 = White; Necrosis 2 
= Brown. 
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Synopsis 
 Cortical spreading depression (CSD) was visualized for the first time using manganese-enhanced MRI (MEMRI) following topical application of 4M KCl 
to the exposed rat cortex.  The region of MEMRI signal enhancement was confined to a 1.0-1.5-mm-thick cortical layer extending radially from the induction 
site.  MEMRI allowed visualization of CSD over the entire cortical layer in the affected hemisphere.  These results are consistent with previous studies of 
CSD using DWI and should be useful for investigating CSD itself as well as its role in cerebral ischemia.   
Introduction 
 Cortical spreading depression (CSD) is characterized by a spontaneous and reversible depression of electrical activity that spreads from the site of onset as 
a radial wave across the cortex with a speed of 2-5 mm/min.1  CSD is accompanied by an ionic redistribution across the cell membrane, with efflux of K+ and 
influx of Na+, Cl-, Ca2+and water.  Recent studies have reported the use of Mn2+ as a membrane-depolarization-dependent contrast agent for monitoring 
neuronal activation following the application of glutamate,2 as well as in the study of focal ischemia.3  Extracellular accumulation of K+ and/or glutamate is 
believed to play a central role in the propagation of CSDs.  Since Mn2+ has an ionic radius similar to that of Ca2+, and is transported into the cell in a manner 
similar to Ca2+, it should be possible to use Mn2+to track the spatial distribution of CSD using MEMRI. 
Methods 
 Seven male Sprague-Dawley rats weighing 300-350g were anesthetized with an intraperitoneal injection of chloral hydrate (400 mg/kg).  Manganese 
chloride (MnCl2; Sigma), dissolved to 74.5mM in isotonic saline, was infused through the left femoral vein at a rate of 3.97µmol/min (3.2ml/hr) using a 
syringe pump (model 11; Harvard Apparatus) for 32 min.  Ten minutes after start the of MnCl2 infusion, 25% D-mannitol solution (5ml/kg; Sigma) was 
injected through the external carotid artery (ECA) over 2 min.  For glutamate administration (N = 2), L-glutamic acid solution (0.2ml of 10mg/ml; Sigma) was 
injected through the ECA 22 min. after start of MnCl2 infusion.  For CSD (N = 2), the fronto-parietal cranium was exposed by a midsagittal incision, and a 
burr hole, 1.5 mm in diameter, was made in the right parietooccipital cortex 1 mm anterior and 1.5 mm lateral of the lambda.  The dura was excised with a 23-
gauge needle to expose the surface of the cortex.  Application of 4M KCl was performed in the following manner, 22 min. after start of MnCl2 infusion:  3 
min. 4M KCl exposure, saline wash → 3 min. waiting period → 3 min. 4M KCl exposure, saline wash.  For the corresponding controls (N = 3), 
physiologically buffered saline (NaCl) was applied in place of the glutamate or KCl. 
 MRI experiments were performed with a Bruker Biospin 2.0T/45 cm imaging spectrometer operating at 85.56 MHz for 1H and equipped with ±20G/cm 
self-shielded gradients.  T1-weighted imaging was performed using the following acquisition parameters: TR/TE = 300.0/12.0 msec, FOV = 4 cm × 4 cm, 
matrix size = 256 × 256.  For the glutamate administration group and controls, six 3-mm slices were acquired with NEX = 2.  For the CSD group and controls, 
eight 2-mm slices were acquired with NEX = 4. 
Results 
 Fig.1A shows the signal enhancement from T1-weighted MEMRI following glutamate administration.  Average enhancement in the cortex is 129% ± 5%.  
Fig.1C shows the signal enhancement from T1-weighted MEMRI following CSD.  Average enhancement in the cortex is 180% ± 20%.  No significant 
changes in cortical signal intensity were detected for the saline control (Fig.1B) or the NaCl control for CSD (Fig.1D).  
 
Discussion 
 For CSD, the region of signal enhancement was confined to a 1.0-1.5-mm-thick cortical layer extending radially from the induction site. These results are 
consistent with previous studies of CSD using DWI (Fig.2), in which a region of decreased ADC, approximately 2mm in size, propagates away from the 
application site to the lower cortex.  In contrast to the transient ADC changes accompanying DWI visualization of CSD, MEMRI “records” all cortical regions 
that have undergone CSD-induced depolarizations and thus CSDs appear as a hyperintense ‘streak’ down the cortex (Fig.1C).  Given the relatively rapid 
propagation of CSDs relative to DWI acquisition, only a single slice visualization of CSDs is possible using this approach.  In contrast, MEMRI has the 
advantage of multi-slice, whole-brain recording since the spatial history of CSD propagation is permanently recorded by the uptake of Mn2+.  This method 
should be useful for investigating CSD itself as well as its role in cerebral ischemia3. 
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Figure 1: T1-weighted MEMRI  following glutamate administration and CSD.  (A) Neuronal  
activation following glutamate administration.  (B) Saline control.  (C) Cortical enhancement 
following 4M KCl application.  (D) NaCl application.  Signal enhancement following CSD in 
the presence of Mn2+ is clearly visible in the right cortex of (C).  Arrows highlight regions of 
MEMRI enhancement. 
Figure 2: ADC maps for rat 
brain exposed to physiologically 
buffered saline (NaCl) and 3M 
KCl.  The intensity is 
proportional to Dapp and a 
nonlinear mapping, such that 
values of Dapp below 0.55 × 10-5 
cm2 s-1 appear nearly black, 
allowing exaggeration of the 
affected region.  The maps 
acquired after NaCl application 
appear the same and are 
indicative of a normal rat brain.  
After application of 3M KCl, a 
region of decreased diffusion 
coefficient, approximately 2 mm 
in size, is clearly visible moving 
away from the application site to 
the lower cortex.  Reprinted 
from Ref. 4 with permission 
from Wiley-Liss, Inc. 
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Fig.3: Plot of tumor growth delay and cell kill versus a change in KM viable volume. 
Volume changes were calculated based on the difference between pre-treatment V1+V2 
and the minimum V1+V2 volume post-treatment on an animal-by-animal basis. 
 Fig.1: A multispectral (MS) image of a 
RIF-1 tumor. (A) KM map. (B) 
Hematoxylin-Eosin (H&E) Image.  The 
map derived by k-means (A) depicts the 
segmentation of the tumor into two regions 
of viable tumor and two regions of 
necrosis.    Tissue assignments are:  Viable 
1 (V1) = Green; Viable 2 (V2) = Yellow, 
Necrosis 1 = Red (N1); Necrosis 2 (N2) = 
Blue, Adipose Tissue  = Orange.    A B N1 
N2 
V1 
V2 
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Fig.2: Plot of tumor growth on an animal-by-animal basis pre- and post-
irradiation.  Individual volumes were calculated from caliper measurements using 
the equation  V = (π/6)*(l × w × h) where l = length, w = width, and h = height.  
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Introduction 
 Assessment of therapeutic efficacy is confounded by intra-tumor and inter-tumor heterogeneity.  Variable pre-treatment tissue composition, 
tumor size, and growth kinetics, as well as post-treatment cell kill and tumor regrowth complicate dose-optimization and comparative treatment 
regimens in animal oncology studies.  A multi-spectral (MS) analysis approach using ADC, T2, and M0 maps has been shown to aid in the 
differentiation between viable and necrotic tissue, as well as the identification of multiple compartments within necrotic tissue.1  Here, we report on a 
single-dose radiotherapy study using RIF-1 tumors in which MS analysis, using k-means (KM) clustering, was used to identify multiple 
compartments in both viable and necrotic tissue.  This methodology combined with the contributions of cell kill and tumor growth kinetics should 
provide a better understanding of the physiological dynamics of treated tumors.  
Methods 
 Seven 6-8 week-old female C3H mice weighing 20-25g were anesthetized with an intraperitoneal injection of ketamine/zylazine 
(100mg/kg:10mg/kg).  All mice were inoculated with 1×106 RIF-1 cells (0.15ml), delivered through a subcutaneous injection into the right hind leg.  
Tumors were allowed to develop for 3-4wks, yielding an approximate 1.0cc starting volume.  
 Data were acquired with a Bruker Biospin 2.0T/45cm imaging spectrometer operating at 85.56MHz for 1H and equipped with ±20G/cm self-
shielded gradients.  Image acquisition was performed along the coronal plane [128×128, FOV=3cm, slices=8, slice thickness=1mm].  A DW-SE 
sequence was used to acquire the images at six b-values (15 → 760 s mm-2) with TR/TE=2000/53ms, δ=4ms, ∆=35ms, resulting in an effective 
diffusion time tdif=33.7ms.  A T2W-SE sequence was used to acquire images at six echo times (12.2 → 90 ms) with TR=2000ms.  Tumors were 
irradiated with 1000cGy at a rate of 300cGy/min (Siemens Mevatron 77, 6 MeV electrons, Tufts University Veterinary School of Medicine).  
Imaging was performed 1d pre-treatment, 5hr, 1d, 2d post-treatment, and every 2d thereafter until tumor doubling (maximum 10d post-treatment). 
 ADC, T2, and M0 parameter-maps were generated using routines written in IDL® (RSI, Boulder, CO). Tissue classification was performed using 
the k-means (KM) clustering algorithm.  KM was applied to segment data into two regions each of viable tumor (V1,V2) and necrosis (N1,N2), and 
one region of adipose tissue.  Growth kinetic calculations and cell kill were determined using an exponential model of tumor growth2 and the 
mathematical model proposed by Ross et al,3 respectively. 
  
 
 
 
 
  
  
  
         
 Results 
This method allows identification of tissue heterogeneity within viable tumor 
and necrosis.  Fig.1 shows the cluster assignments for a representative RIF-1 
tumor (Fig.1A) and the corresponding H&E image (Fig.1B) at 6d post-
treatment.  Fig.2 shows the tumor growth curves on an animal-by-animal basis 
pre- and post-irradiation.  Fig.3 shows the correlation between the tumor 
growth delay (TGD), cell kill, and the change in KM total viable volume 
(V1+V2) pre-irradiation versus the minimum volume post-irradiation (1d or 2d 
post depending on the animal).  There was a strong correlation between the 
change in V1+V2 and the resultant TGD (R = 0.78) and cell kill (R = 0.70).  
The relative contributions of pre-treatment V1 and V2 volumes versus post-
treatment kinetic parameters were investigated.  An increase in pre-treatment 
V1 correlated with a decrease in both TGD (R = 0.82) and cell kill (R = 0.83).  
There was no correlation between pre-treatment V2 volume and TGD or cell 
kill.   
    Discussion 
These results suggest that V1 is well-oxygenated, radiosensitive tissue, while 
V2 is hypoxic, and therefore, radioresistant.  The assignment of V1 and V2 will 
be validated using immunohistochemical (IHC) staining for hypoxic-inducible 
factor 1-alpha (HIF-1α).  Since tumor oxygenation is a major factor for 
effective treatment and can be spatially heterogeneous across the tumor, MS 
methods should be helpful in monitoring the range of tissue viability as a 
function of time post-treatment. 
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Fig.3: Plot of ADC values versus time.  Error bars = SEM.  Labels indicate 
number of animals per timepoint.  Asterisks denote significance (p < 0.05), 
comparing each time point post-irradiation to pre-irradiation values.     
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 Figure 1: A multispectral (MS) image of a 
representative RIF-1 tumor. (A) KM map. 
(B) Hematoxylin-Eosin (H&E) Image.  The 
map derived by k-means (A) depicts the 
segmentation of the tumor into two regions 
of viable tumor and two regions of necrosis.  
Tissue assignments are:  Viable 1 (V1) = 
Green; Viable 2 (V2) = Yellow, Necrosis 1 = 
Red (N1); Necrosis 2 (N2) = Blue, Adipose 
Tissue  = Orange.    A B N1 
N2 
V1 
V2 
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Introduction 
 Previous studies employing diffusion MRI have shown that rapid changes in the apparent diffusion coefficient (ADC) following 
therapeutic intervention can indicate a positive therapeutic response.1,2  Although tissue ADCs are known to correlate with cell density, increased 
ADCs at early timepoints post-treatment may be the result of therapeutically-induced changes in ADC such as vasogenic edema.  In order to 
understand the various contributions to the ADC response, we have performed multispectral (MS) analysis using ADC, T2 and M0 for subdivision of 
tissue into regions of viable tumor and necrosis.  Tissue segmentation using this methodology provides insight into the various processes whose 
combination yield the total ADC response over time. 
Methods 
 Seven 6-8 week-old female C3H mice weighing 20-25g were anesthetized with an intraperitoneal injection of ketamine/zylazine 
(100mg/kg:10mg/kg).  All mice were inoculated with 1×106 RIF-1 cells (0.15ml), delivered through a subcutaneous injection into the right hind leg.  
Tumors were allowed to develop for 3-4wks, yielding an approximate 1.0cc starting volume.  
 Data were acquired with a Bruker Biospin 2.0T/45cm imaging spectrometer operating at 85.56MHz for 1H and equipped with ±20G/cm self-
shielded gradients.  Image acquisition was performed along the coronal plane [128×128, FOV=3cm, slices=8, slice thickness=1mm].  A DW-SE 
sequence was used to acquire the images at six b-values (15 → 760 s mm-2) with TR/TE=2000/53ms, δ=4ms, ∆=35ms, resulting in an effective 
diffusion time tdif=33.7ms.  A T2W-SE sequence was used to acquire images at six echo times (12.2 → 90 ms) with TR=2000ms.  Tumors were 
irradiated with 1000cGy at a rate of 300cGy/min (Siemens Mevatron 77, 6 MeV electrons, Tufts University Veterinary School of Medicine).  
Imaging was performed 1d pre-treatment, 5hr, 1d, 2d post-treatment, and every 2d thereafter until tumor doubling (maximum 10d post-treatment). 
 ADC, T2, and M0 parameter-maps were generated using routines written in IDL® (RSI, Boulder, CO). Tissue classification was performed using 
the k-means (KM) clustering algorithm.  KM was applied to segment data into two regions each of viable tumor (V1,V2) and necrosis (N1,N2), and 
one region of adipose tissue.  Average ADC values were calculated on an animal-by-animal basis as well as for individual cluster volumes. 
 
  
 
 
 
 
 
   
  
         
 Results 
Fig.1 shows the cluster assignments for a representative RIF-1 tumor 
(Fig.1A) and the corresponding H&E image (Fig.1B) at 6d post-treatment.  
Fig.2 shows the total viable (V1+V2) and necrotic (N1+N2) tumor volumes 
pre- and post-irradiation as determined by the KM algorithm.  There was no 
significant change in KM total tumor volume (V1+V2+N1+N2) until after day 
6.  From day 8, there was a significant increase in viable and necrotic tissue, 
respectively.   Fig.3 shows the temporal evolution of the ADC in each tissue 
classification as well as the total tumor ADC.   
 Discussion 
The trend in increased total ADC prior to day 4 is consistent with previous 
observations, although the radiotherapy-induced ADC increase is less than 
values reported in studies using chemotherapy.1,2  An increase in ADC can 
result from an increase in the necrotic fraction of the tumor.  However, the 
increase in necrosis is not observed here until after day 8 (Fig.2).  In Fig.3, 
there is an increase in total ADC that occurs prior to the change in necrotic 
fraction.  This trend is driven by the increase in viable tissue ADC; the necrotic 
tissue ADC remains constant over this period.  In Fig.2, the viable tumor 
regrowth begins after day 6, with an increase in necrosis after day 8.  Note that 
after the initial increase, the viable ADC becomes constant from days 2 – 8 
until the point of viable tumor regrowth (day 8).  The decrease in viable ADC 
at day 10 is consistent with an increase in cell density.  These observations 
suggest that the early increase in total ADC is not due to a reduction in cell 
density, but instead may be a result of radiation-induced vasogenic edema. 
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